Our work, our stories, 2011-2012 by National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
N a t i o n a l  C e n t e r  f o r  E m e r g i n g  a n d  Z o o n o t i c  I n f e c t i o u s  D i s e a s e s
National Center for Emerging and Zoonotic Infectious Diseases
lucing K l e b s i e l l a  p n e u m o n i a e  | CDC Drug Service | Central line bloodstream infection | Chikungunya fever | Cholera | Chronic fatigue syndro 
r | C r y p t o c o c c u s  \ C r y p t o s p o r i d i u m  | Dengue fever | Diarrheal diseases | Eastern equine encephalitis | Ebola hemorrhagic fever | Ehrlichi< 
:tion | Equine morbillivirus | Flaviviruses | Filoviruses | Foodborne diseases | FoodNet | Food safety | G i a r d i a  | Glanders | Global migration 
s disease | Immigrant, refugee, and migrant health | Immunization safety | Japanese encephalitis | Junin virus | Kawasaki disease | K l e b s i  
>sa fever | Leptospirosis | Listeriosis | Lujo virus | Lyme disease | Lymphocytic choriomeningitis | Machupo virus | Marburg hemorrhagic fe 
o b a c t e r i u m  a b s c e s s u s  in  healthcare settings | National Healthcare Safety Network | N a e g l e r i a  f o w l e r i  | National Antim icrobial Resistani 
n diseases | Pseudocowpox | PulseNet | Puumala virus | Q  fever | Quarantine stations | Rabies | Raccoonpox | Rat-bite fever | Recreational v ,  
set Agent Program | Shiga toxin-producing E .  c o l i  \ S h ig e l l a  | Skunkpox | Slow virus | Smallpox | Squirrelpox | Tanapox | Tickbome encephalitis | Tula 
it  Reporting System (VAERS) | Vaccine safety | V i b r i o  v u l n i f i c u s  | Viral hemorrhagic fevers | Volepox | Waterborne diseases | West Nile vi 
e t o b a c t e r  infection | Actinomvcosfcj  Active Bacterial Core surveillance (ABCs) I Aerobic organisms I A1 Kumrah virus | Anaplasmosis | Anin 
iafety Level 4 laboratory | Bioter 
lucing K l e b s i e l l a  p n e u m o n i a e  | CE 
r | C r y p t o c o c c u s  \ C r y p t o s p o r i d i u i  
;tion | Equine morbillivirus | Fla 
s disease | Immigrant, refugee;
>sa fever | Leptospirosis | Listerio
re^r
Y ou c a n  d o w n lo a d  a n d  p r in t  
NCEZID: Our Work, Our Stories 2011-2012 
at w w w . c d c . g o v / n c e z i d / 2 0 1 1 - 2 0 1 2 - r e p o r t  , 
an  in d e x e d  s ite  w h e r e  y o u  ca n  
q u ic k ly  f in d  s ta te -  a n d  to p ic - s p e c if ic  in fo r m a t io n .
norrhagic fever | Botulism | Bov 
Cholera | Chronic fatigue syndro 
)la hemorrhagic fever | Ehrlichic 
l i a  | Glanders | Global migration 
virus | Kawasaki disease | K l e b s i  
virus | Marburg hemorrhagic fe1
o b a c t e r i u m  a b s c e s s u s  in  healthca 'Su.iings | ivauu iu i iiu u u iu u l J iiL iy  in liw u ir  | I ' m t g w u u  jiuw e /rfN a tiona l Antim icrobial Resistani 
n diseases | Pseudocowpox | PulseNet | Puumala virus | Q  fever | Quarantine stations | Rabies | Raccoonpox | Rat-bite fever | Recreational w 
set Agent Program | Shiga toxin-producing E .  c o l i  \ S h ig e l l a  | Skunkpox | Slow virus | Smallpox | Squirrelpox | Tanapox | Tickborne encephalitis | Tula 
it  Reporting System (VAERS) | Vaccine safety | V i b r i o  v u l n i f i c u s  | Viral hemorrhagic fevers | Volepox | Waterborne diseases | West Nile vi 
\ e t o b a c t e r  infection | Actinomycosis | Active Bacterial Core surveillance (ABCs) | Aerobic organisms | A1 Kumrah virus | Anaplasmosis | Anin 
;afety Level 4 laboratory | Bioterrorism preparedness | Blood, organ, and other tissue safety | Bolivian hemorrhagic fever | Botulism | Bov 
lucing K l e b s i e l l a  p n e u m o n i a e  | CDC Drug Service | Central line bloodstream infection | Chikungunya fever | Cholera | Chronic fatigue syndro 
r | C r y p t o c o c c u s  \ C r y p t o s p o r i d i u m  | Dengue fever | Diarrheal diseases | Eastern equine encephalitis | Ebola hemorrhagic fever | Ehrlichi< 
:tion | Equine morbillivirus | Flaviviruses | Filoviruses | Foodborne diseases | FoodNet | Food safety | G i a r d i a  | Glanders | Global migration 
s disease | Immigrant, refugee, and migrant health | Immunization safety | Japanese encephalitis | Junin virus | Kawasaki disease | K l e b s i  
ssa fever | Leptospirosis | Listeriosis | Lujo virus | Lyme disease | Lymphocytic choriomeningitis | Machupo virus | Marburg hemorrhagic fe 
o b a c t e r i u m  a b s c e s s u s  in  healthcare settings | National Healthcare Safety Network | N a e g l e r i a  f o w l e r i  | National Antim icrobial Resistani 
n diseases | Pseudocowpox | PulseNet | Puumala virus | Q  fever | Quarantine stations | Rabies | Raccoonpox | Rat-bite fever | Recreational w 
set Agent Program | Shiga toxin-producing E .  c o l i  \ S h ig e U a  | Skunkpox | Slow virus | Smallpox | Squirrelpox | Tanapox | Tickbome encephalitis | Tula
f  "Waterborne diseases | West Nile vi
Suggested Citation: Centers for Disease Control and Prevention (CDC).
i t  Reporting System (VAERS) 
. e t o b a c t e r  infection | Actinomyco: 
iafety Level 4 laboratory | Bioter
National Center for Emerging and Zoonotic Infectious Diseases: our work, our 
stories, 2011-2012. Atlanta, GA: CDC; 2013.
mrah virus | Anaplasmosis | Anin 
Tiorrhagic fever | Botulism | Bov
lucing K l e b s i e l l a  p n e u m o n i a e  | CDC Drug Service | Central line bloodstream infection | Chikungunya fever | Cholera | Chronic fatigue syndro 
r | C r y p t o c o c c u s  \ C r y p t o s p o r i d i u m  | Dengue fever | Diarrheal diseases | Eastern equine encephalitis | Ebola hemorrhagic fever | Ehrlichic 
:tion | Equine morbillivirus | Flaviviruses | Filoviruses | Foodborne diseases | FoodNet | Food safety | G i a r d i a  | Glanders | Global migration
NCEZID: Our Work, Our Stories 2011-2012
— T a b l e  o f  C o n t e n t s  —
In troduction .....................................................................................................................................ii
About our name................................................................................................................ .................ii
Letter from the Director.................................................................................................... ................ 1
Guarding against the gamut of infectious diseases— NCEZID's seven divisions................. .................3
About our partners........................................................................................................... .................8
NCEZID 2011- 2012: Highlighted accomplishments........................................................... .................9
[ Our m any ro le s ........................................................................................................... ................13
Supporting CDC's infectious disease mission by...
Responding to outbreaks ............................................................................................. ............... 13
Providing laboratory science.......................................................................................... .............. 24
Improving public health preparedness .............. 30
Extending our reach around the globe............................................................................ .............. 35
Securing state, local, and tribal capacity........................................................................ ............... 43
Investigating how diseases from animals are spread to people........................................ .............. 51
[ Taking a c tio n ............................................................................................................... ................59
Supporting the prevention of infectious disease by focusing on...
Healthcare-associated infections ..................................................................................... ............... 59
Antimicrobial resistance..................................................................................................... ............... 64
Foodborne diseases and food safety.................................................................................. ............... 69
Vector-borne diseases........................................................................................................ ............... 73
Highly pathogenic organisms............................................................................................ ............... 78
Global migration and quarantine....................................................................................... ............... 82
Waterborne diseases and water safety............................................................................ .............. 86
[ NCEZID in the public e y e ........................................................................................................93
NCEZID in the media 93
Science is not just for scientists anymore........................................................................ .............. 94
A winning strategy to make a measurable impact.......................................................... .............. 95
Emerging Infectious Diseases.......................................................................................... ............... 96
Key publications............................................................................................................ .............. 97
CDC responds to multistate outbreak of fungal meningitis............................................. .............. 99
[ Our o rg a n iz a tio n ...................................................................................................................100
NCEZID organization chart................................................................................................. ............. 100
Fact check.......................................................................................................................... ............. 101
NCEZID budget.................................................................................................................. ............. 102
In d e x .............................................................................................................................. ............104
Table o f Contents
NCEZID: Our Work, Our Stories 2011-2012
▲ Courtesy Olaf Hajek
A b o u t  o u r  n a m e
In fectious diseases are illnesses caused by germs (such as bacteria, viruses, and fungi) that enter the 
body, multiply, and can cause an infection.
• Some infectious diseases are contagious (or communicable), that is, spread from one person to another.
• Other infectious diseases can be spread by germs carried in air, water, food, or soil. They can also ue spread uy 
vectors (like biting insects) or by animals.
Em erging means infections that have increased recently or are threatening to increase in the near future. 
These infections could be
• completely new (like SARS).
• reappearing in an area (like dengue in south Florida).
• old infections that have become resistant to antibiotics (like staph and the deadly gram-negative infections 
that are cropping up in hospitals).
Zoonotic  means infectious diseases of animals that are spread to humans by ticks, mosquitoes, or fleas or 
contact with animals; these diseases include
• Lyme disease (spread by ticks).
• West Nile virus disease (spread by mosquitoes).
• rabies (spread by mammals).
ii About our name
L e t t e r  f r o m  t h e  D i r e c t o r
For the National Center for Em erging and Zoonotic Infectious Diseases 
(NCEZID), the past 2 years have presented wide-ranging challenges as well 
as exciting new opportunities to m aximize the health o f people both in the 
United States and abroad. The Center’s work during that period is bracketed 
by our response to large and devastating outbreaks— from  cholera in Haiti in 
fall 2010 to West Nile virus disease and fungal m eningitis that spread across 
the country in the sum m er and fall o f 2012. Guided by the Center’s vision to 
“prevent infections, protect people, save lives,” we have m ade notable progress 
on many fronts in dim inishing the burden o f infectious disease.
National Center for Emerging and Zoonotic Infectious Diseases: Our Work, Our Stories 
2011-2012 serves several purposes. First, it highlights m ajor accomplishments from  fiscal 
years 2011 and 2012 (October 1, 2010-Septem ber 30, 2012). NCEZID is CDC’s newest national 
center, created during the organizational improvement initiative o f 2009-2010. One of our 
overarching principles is to be transparent and accountable, and this first report (known by 
the shorter title NCEZID: Our Work, Our Stories 2011-2012) signals that we are committed to 
providing regular updates about our progress in protecting people from  emerging and zoonotic 
infectious diseases. And finally, NCEZID: Our Work, Our Stories 2011-2012 places NCEZID’s 
accomplishments in the context o f the larger public health m issions o f CDC and the Office of 
Infectious Diseases.
NCEZID’s work overall directly reflects current CDC priorities to strengthen surveillance and 
epidemiology, enhance the agency’s ability to support state and local public health, provide 
leadership in global health, promote effective public health policy, and address the leading 
causes o f death, illness, and disability. And, as home to two of seven o f CDC’s domestic 
“winnable battles” (healthcare-associated infections and food safety), NCEZID is developing 
scalable strategies that will have a m easurable and significant im pact on public health. NCEZID:
Our Work, Our Stories 2011-2012 also shows how NCEZID priorities and achievements align 
with the principles guiding all infectious disease work throughout the agency, as described in 
A CDC Framework_ for Preventing Infectious Diseases: Sustaining the Essentials and Innovating 
for the Future. And, lastly, the review o f achievements o f the past 2 years helped inform  the 
direction for the Center’s future work, as outlined in the newly released National Center for 
Emerging and Zoonotic Infectious Diseases Strategic Plan, 2012-2017.
The prevention and control o f em erging and zoonotic infectious diseases is arduous work, but 
we have m ade great strides since the fall o f 2010. To provide a context for better understanding 
the significance o f these accomplishments, this report begins with a section identifying 
NCEZID’s core value to CDC and public health overall. Our many roles delineates the parts 
o f the broader agency infectious disease m ission that NCEZID is responsible for m aking 
happen— responding to outbreaks, m anaging world-class laboratories, ensuring public health 
preparedness, overseeing a unique portfolio o f global activities, and investigating how diseases 
from  anim als are spread to people.
Continued on next page ►
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These roles direct action on a variety o f fronts. Taking action details the Center’s work that 
focuses on healthcare-associated infections, antimicrobial resistance, foodborne disease 
and food safety, vector-borne diseases, high-consequence pathogens, global quarantine and 
migration, and waterborne disease and water safety. Most, but not all, o f the Center’s work 
falls within one o f these areas. Absence from  this report, however, does not signify lack of 
importance. NCEZID: Our Work, Our Stories 2011-2012 is not a comprehensive sum m ary o f all 
Center activities o f the past 2 years. Limited space dictates that it is more like a highlight reel of 
our m ost notable accomplishments.
NCEZID is comm itted to m axim izing health by preventing and controlling em erging and 
zoonotic infectious diseases even in the face o f projected economic constraints. That means 
finding better ways to perform  world-class science; translate and communicate results in an 
accurate, timely, and effective manner; and promote fiscal and program  efficiencies. Enhancing 
our ever-expanding extensive network o f partnerships, both inside and outside CDC, is also 
critical to ensuring that more lives here and around the world are saved. Looking ahead, we will 
continue to strive and, when possible, redouble efforts to meet high-priority goals— expanding 
our portfolio o f work on antimicrobial resistance, exploring innovative new approaches for 
detecting pathogens and diagnosing diseases, strengthening our foodborne disease surveillance 
and response capabilities, and bolstering the nation’s preparedness for emerging infectious 
disease threats, to name ju st a few. Woven throughout all the work we do is our commitment 
to promote health equity, that is to identify ways we can reduce infectious disease disparities in 
vulnerable populations with distinct needs, such as racial and ethnic minorities, im m igrants, 
and people who are economically disadvantaged.
But as we usher in a new year, NCEZID will be guided by a new strategic plan that has identified 
the essential activities and services related to the Center’s m ission that m ust be sustained— and 
where possible advanced— in the 5 years ahead. We in the NCEZID Office o f the Director 
also understand that finding new and better ways to champion the professional growth and 
development o f our close to 1,900-member workforce is inextricably linked to our success in 
reducing illness and death from  infectious disease.
On behalf o f the extraordinarily dedicated and talented staff o f the National Center for 
Em erging and Zoonotic Infectious D iseases, I am  pleased to present NCEZID: Our Work, Our 
Stories 2011-2012, a report o f our accomplishments and activities during the past 2 years.
Beth P. Bell, MD, MPH 
Director,
National Center for Em erging and Zoonotic Infectious Diseases 
January 2013
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G u a r d i n g  a g a i n s t  t h e  g a m u t  o f  i n f e c t i o u s  
d i s e a s e s —  N C E Z I D ' s  s e v e n  d i v i s i o n s
NCEZID is made up of seven divisions that work with partners throughout the United States and around the world 
to prevent illness, disability, and death caused by a wide range of infectious diseases— from the rare but deadly, 
like anthrax and Ebola hemorrhagic fever, to the more common, like foodborne disease and healthcare-associated 
infections. Because the diverse workforces of these seven divisions include an equally broad spectrum of infectious 
disease expertise, we are better able to identify mysterious— and sometimes very lethal— illnesses, contain 
outbreaks that sometimes span many states, and save lives.
Some of the challenges NCEZID’s seven divisions face daily include
• Foodborne illness. One in six Americans gets sick each year from eating contaminated food. Illnesses caused 
by Salmonella and E. coli infections are costly and all too common.
• Healthcare-associated infections. At any given time, about 1 in every 20 patients has an infection related to 
their hospital care. Infections are popping up in hospitals, nursing homes, and other healthcare settings, like 
dialysis centers.
• Antimicrobial resistance. Methicillin-resistant Staphylococcus aureus 
(MRSA) is one of the more familiar types of antimicrobial-resistant 
infections, but many others are rapidly spreading in hospitals, the 
community, and even on the farm.
• Deadly diseases. Germs that cause smallpox, anthrax, rabies,
Ebola hemorrhagic fever, and plague require 24/7 vigilance, 
especially because of the threat of bioterrorism.
• Illnesses that affect immigrants, refugees, 
migrants, expatriates, and travelers. Travelers 
can unknowingly pick up— and return 
with— infectious diseases, even some that we 
thought were no longer a threat, like measles.
• Diseases spread by mosquitoes, ticks, and 
fleas. Each year, scientists discover, on average, 
about two new mosquito-transmitted viruses 
that can make people sick.
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T h e  C e n t e r ' s  s e v e n  d i v i s i o n s
D i v i s i o n  o f  F o o d b o r n e ,  W a t e r b o r n e ,  
a n d  E n v i r o n m e n t a l  D i s e a s e s
Focus:
To prevent diseases caused by contaminated food or water or by
animal contact, and detect and contain fungal infections.
Some key activities:
• Conduct surveillance of foodborne illnesses to track trends, 
identify risk factors, define the burden, find new drug resistance, 
and attribute illnesses to specific foods.
• Quickly detect, investigate, and control foodborne outbreaks, 
including those spanning multiple states like the outbreak of 
Listeria in cantaloupes that involved 28 states.
▲ CDC works to prevent diseases caused 
by contaminated food and water 
and dangerous fungal infections, 
usually found in soil. But in fall 2012, 
fungal-contaminated steroid injections 
caused a multistate outbreak of fungal 
meningitis and other infections .
• Direct work in global water, sanitation, and hygiene (WASH)-related disease to identify new ways to reduce 
diarrheal diseases, such as cholera and typhoid.
• Use new communication and outreach to keep our domestic drinking water, swimming pools, lakes, and other 
water sources safe.
• Detect domestic and global fungal threats, such as candidiasis, cryptococcosis, and mucormycosis, so that they 
can be quickly contained before causing harm.
http://www.cdc.gov/ncezid/dfwed/
CDC's Thomas George uses a Jacob's ladder 
to conduct an offshore boarding of a vessel 
with US Coast Guard and Customs and Border 
Protection partners . Courtesy Gale Galland
D i v i s i o n  o f  G l o b a l  M i g r a t i o n  a n d  Q u a r a n t i n e
Focus:
To protect the health of our communities in a globally mobile world by preventing the introduction,
transmission, and spread of communicable diseases.
Some key activities:
• Manage programs to screen, diagnose, treat, and prevent infectious diseases in immigrants 
and refugees.
• Partner for health at airports, seaports, and land borders.
• Provide vital health information to help international travelers stay healthy before, during, 
and after their trips.
• Promote the safe importation of animals and animal products through enforcement of regulations.
• Respond to global public health emergencies to slow the introduction and spread of illness to US 
communities— for example, cholera in Haiti, the radiation disaster in Japan, H1N1 pandemic flu, 
and tuberculosis outbreaks near the US-Mexico border.
http://www.cdc.gov/ncezid/dgmq/
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D i v i s i o n  o f  H e a l t h c a r e  Q u a l i t y  P r o m o t i o n
Focus:
To protect patients and healthcare workers and to promote safety in healthcare settings.
Some key activities:
• Investigate and respond to emerging infections and adverse events in healthcare facilities, 
including healthcare-associated infections; antimicrobial drug-resistant infections; 
adverse events from the use or misuse of a drug (like accidental overdoses); blood, organ, 
and tissue safety; and vaccine safety.
• Support the enhancement of state infrastructure for elimination of healthcare-associated 
infections.
• Develop and disseminate evidence-based guidelines and recommendations to prevent and 
control healthcare-associated infections, antimicrobial resistance, and medication errors.
• Provide healthcare facilities, states, and federal agencies with data for action through 
the National Healthcare Safety Network (NHSN), a tool for monitoring and preventing 
healthcare-associated infections, used by healthcare facilities in all 50 states.
http://www.cdc.gov/ncezid/dhqp/
▲ Healthcare-associated infections are also a problem 
for the millions of older adults living in nursing homes 
and assisted living facilities.
D i v i s i o n  o f  H i g h - C o n s e q u e n c e  P a t h o g e n s  a n d  P a t h o l o g y
Focus:
To improve public health and safety domestically and globally by preventing illness and death caused by highly 
lethal or unexplained diseases.
Some key activities:
• Monitor, investigate, and study diseases caused by highly hazardous bacteria and viruses— such as those that 
cause anthrax and viral hemorrhagic fevers (like Ebola in Africa).
• Investigate wildlife zoonoses and find new ways to prevent zoonotic 
infections (like rabies and leptospirosis) that spread from animals to people.
• Conduct investigations of unexplained critical illness and death and 
diseases of unknown origin and efforts to uncover new infectious diseases. 
This work contributed to the identification of SARS and hantavirus 
pulmonary syndrome.
• Develop better and faster diagnostic tests that help us improve our 
understanding of the impact of vaccines on human papillomavirus infection.
• Track specific prion diseases (diseases that attack the brain and central 
nervous system), such as Creutzfeldt-Jakob disease.
• Implement educational campaigns and outreach efforts on chronic fatigue 
syndrome, including diagnosis and intervention recommendations for 
physicians and coping/management options for patients.
http://www.cdc.gov/ncezid/dhcpp/
▲ In 2012, 10 confirmed cases of 
hantavirus infection were reported 
in people who had recently visited 
Yosemite National Park. Infection 
was caused by exposure to 
hantavirus-infected rodents such 
as deer mice (pictured).
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D i v i s i o n  o f  P r e p a r e d n e s s  a n d  E m e r g i n g  I n f e c t i o n s
Focus:
To assure that the public health system can detect and respond to infectious disease threats, with a special focus on 
emerging pathogens, biological warfare agents, and the diseases that are of particular concern to people living in 
Alaska and other Arctic regions.
Some key activities:
• Help prepare CDC and its partners to use vaccines, drugs, and diagnostic 
tests— countermeasures that would be critically important to saving lives during a 
large-scale public health emergency caused by bioterrorists.
• Collaborate with public health laboratories throughout the world to implement the 
quality standards necessary for effective disease detection and successful partnerships.
• Serve as an effective steward for the Emerging Infections Program and the 
Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement 
to support infectious disease epidemiologic investigations, laboratory infrastructure 
and expertise, and surveillance for state and local health departments.
• Manage the Laboratory Response Network, which links 160 highly specialized 
laboratories, including health department laboratories, federal and military 
laboratories, environmental testing and diagnostic veterinary laboratories, as well as 
international laboratories. This unique network of laboratories is designed to respond 
to bioterrorism, chemical terrorism, and other public health emergencies.
• Target diseases that are a special problem for Alaska Natives, such as viral hepatitis and 
foodborne botulism.
http://www.cdc.gov/ncezid/dpei/
Preparing CDC and its partners to use vaccines, drugs, 
and diagnostic tests would be critically important to 
saving lives during a public health emergency, such as 
the release of a biological agent like Bacillus anthracis, 
which causes anthrax
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D i v i s i o n  o f  S c i e n t i f i c  R e s o u r c e s
Focus:
To provide support to CDC laboratories in responding to public health
needs through the supply of state-of-the-art technology and high-quality
services and products.
Some key activities:
• Provide genomic sequencing, proteomics technologies, oligonucleotide 
and peptide synthesis, and bioinformatic support to aid the identification 
and characterization of bacteria, viruses, fungi, and other pathogens.
• Provide CDC laboratorians with high-quality laboratory products 
and services in compliance with US Food and Drug Administration 
regulations.
• Distribute investigational and licensed drugs and unique biologicals 
(antitoxins) to approved physicians for treatment of rare, tropical, or 
exceptional diseases.
• Provide accessioning services for specimens sent to CDC for reference 
and diagnostic testing and manage shipment of outgoing specimens, 
microbiologic organisms, and biologicals.
http://www.cdc.gov/ncezid/dsr/
▲ Providing laboratorians throughout CDC with state-of-the-art
technology and high-quality products that they need to do their work.
D i v i s i o n  o f  V e c t o r - B o r n e  D i s e a s e s
Focus:
To identify and respond to vector-borne disease that affects human health, domestically and globally.
Some key activities:
• Identify and respond to emerging and newly discovered pathogens.
• Improve diagnostic tests and serve as a reference laboratory for 
vector-borne pathogens.
• Investigate improvements to pesticides and repellents that target 
mosquitoes, ticks, and fleas.
• Develop and evaluate vaccines for dengue, Japanese encephalitis, 
and other vector-borne viruses and bacteria.
• Train domestic and global public health workers to prevent, 
diagnose, and control vector-borne diseases.
• Conduct surveillance and monitor impact and spread of vector- 
borne diseases.▲ Checking dog's ears for ticks during an 
outbreak of Rocky Mountain spotted fever. 
Courtesy Craig Manning http://www.cdc.gov/ncezid/dvb d/
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A b o u t  o u r  p a r t n e r s
We would be able to accomplish little without the help of our many partners. We don’t have enough space to list 
them all, but here are a few examples of notable work that would not have happened without their contributions:
/  t • The September 2011 outbreak of listeriosis, the deadliest foodborne outbreak
y ' ’■ in nearly a century, was linked to a single cantaloupe farm in Colorado and is a
™ textbook example of how coordinated public health partnerships save lives. It is
estimated that up to twice as many people would have been infected had it not 
been for the quick work of alert Colorado public health officials, CDC’s PulseNet 
'.Et laboratory analysis, and the US Food and Drug Administration’s trace-back 
investigation. The outbreak was detected, its source identified, and a national 
W \ warning issued— all in just a matter of days.
• Although human rabies has been virtually eliminated in the United States, globally 
the disease kills more than 55,000 people each year, mostly children, usually 
from dog bites. The Center’s rabies group works closely with partners such as the 
World Health Organization and is engaged in several international collaborations, 
including an award-winning grassroots rabies control project in the Philippines. 
Despite major obstacles to rabies control in resource-poor countries, NCEZID 
has outlined steps for a way forward to work with partners to eradicate this 
horrific— and highly preventable— disease.
• Epidemic cholera emerged in Haiti in October 2010, and the disease spread rapidly 
throughout the country, sickening more than half a million people. NCEZID experts 
worked closely with many partners— including colleagues from CDC’s Center for 
Global Health and other US agencies, the World Health Organization, international 
governments, and nongovernmental organizations— in an international response 
to assist Haiti. The effort is estimated to have saved at least 7,000 lives. NCEZID 
continues to focus on ways to improve water, sanitation, and hygiene systems as 
part of a strategy to prevent cholera-related illness and deaths in Haiti.
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N C E Z I D  2 0 1 1 -  2 0 1 2 :  
H i g h l i g h t e d  a c c o m p l i s h m e n t s
• Reported substantial decreases in healthcare-associated infections. (pg 61)
• Developed one of the first dengue candidate vaccines to enter human clinical trials 
that will, if trials are successful, protect people from all four dengue viruses. (pg 75-76)
• Developed and disseminated a rapid, inexpensive bedside diagnostic dipstick test to
reduce the time and cost of diagnosing plague. (pg 25)
• Integrated hygiene education into antenatal care clinics in Malawi that will help 
to improve hygiene to reduce illness and disease from diarrhea and other diseases 
transmitted through water. (pg 88)
r i B i r'' • A j '
• Published the first estimates of foodborne illness in a decade that also included 
estimates for hospitalizations and deaths caused by these illnesses. This complex 
analysis included 31 pathogens known to cause foodborne illness and unspecified 
agents that cause acute gastroenteritis illnesses. (pg 71)
• Developed a highly effective natural repellent and insecticide against mosquitoes 
and ticks and licensed it to commercial partners to develop products for consumer 
purchase. (pg 74)
• Completed successful trials for a vaccine against Rift Valley fever, an acute fever- 
causing viral disease, for use in livestock. Vaccinating livestock will eliminate one of the 
most significant sources of Rift Valley fever in people living in Africa and the Arabian 
Peninsula. (pg 79)
• Initiated an emergency response to a multistate outbreak of fungal meningitis 
and other infections among patients who received contaminated steroid injections; 
worked closely with state and local health departments to track down and contact more 
than 14,000 exposed patients; issued clinical diagnostic and treatment guidance; and 
rapidly developed a new laboratory test to help diagnose these infections. This effort 
illustrates the power of public health in action—  quickly detecting a serious health 
problem, alerting the public, and leading a targeted response—  to protect the country 
from infectious disease threats. (pg 99)
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N C E Z ID  2 0 1 1 -  2 0 1 2 :  H i g h l i g h t e d  a c c o m p l i s h m e n t s ,  c o n t i n u e d
Following CDC's guidance, healthcare workers at a clinic in a refugee camp 
in Thailand watch to make sure that refugees with tuberculosis are taking 
their medicine before they come to the United States.
In collaboration with the Colorado Department of Public 
Health and Environment, quickly responded to a deadly 
outbreak of listeriosis in cantaloupes. The numbers of 
cases and deaths would have been 25% higher without this 
timely, effective public health intervention. (pg 71)
Saved state public health departments millions of dollars 
' , ' tuberculosis screening and treatment
of immigrants and refugees prior to their arrival in the 
United States.(pg 84)
Identified three new strains of germs that are difficult 
to treat because they have high levels of resistance to 
antibiotics. Better understanding of this family of germs, 
called carbapenem-resistant Enterobacteriaceae (or CRE), will 
help us more effectively diagnose and treat them. (pg 66)
Provide healthcare facilities, states, and federal agencies with data for action through the 
National Healthcare Safety Network (NHSN), a tool for monitoring and preventing healthcare- 
associated infections, used by healthcare facilities in all 50 states. (pg 62)
Investigated and provided laboratory testing through the Laboratory Response Network 
(LRN) for a case of inhalation anthrax in Minnesota. The LRN helps to quickly detect and respond 
to acts of chemical and biological terrorism and other 
high-priority public health emergencies. (pg 34)
Released A Public Heath Action Plan to Combat
Antimicrobial Resistance in collaboration with 
the federal Interagency Task Force on Antimicrobial 
Resistance. (pg 67)
Discovered two new tick-borne pathogens in the
United States. Further research into these pathogens 
will help us better understand their role in human 
illness and how to decrease it.(pg 75)
▲ A new Ehrlichia species was one of the two new tick- 
borne pathogens discovered . It causes ehrlichiosis, a 
bacterial disease commonly transmitted to people by 
the bite of an infected lone star tick (pictured) .
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The 1,000 or more foodborne 
outbreaks that are reported 
annually reveal familiar culprits, 
like Salmonella .
N C E Z ID  2 0 1 1 -  2 0 1 2 :  
H i g h l i g h t e d  a c c o m p l i s h m e n t s ,  c o n t i n u e d
• Improved methods to more quickly detect and respond to 
multistate outbreaks of foodborne " ' " help us 
respond even faster to future outbreaks. (pg 71)
• Worked in collaboration with Oxford University Press to develop 
a mobile app of CDC Health Information for International 
Travel2012 (The Yellow Book). This collaboration demonstrates 
the benefits of public-private partnerships. (pg 84)
• Reported that higher rates of "water-washed disease,"
caused by inadequate hand or body hygiene, are linked directly 
to an inadequate supply of clean water in rural Alaska Native 
households. Better understanding of the health impact of the 
lack of running water in nearly one-quarter of rural Alaska Native 
homes is the first step in reducing disease. (pg 46)
CDC's laboratories at Fort Collins, Colorado, 
helped develop vaccines to prevent dengue . 
Courtesy Judith Lavelle ►
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CDC responded to an outbreak of dengue in the Marshall Islands. Here a 
rapid diagnostic test that detects the presence of dengue virus in people 
with dengue-like symptoms is being demonstrated. Courtesy Tyler M. Sharp
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O u r  m a n y  r o l e s
S u p p o r t i n g C D C s  i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
R e s p o n d i n g  t o  o u t b r e a k s
CDC plays a critical role in the investigation of local, state, national, and international outbreaks of 
diseases, such as a group of people who get sick from contaminated food or a cluster of hospitalized 
patients acquiring an infection. Since 1946, CDC has provided rapid assistance to states, federal 
agencies, international organizations, and ministries of health, often through formal requests for 
epidemic-assistance investigations, called Epi-Aids. The Epi-Aid mechanism provides CDC with the 
agility to respond rapidly to serious and urgent public health crises, and NCEZID conducts more 
Epi-Aid investigations of outbreaks each year than any other Center at CDC. From October 2010 to 
September 2012, we responded to more than 100 Epi-Aid requests (domestic and worldwide) for 
assistance with outbreaks of infectious diseases.
NCEZID responds to outbreaks of infectious diseases at the request of a state health department 
or other countries. We work in close collaboration with the health department to ensure a rapid 
and coordinated investigation and response. We augment varied state and local capacity through 
technical assistance, epidemiologic investigation, and laboratory support. NCEZID experts are 
also involved when the source of infection is very uncommon, new, or complex. For example, 
we recently identified a new tick-borne pathogen, an Ehrlichia muris-like agent, in Missouri in 
collaboration with the state health department. We seek to identify and stop emerging problems 
before they can spread and endanger public health.
Outbreaks often cross state borders. In these instances, NCEZID leads coordination across health 
departments, including communication and epidemiologic investigation, to enable more rapid 
identification and elimination of the source of disease during an outbreak. Our response to an 
outbreak does not end once the source of the outbreak has been identified and stopped. We use the 
information gathered during the investigation to work with health departments, partners, other 
federal agencies, and policymakers to implement strategies to prevent future outbreaks. NCEZID’s 
response to outbreaks of infectious disease along with a thoughtful evaluation of strategies to 
prevent further outbreaks continues to improve public health.
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S e l e c t e d  N C E Z I D  E p i - A i d  i n v e s t i g a t i o n s ,  
U n i t e d  S t a t e s ,  2 0 1 0 - 2 0 1 2
MA
RequestedEpi-Aid
Requested Epi-Aid that involved more than one state
No Epi-Aid requested
Selected NCEZID Epi-Aid investigations, United States, October 2010-September 2012
State
AL Investigation of an outbreak of a bacterial infection (Serratia spp. bacteremia) in patients being fed through an IV
AK Investigation of an outbreak of CA-MRSA (community-associated methicillin-resistant Staphylococcus aureus) skin infections in the Yukon-Kuskokwim Delta region
AZ Investigation of a cluster of cases of a suspected, rare disorder (Guillain-Barre syndrome) in residents of the border area of Arizona and Sonora, Mexico
AZ Evaluation of dogs as indicators for human risk for tick-borne disease (Rocky Mountain spotted fever)1
AZ Evaluation of a tick-borne disease (Rocky Mountain spotted fever) prevention program on the San Carlos Apache Reservation2
AZ Multistate investigation of suicide among Bhutanese refugees in the United States
AZ Multistate assessment of risk for a tick-borne disease (Rocky Mountain spotted fever) in the Navajo Nation3
AZ Investigation of a fatal case of a tick-borne disease (Rocky Mountain spotted fever) and a dog serosurvey (blood survey) in the Hopi Tribe4
AZ Survey of a dog serosurvey (blood survey) in the Tohono O'odham Nation1
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Selected NCEZID Epi-Aid investigations, United States, October 2010-September 2012
State
AR Investigation of an outbreak of foodborne illness (from Salmonella) at two prisons
CA Investigation of human rabies
CA Investigation of hantavirus pulmonary syndrome (a sometimes deadly disease spread by infected mice and rats) in visitors to Yosemite National Park
CA Multistate evaluation of the mental and physical health of Iraqi refugees resettled in the United States
CA Multistate investigation of fungal eye infections after eye surgery
CO Investigation of an outbreak of foodborne illness (from Listeria) among pregnant women exposed to contaminated cantaloupe
CO Investigation of a cluster of invasive pneumococcal disease, which can result in pneumonia or other serious infections, in an assisted living facility
CO Investigation of an outbreak of healthcare-associated infections (from Clostridium difficile) in pediatric cancer patients
CO Multistate assessment of risk for a tick-borne disease (Rocky Mountain spotted fever) in the Navajo Nation3
DC Multistate investigation of an outbreak of bacterial infections (from Salmonella Bareilly)
DC and 
international
Multistate investigation of a suspected cluster of venous thromboembolism (VTE) and pulmonary 
embolism (PE), which may be life-threatening, among government workers
FL Investigation of an outbreak of drug-resistant bacterial infections (carbapenem-resistant Klebsiella pneumoniae) in a long-term acute care hospital
FL Investigation of a tuberculosis outbreak associated with homelessness
FL Investigation of a cluster of surgical site infections in patients undergoing heart surgery
FL Investigation of an outbreak of bacterial infections (Legionnaires' disease) associated with travel on a cruise ship
GA Investigation of an increase in the number of eye infections caused by Acanthamoeba keratitis
GA Investigation of hepatitis C infections at an outpatient facility
GA Assessment of the need for rabies treatment after exposure to a bat during an airline flight
GA Investigation of an outbreak of bacterial infections (from group A Streptococcus) among residents of a nursing home
GA Investigation of a viral infection (lymphocytic choriomeningitis virus) in mice shipped from a commercial facility
GA Multistate investigation of mosquito-borne disease (dengue) among Georgia and Nebraska travelers returning from Haiti
GA Multistate investigation of suicide among Bhutanese refugees in the United States
ID Evaluation of the mental and physical health of Iraqi refugees resettled in the United States
IL Investigation of human cowpox, a rare disease that usually resolves but occasionally causes death, in a laboratory researcher
IL Multistate survey of NICUs reporting to the National Healthcare Safety Network
KS Investigation of a cluster of bacterial infections (from Burkholderia cepacia) in patients in an acute care hospital
KY Assessment of potential human exposure to rabies from bats in the sleeping areas of a rural learning center
LA Investigation of an outbreak of bacterial infections (from Francisella novicida) among inmates at a prison
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Selected NCEZID Epi-Aid investigations, United States, October 2010-September 2012
State
MI Evaluation of the spread of and risk factors for a drug-resistant bacterial infection (from vancomycin- resistant Staphylococcus aureus) and its precursor organisms
MI Investigation of a bacterial infection in dogs (from Leptospira) and evaluation of public health risk among humans
MI Evaluation of community preparedness for emergencies
MI Multistate evaluation of the mental and physical health of Iraqi refugees resettled in the United States
MI and 
international
Multistate investigation of a group of wedding attendees who were possibly exposed to foodborne 
illness-causing bacteria (Listeria monocytogenes)
MN Investigation of a vitamin B12 deficiency in resettled Bhutanese refugees
MO Investigation of a cluster of cases of bacterial meningitis among patients at an outpatient clinic
MO Investigation of severe fungal soft tissue infections after a tornado
MO Investigation of an outbreak of E. coli O157 infections
MT Multistate investigation of an outbreak of bacterial infections (from Q fever) associated with a goat farm
NE Multistate investigation of mosquito-borne disease (dengue) among Georgia and Nebraska travelers returning from Haiti
NJ Investigation of rabies in humans
NM Multistate assessment of risk for a tick-borne disease (Rocky Mountain spotted fever) in the Navajo Nation3
NY Multistate investigation of suicide among Bhutanese refugees in the United States
NY Multistate investigation of the persistence of eye infections caused by Acanthamoeba keratitis following an outbreak of Acanthamoeba keratitis in 2007
OH Monitoring of human contacts and adverse health events associated with the distribution of a new oral rabies vaccine for wildlife
OR Multistate investigation of fungal infections (from Cryptococcus gattii) in the Pacific Northwest
PA Investigation of an outbreak of bacterial infections (from group A Streptococcus) in a skilled nursing facility
PA Investigation of infections with a new strain of influenza (H3N2)
RI Investigation of a cluster of bacterial infections (from Streptococcus pneumoniae) among children living at a psychiatric facility
SC Identification of opportunities to prevent people from exposure to rabies in residential structures
TX Investigation of an outbreak of bacterial infections (from Herbaspirillum spp.) in cancer patients
TX Investigation of an outbreak of West Nile virus infections
TX Evaluation of the impact of adult mosquito control during a West Nile virus outbreak
TX Multistate investigation of suicide among Bhutanese refugees in the United States
TX Multistate evaluation of the mental and physical health of Iraqi refugees resettled in the United States
TX and 
Kenya
Multistate assessment of the need for rabies treatment after exposure to a rabid zebra at a travel lodge
UT Investigation of pruno culture (homemade wine) in a prison and its association with botulism
UT Multistate assessment of risk for a tick-borne disease (Rocky Mountain spotted fever) in the Navajo Nation3
VA Investigation of intestinal tissue death (necrotizing entercolitis) in infants receiving feeding thickening agents
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Selected NCEZID Epi-Aid investigations, United States, October 2010-September 2012
State
WA Investigation of intestinal tissue death (necrotizing entercolitis) in infants receiving feeding thickening agents
WA Multistate investigation of fungal infections (from Cryptococcus gattii) in the Pacific Northwest
WA Multistate investigation of an outbreak of bacterial infections (from Q fever) associated with a goat farm
WV Investigation of a cluster of bloodstream infections (from Tsukamurella spp.) at an outpatient cancer clinic
Wl Multistate investigation of an outbreak of bacterial infections (from Salmonella Typhimurium) associated with exposure to microbiology laboratories
1 Epi-Aid investigation was requested by the Tohono O'odham Nation, a federally recognized tribe located in Arizona.
2 Epi-Aid investigation was requested by the San Carlos Apache Tribe, a federally recognized tribe  located in Arizona.
3 Epi-Aid investigation was requested by the Navajo Nation, a federally recognized tribe  located in Arizona, Colorado,
New Mexico, and Utah.
4 Epi-Aid investigation was requested by the Hopi Tribe, a federally recognized tribe  located in Arizona.
Investigation requests received by CDC's Emergency Operations Center
Multistate investigation of cholera cases in US residents associated with a wedding in the Dominican Republic 
Multistate investigation of the incidence of diarrhea in US medical personnel working with cholera patients in Haiti
Investigations requested by US territories and freely associated states
Territory
Marshall Islands Investigation of an outbreak of mosquito-borne disease (dengue)
Guam Assessment of communicable disease surveillance, including evaluation of surveillance in mobile populations
Puerto Rico Investigation of cases of a fatal bacterial infection (from Leptospira)
US Virgin Islands Investigation of an outbreak of gastrointestinal illness associated with a hotel
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“Controlling outbreaks is the m ost im m ediate  
w ay we p reven t disease and save lives"  
Benjamin Silk, Lt. Cmdr., US Public Health Service
Dr. Benjamin Silk presents key 
information on listeriosis in the 
aftermath of the large 2011 outbreak 
as part of the CDC Expert Commentary 
in Partnership with Medscape series. ►
B e n j a m i n  S i lk ,  C D C  d i s e a s e  d e t e c t i v e
Fresh out of college, Benjamin Silk served in the Peace Corps in El Salvador in the 1990s, working on rural water 
sanitation. Now Dr. Silk applies his idealism to his work at CDC, where he played a key role in CDC’s response 
to the deadliest foodborne disease outbreak in the United States in nearly a century. In 2011, a new source of 
Listeria infection— cantaloupe— was identified, and the outbreak stopped quickly. As tragic as this outbreak was 
(33 people died), swift and coordinated public health actions, starting in Colorado, saved lives.
Dr. Silk, who has 16 years of experience in public health disease tracking, investigation, and research as well as 
service as a CDC Epidemic Intelligence Service officer from 2008 to 2010 reflected, “This historic outbreak will 
also allow us to learn more about how to investigate Listeria, and especially how to prevent contamination of 
cantaloupes and other foods in the future. These lessons will be very valuable to the public health and regulatory 
officials who are working constantly to prevent Listeria outbreaks.”
18 Our many roles: Responding to outbreaks
NCEZID: Our Work, Our Stories 2011-2012
F i g h t i n g  a  r e a l - l i f e  " c o n t a g i o n "  in  t h e  M a r s h a l l  I s l a n d s
The whole thing unfolded as if it were a movie. An outbreak of dengue fever, the mosquito-borne illness that 
occurs in tropical climates. The setting— a small island chain in the Pacific. A local government requesting 
assistance to control the outbreak. Tyler M. Sharp, Epidemic Intelligence Service (EIS) officer at the CDC Dengue 
Branch, was assigned to head to the middle of the Pacific (4/ hours by plane west of Honolulu) and remembers 
thinking, “I certainly didn’t want to end up like Kate Winslet’s character in the Hollywood blockbuster Contagion’.’
There was lurking concern about the possibility of dengue activity in the Marshall Islands, so sporadic testing of 
patients with fever was being done using rapid diagnostic tests for dengue. Indeed, the outbreak began with three 
children showing up in a hospital in Majuro, the capital of the Republic of the Marshall Islands, with the same 
symptoms: fever, headache, and body pain. The astute clinical team who attended all three children connected the 
dots, “This is dengue.” Positive rapid tests on these children launched recognition of the outbreak and triggered the 
response. By the time the CDC team arrived in Majuro, the city teemed with dengue. Mosquito experts from CDC 
surveyed the local community and found mosquitoes that transmit dengue virus everywhere they looked.
CDC, along with the US Department of Defense; the World Health Organization; the Department of State and 
USAID; governments of Taiwan, Japan, and Australia; and the local government and community worked together 
on many fronts. Local healthcare professionals were 
trained in best methods to diagnose and treat dengue.
Surveillance was established to identify cases throughout 
the island-country that extends 1,000 miles from the 
northernmost to southernmost point. Teams began 
wide-scale mosquito control efforts to reduce, and where 
possible, eliminate mosquito-producing sites in the two 
major population centers of Majuro and Ebeye. As it 
turned out, not only did EIS officer Sharp survive, but so 
did each of the nearly 1,300 people who had come down 
with dengue during the roughly 2-month-long outbreak.
▲ To keep dengue patients in an area where nurses and doctors could keep 
a close eye on them, a dengue ward was established in what had been the 
gym in Majuro Hospital. Hospitalized patients were asked to stay under 
mosquito nets to prevent mosquitoes from feeding on them, an attempt to 
reduce the risk of hospital workers and other patients becoming infected. 
Courtesy Tyler M. Sharp
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T o r n a d o  s u r v i v o r s  b a t t l e  d e a d l y  f u n g u s  in  J o p l i n ,  M i s s o u r i
On May 22, 2011, an EF5 tornado— the highest classification for a twister— ripped through the heart of Joplin, 
Missouri, killing 161 people and leveling homes, buildings, and trees. The tornado damaged or destroyed more 
than 8,000 structures, one-third of the city.
When people sustain massive traumatic injuries, their natural defenses are weakened, paving the way for 
pathogens (germs) to enter the body and cause infection. Some injured survivors in Joplin began showing signs 
of an unusual wound infection, and it was several days before it was diagnosed as a serious fungal infection. 
When the news of a potential outbreak of fungal infections reached the community, there was a lot of fear and 
concern, especially for relief workers who worried they might also be at risk.
CDC sent a team to Missouri to help with the investigation. The local laboratories in Missouri were quickly able 
to identify the infection as mucormycosis so that the medical teams could begin the correct treatment. When 
the first samples arrived at CDC from Joplin, the type of fungus had not been confirmed. The laboratory team 
identified the type of fungus causing the mucormycosis skin infections as a type found in soil and water around 
the world and known occasionally to cause the same type of skin infections in people who had been involved in 
motor vehicle crashes or other disasters. Epidemiologists, however, are still trying to identify exactly how people 
were exposed to the fungus.
Nothing can prepare an 
investigation team for the 
emotional interviews with 
trauma survivors. As one 
reflected, “Every disaster is 
different, and probably whether 
you witness one or a hundred, 
every single one of them is going 
to leave a lasting impression.
I will never, ever forget some of 
those stories or the devastation 
that we saw in Joplin.”
▲ This photo, taken approximately 5 weeks after the tornado, shows the 
remains of a mucormycosis case-patient's home that was destroyed.
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O h ,  g i v e  m e  a  h o m e  
w h e r e  b r o w n  d o g  t i c k s  
d o n ' t  r o a m
Rocky Mountain spotted fever (RMSF) emerged in eastern 
Arizona in 2003. It causes moderate to severe illness, but 
when treatment is delayed, it can develop into severe illness, 
even death. In this region, the descriptively named brown 
dog tick is the vector for transmission. An unchecked dog 
population plays an important role, because dogs serve 
as hosts to these ticks in each life stage. But preliminary 
findings from a 2012 pilot project in a neighborhood on the 
San Carlos Apache Reservation are causing optimism among 
scientists working to reduce RMSF. Improving people’s 
health, it turns out, has everything to do with improving the 
health of pets.
From 2003 to 2012, several factors converged to cause 
a regional RMSF epidemic that extended across four 
reservations. An absence of organized animal control 
programs, compounded by limited access to veterinary care, 
resulted in an ever-increasing dog population, with tick- 
infested stray dogs roaming freely. Each year, large numbers 
of puppies are born, providing a ready and sustained source 
of hosts from which ticks may feed.
In 2012, CDC worked with tribal, public, private, and academic partners to launch the “RMSF Rodeo,” a pilot 
project on the San Carlos Apache Reservation. One of the neighborhoods on the reservation was selected for 
the project. About 95% of homes in the neighborhood participated in the pilot. In the spring-summer months, 
neighborhood yards were sprayed for ticks four times, instead of just once. Every dog received a free collar and 
license and an 8-month tick collar from Bayer Chemical Company Healthcare/Animal Health Division. Free spay 
and neuter services were offered. Residents were encouraged to restrain free-roaming dogs by tether or fence.
The project proved highly successful; 99% of dogs in the RMSF Rodeo community were tick-free by the project’s 
conclusion. By designing a small and well-scaled pilot project that the tribe could expand to the entire reservation, 
it is hoped that Rocky Mountain spotted fever in eastern Arizona will be significantly reduced.
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O n e  &  O n l y —  
P r e v e n t i n g  i n j e c t i o n  e r r o r s  
in  h e a l t h c a r e  s e t t i n g s
“One and only” refers to using needles and syringes 
only once. They should not be used for more than one 
patient or reused to draw up additional medication.
Unfortunately, Dr. Evelyn McKnight, mother of 
three, learned the hard way that this practice was 
not always followed. Dr. McKnight was infected with 
hepatitis C virus (HCV) while battling a recurrence of 
breast cancer in 2000. In total, 99 patients at the same 
oncology clinic became infected with HCV when 
their provider failed to follow safe injection practices.
This was one of the largest healthcare-associated 
outbreaks of HCV infections in US history.
Since 2001, at least 150,000 US patients have been negatively impacted by unsafe medical injections. In response, 
CDC and the Safe Injection Practices Coalition (SIPC) are leading the One & Only Campaign to raise awareness 
among patients and healthcare providers about safe injection practices. The campaign aims to eradicate outbreaks 
resulting from unsafe injection practices and has developed the following “3 Things Every Provider Should Know”:
• Needles and syringes are single-use devices. They should not be used for more than one patient or reused to 
draw up additional medication.
• Do not administer medications from a single-dose vial or IV bag to multiple patients.





[ ■ ' I ' « '  I ■ I
Safe Injection Practices Coalition 
w w w .O N E andO N L Y cam paign .org
4 Injection safety is part of the minimum expectation 
for safe care anywhere healthcare is delivered. But 
CDC has had to investigate numerous outbreaks of 
life-threatening infections caused by injection errors. 
Since 2001, at least 150,000 US patients have been 
negatively impacted by unsafe medical injections.
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P a r a l y s i s  in  t h e  d e s e r t —  
A n  u n p r e c e d e n t e d  b i n a t i o n a l  o u t b r e a k  
o f  G u i l l a i n - B a r r e  s y n d r o m e
On June 17, 2011, CDC was contacted by the Arizona Department of Health Services regarding an unusual number 
of Guillain-Barre syndrome (GBS) cases in the Yuma area, near the US-Mexico border. GBS is a disease that 
affects the nervous system and can cause paralysis and, in some cases, death. Nearly all cases of GBS are sporadic, 
and clusters of several people in one area coming down with GBS are extremely rare. Campylobacter jejuni is a 
bacterium that often causes diarrhea, and the infection (called campylobacteriosis) is a common precursor to GBS 
in North America. At the same time as the cluster of GBS cases had been reported, routine surveillance noted an 
increase in Campylobacter jejuni infections.
Within 2 weeks, federal, state, and local epidemiologists met with 
their Mexican counterparts in San Luis Rio Colorado to fully 
investigate the outbreak. The binational team, including Arizona’s 
Office of Border Health, ultimately classified 26 patients with GBS,
8 cases in Arizona and 18 cases in Mexico. This unprecedented GBS 
cluster, 26 times the expected rate in a 3-month period, was likely 
caused by a large outbreak of waterborne campylobacteriosis that 
affected the region’s water supply. CDC conducted an environmental 
health investigation to better understand the local water systems 
and establish relationships with water managers to improve water 
treatment and disinfection practices.
The number of people who live, work, and travel between the United 
States and Mexico has led to a sharing of culture and commerce as 
well as health issues, including infectious diseases. As this response 
to the outbreak of GBS demonstrates, CDC’s strong relationships 
with border health partners and Mexican public health officials is 
essential for rapid and targeted response to binational outbreaks of 
infectious diseases. To that end, HHS Secretary Kathleen Sebelius and 
Mexico Secretary of Health Salomon Chertorivski signed a US-Mexico 
declaration on May 22, 2012, which formally adopted guidelines for 
both countries to follow when responding to public health events 
affecting both countries.
▲ Neuroepidemiologists Dr. Jim Sejvar (CDC) and Dr. Francisco Arzate 
(DGE Dirección General de Epidemiología) evaluate one of the patients 
recovering from GBS in his home in San Luís Río Colorado, Sonora.
The patient had recently begun to be able to stand up on his own after 
battling GBS for over a month. Courtesy Maureen Fonseca-Ford
Our many roles: Responding to outbreaks 23
NCEZID: Our Work, Our Stories 2011-2012
S u p p o r t i n g C D C s  i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
Karen Miernyk, an Alaska Native Tribal Health Consortium employee, 
works in the Arctic Investigations Program lab, which features 
outstanding diagnostics, facilities, and scientists.A
P r o v i d i n g  l a b o r a t o r y  s c i e n c e
NCEZID provides high-quality laboratory science to protect the 
public from infectious diseases and other health threats. Our 
laboratories maintain unique and critical capacities, including 
serving as reference labs, conducting tests on or identifying 
pathogens in samples from around the world, evaluating pathogens 
from outbreaks of infectious disease, providing reagents for use 
in laboratory work, developing diagnostic tests to more quickly 
and easily identify new diseases, and researching a wide range 
of pathogens to understand better the nature of significant and 
emerging pathogens. State health departments’ laboratories and 
other laboratories rely on NCEZID’s labs for assistance with rare 
and complex pathogens and other issues. Research conducted by 
our laboratories has been used to develop prevention strategies and 
technology to reduce the burden of infectious diseases.
The enormous diversity of microbes— combined with their ability 
to evolve and adapt to changing populations, environments, 
practices, and technologies— creates ongoing threats to health 
and continually challenges CDCs ability to prevent and control 
disease. CDC must always be prepared for the unexpected. That 
means continuing to build state and local public health laboratory 
capacity throughout the United States and strengthening CDC’s core 
infectious disease laboratories.
In all we do, NCEZID relies on collaborations with other federal agencies, state and local public 
health agencies, healthcare organizations, and many other domestic and international partners. This 
is equally true of our laboratories— a central element of the nation’s public health laboratory system 
and of the global public health laboratory system as well. CDC laboratorians partner closely with 
various federal agencies, the World Health Organization, ministries of health in many countries, and 
with industry and non-governmental organizations.
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T h e  p l a g u e  d i p s t i c k —  
B r i n g i n g  t h e  l a b o r a t o r y  
t o  t h e  b e d s i d e
Now rare in the United States, plague remains a real threat to 
human health in sub-Saharan Africa and Madagascar. These 
regions account for more than 95% of the world’s reported plague 
cases. Fatality rates for untreated infections range from 50% to 
60% for bubonic plague to nearly 100% for pneumonic infections.
The most common form of plague is bubonic plague, 
characterized early by high fever, and later by painful lymph node 
swellings called “buboes.” Additionally, the infection can spread 
to the patient’s lungs, resulting in pneumonic plague, which may 
be spread to others via infectious respiratory droplets.
Unfortunately, early clinical diagnosis of plague is difficult and can delay effective treatment. Sending samples 
away for laboratory verification can take weeks. Overcoming these barriers to effective diagnosis and timely 
treatment has been a priority for CDC laboratorians. Researchers recently developed, manufactured, and 
field-tested a rapid, affordable diagnostic tool— the plague dipstick. The point-of-care plague dipstick brings 
the laboratory to the bedside.
Dipsticks provide significant improvement in terms of time, ease of use, storage, and handling. Healthcare 
workers can be quickly trained to apply blood or lymph node aspirate to the dipstick, which yields results in 
15 minutes. The dipsticks do not require electricity or refrigeration— important in an environment where 
electricity is sporadic. Each test costs less than 50 cents to produce. The plague dipstick is now being submitted 
to the US Food and Drug Administration for final clearance.
Healthcare workers can be 
quickly trained to apply 
blood or lymph node 
aspirate to the dipstick, 
which yields results in 15 
minutes. The dipsticks do 
not require electricity or 
refrigeration—  important 
in an environment where 
electricity is sporadic. 
Courtesy Martin Schriefer
I In October 2012, this Ugandan farmer 
(third from left) had symptoms of plague. 
He was immediately tested with the rapid 
plague dipstick test and learned in 15 
minutes that he had tested positive. He was 
treated with antibiotics, fully recovered, 
and was back working in 3 days. Also 
pictured: Ugandan clinical coordinator, Dr. 
Titus Apangu (center, wearing a tie) and 
NCEZID Director Dr. Beth P. Bell (far right).
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PulseNet at work—  Detecting hazardous hazelnuts
They’re usually in bowls of mixed nuts that are a holiday staple. But for 8 people who lived in Michigan, 
Wisconsin, and Minnesota, the 2010 holidays weren’t so merry. Beginning in late December, they all came 
down with a rare and serious illness caused by Escherichia coli Q157:H7 (E. coli) that was lurking in, of all 
places, hazelnuts.
How was this outbreak confined to only eight people? PulseNet, a national network of laboratories coordinated 
by CDC consisting of state and local health departments and federal agencies (US Department of Agriculture/ 
Food Safety and Inspection Service, US Food and Drug Administration), quickly identified that the type of E. coli 
stood out from other cases of E. coli infection that were occurring at the same time. Without PulseNet’s ability to 
match up bacteria from sick people in many locations, this outbreak would not have been caught.
So how does PulseNet really work? John Besser, CDC microbiologist, explains, “PulseNet tracks foodborne 
illness like the FBI tracks criminals. It compares the ‘DNA fingerprints’ of bacteria from patients to find 
clusters of disease that might represent unrecognized outbreaks. Health officials can’t stop an outbreak, and 
industry and regulatory agencies can’t make changes to our food and water delivery systems, if they don’t know 
that outbreaks are occurring. That’s where PulseNet comes in. Public health laboratories in all 50 states and food 
regulatory and agriculture agencies across the United States use PulseNet to track foodborne diseases within 
their jurisdictions and compare their findings to those from laboratories across the network through a central 
database at CDC in Atlanta. Because food is truly an international commodity, PulseNet International also has 
been established in 82 countries around the globe.”
In less than 3 months, and with only eight illnesses, the outbreak and food source were identified, the product 
recalled, and no one died. CDC and its food safety partners also discovered a new food vehicle for E. coli 
O157:H7 infections— hazelnuts.
PulseNet tracks what is being reported to CDC 
today compared with what was reported in the 
past to look for changes. Since 1996, PulseNet 
has built a database that contains nearly half 
a million isolates of bacteria from food, the 
environment, and human foodborne illness. ►
I s o la t e s  R e p o r te d  t o  P u ls e N e t  U SA , 
1 9 9 6 - 2 0 1 1
□ Human ■ Food/Animal/Environment
*Entries are individual specimen patterns uploaded to PulseNet USA and include submissions to the Salmonella, 
Shiga toxin-producing E. coli O157 and non-O157, Shigella, Listeria, and Campylobacter databases.
26 Our many roles: Providing laboratory science
NCEZID: Our Work, Our Stories 2011-2012
W h a t  i s  t h i s ?  N C E Z ID 's  " P a t h  L a b "  h e l p s  f i n d  t h e  a n s w e r
When public health specialists are having a hard time while investigating unusual infectious diseases, they 
often call on CDC’s Infectious Diseases Pathology Branch for help. The unique expertise of the “Path Lab” 
often enables CDC to respond rapidly to public health threats posed by various infectious disease agents, 
some of which are previously unknown or highly lethal.
In the early 1990s, the Path Lab, working closely with other public health investigators, identified and 
characterized a previously unrecognized type of hantavirus that was causing severe respiratory illness 
and death among residents of the southwestern United States. The branch’s work was also central to CDC’s 
success in responding to outbreaks of Ebola hemorrhagic fever in several African nations between 1995 
and 2002, leptospirosis in Nicaragua in 1996, Nipah virus encephalitis in Malaysia and Singapore in 2000, 
and West Nile virus infection in the United States in 2000 and 2002.
During the anthrax crisis in the United States in 2001, the Infectious Diseases Pathology Branch provided 
expert diagnostic support and consultation to emergency response teams in different US cities. In 2003, the 
branch’s contribution was instrumental in CDC’s success in identifying and characterizing a new coronavirus 
that was causing SARS. More recently, the path lab has investigated various novel transplant-associated 
infections in addition to characterizing the pathology and pathogenesis of pandemic influenza and, in 2012, 
fungal meningitis and other fungal infections.
The Infectious Diseases Pathology Branch’s talented staff stays on the cutting edge of innovation by 
continually refining testing methods to produce greater precision and faster results, supporting field 
investigations to strengthen connections between science in the lab and on the ground, and developing 
models for vaccines and drug therapies.
▲ Dr. Sherif Zaki, chief of 
the Infectious Diseases 
Pathology Branch. The Branch 
collaborates broadly with other 
infectious disease groups at 
CDC to conduct laboratory 
studies and investigations of 
infectious diseases of unknown 
cause or origin. The branch 
also works to identify new or 
emerging pathogens.
L e a d i n g  t h e  h u n t  f o r  a n t i m i c r o b i a l  r e s i s t a n c e
Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat 
patients who have infectious diseases. However, these drugs have been used so widely and for so long that the 
infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. 
People infected with antimicrobial-resistant organisms are more likely to have longer, more expensive hospital 
stays and may be more likely to die as a result of the infection.
In an effort to combat antimicrobial resistance, CDC’s laboratories are 
at the forefront of efforts to identify newly emerging antimicrobial 
resistance in the United States. The laboratories have identified E. coli 
and Klebsiella pneumoniae, common bacteria that can cause severe 
healthcare-associated infections, including pneumonia, bloodstream 
infections, wound or surgical site infections, and meningitis, that are 
resistant to nearly all antibiotics.
The laboratories use cutting-edge susceptibility testing methods to 
detect emerging resistance to antibiotics. CDC labs also evaluated 
antimicrobial susceptibility testing methods commonly used in 
hospital labs around the country in developing guidance for frontline 
laboratory detection to ensure that laboratories throughout the 
country are able to detect these resistant pathogens.
▲ CDC scientists, like Dr. Brandi Limbago 
pictured here, track antimicrobial-resistant 
pathogens around the globe.
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B i o i n f o r m a t i c s —  
A c c e l e r a t i n g  d e t e c t i o n  a n d  
a n a l y s i s  in  t h e  l a b o r a t o r y
▲ Whole genome 
sequence map of a 
major strain of 
Clostridium difficile, 
a serious healthcare- 
associated infection 
that causes diarrhea 
and accounts for 14,000 
deaths in the United 
States each year.
An attendee at the 2012 Association of Public Health Laboratories 
annual meeting in Seattle was so impressed with a demonstration 
of CDC’s MicrobeNet that he proclaimed over Twitter that it was 
“a hit” and “an excellent resource” for labs. MicrobeNet is one 
of the many bioinformatics core support activities conducted by 
CDC. The agency has placed a high priority on strengthening its 
- bioinformatics capacity.
For more than 15 years, NCEZID has played an important role in the 
development of bioinformatics at CDC. Bioinformatics is the application 
of computer science and information technology to the fields of biology 
and medicine. Bioinformatics generates new knowledge as well as the 
computational tools needed to create that knowledge. The Human Genome 
Project, coordinated by the US Department of Energy and the National Institutes of 
Health, is one of the best-known examples of bioinformatics at work. The project involved 
the identification and mapping of the approximate 25,000 genes of the human genome.
CDC’s MicrobeNet, another important bioinformatics project, is a reference database for genetic identification of 
infectious pathogens that will link CDC laboratories with state and local laboratories. The MicrobeNet platform 
will allow laboratorians throughout the world to browse and match against isolates in CDC’s reference collections, 
using a variety of data types and sources. It will connect them with the appropriate CDC subject matter expertise 
and provide detailed information about the organism, complete with pictures, protocols, and expected test results. 
Other recent bioinformatics projects include the sequencing and analysis of 250 different strains of the foodborne 
pathogen Shiga toxin-producing Escherichia coli (called STEC) for the development and validation of next- 
generation PulseNet methods. CDC’s PulseNet is a national network of public health and food regulatory agency 
laboratories that perform standardized molecular subtyping (“fingerprinting”) of foodborne disease-causing 
bacteria. Another prime example of bioinformatics at work, this sequencing and analysis project will help PulseNet 
more quickly detect and define, and in so doing reduce, outbreaks of foodborne disease.
“CDC’s laboratory scientists are a t the h eart o f  our work to p ro tec t 
Am erica on a 2417 basis. CDC could n o t succeed w ithou t them "
Thomas Frieden, MD, MPH, Director, Centers for Disease Control and Prevention
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M u l t i t a s k i n g  in  t h e  l a b —  
E q u i p m e n t  t h a t  d i a g n o s e s  f lu  c a n  
n o w  b e  u s e d  t o  d i a g n o s e  d e n g u e
In 2012, CDC laboratories developed a new diagnostic test to detect the presence of dengue virus in 
people with symptoms of dengue fever or dengue hemorrhagic fever. Dengue is a painful and sometimes 
deadly viral disease transmitted by mosquitoes that threatens more than 3.5 billion people worldwide, 
and it is a major public health problem in the tropics and subtropics where Aedes aegypti mosquitoes 
are mainly found. Large numbers of travelers return from dengue-endemic areas to the United States 
each year, increasing the possibility of introducing the virus to those parts of the United States where the 
mosquitoes capable of transmitting dengue still thrive.
The new test will help diagnose dengue within the first 7 days after symptoms appear, which is when most people 
are likely to see a healthcare professional and the dengue virus is likely to be present in their blood.
The test can identify all four dengue virus types. This is the first US Food and Drug Administration-approved 
molecular test for dengue that detects evidence of the virus itself. One of the new test’s most important features is 
that it can be performed using existing equipment and supplies that many public health laboratories already use to 
diagnose influenza.
A CDC scientist who works with dengue explained the potential value of such a test: “Patients will be diagnosed 
sooner than before, and public health laboratories will have a clearer picture of the true number of dengue cases.” 
New dengue test kits were made available for distribution in July 2012.
P r o v i d i n g  e s s e n t i a l  s u p p o r t  t o  
l a b o r a t o r i e s  t h r o u g h o u t  C D C
If CDC’s laboratory scientists are, in the words of CDC Director 
Thomas Frieden, “.. .at the heart of our work to protect America 
on a 24/7 basis,” then NCEZID’s Division of Scientific Resources 
(DSR) functions a bit like oxygen, providing laboratorians 
throughout CDC with state-of-the-art technology and high- 
quality products that they need to do their work. DSR provides 
essential support to the public health efforts of CDC laboratorians 
and CDC’s emergency preparedness and response activities, 
including work in next-generation genomic sequencing and 
bioinformatics analyses for fungal, viral, and bacterial pathogens.
As the primary laboratory support infrastructure for the agency, DSR performs many roles. They supply the 
nuts and bolts needed for laboratory research— everything from supplies and glassware to mammalian tissue 
cultures to peptides and custom reagents. They provide resources and technological services to support mission- 
critical diagnostic, reference, and research laboratory programs. They support laboratory investigators in their 
work involving protein and DNA synthesis and sequencing, proteomics, and molecular modeling. DSR is also 
responsible for training the next generation of laboratory animal veterinarians who are needed to support work 
performed in high-containment laboratories.
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i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
I m p r o v i n g  p u b l i c  h e a l t h  
p r e p a r e d n e s s
NCEZID plays a significant role in rapidly detecting and responding to 
infectious disease threats and emergency situations. We work to prevent, 
identify, and control infectious diseases from spreading— whether they 
are naturally occurring, unintentional, or the result of terrorism. We 
focus our preparedness activities on emerging and zoonotic infectious 
diseases— working closely with partners in and outside the government 
to provide strategic vision in preparing the United States to respond to 
threats posed by deadly pathogens that cause smallpox, anthrax, Ebola 
hemorrhagic fever, Marburg hemorrhagic fever, Rift Valley fever virus, 
and hantaviruses. NCEZID has the worlds leading experts in a number 
of these viral and bacterial pathogens, and, therefore, plays a critical 
role in preparing the country against biological threats by providing 
expertise, capacity, and planning.
Our Center has unmatched laboratory capacity and epidemiological resources to respond to 
infectious disease threats. The ability to diagnose disease and identify risk factors for infection 
is critical to preparing properly for an unknown scenario. For example, NCEZID coordinates 
the Laboratory Response Network (LRN), which maintains an integrated network of state and 
local public health, federal, military, and international laboratories that are prepared to detect 
and respond to bioterrorism, chemical terrorism, and other public health emergencies. Since its 
creation, the LRN has played an instrumental role in improving the public health infrastructure by 
helping to boost laboratory capacity across the United States.
NCEZID and its partners produce guidelines on how to diagnose, treat, and prevent the spread of 
infectious diseases when a public health crisis occurs. NCEZID staff support state, local, tribal, and 
territorial partners by providing a comprehensive and standardized set of protocols, plans, and 
procedures for use during an infectious disease emergency. This advance planning and preparation 
saves lives during responses and emergency situations.
S u p p o r t i n g  C D C ’s
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A  p o w e r f u l  n e t w o r k  o f  
l a b o r a t o r i e s  t o  d e t e c t  a n d  
r e s p o n d  t o  t h r e a t s
In the late 1990s, most Americans were more 
concerned about a computer bug than a biological 
one. While the nation’s collective attention was 
fixed on the prophesized Y2K apocalypse, a 
small group of CDC staff and their colleagues 
at the Federal Beaureau of Investigation (FBI),
Department of Defense, and Association of Public 
Health Laboratories were quietly piecing together 
a network of public health laboratories that would 
later become a model for laboratory preparedness 
around the globe.
This forward-looking team created the Laboratory 
Response Network (LRN), a diverse network of 
domestic and international laboratories that can 
spring into action to identify harmful biological and chemical agents. Approximately 160 LRN laboratories located 
in all 50 US states provide diagnostic capacity to identify agents that may be connected to biological or chemical 
terrorism events and infectious diseases. That extensive network provides access to rapid laboratory testing 
throughout the nation, with approximately 90% of people in the United States living within 100 miles of an LRN 
laboratory.
Just 2 years after it was created in 1999, the LRN played a pivotal role in identifying Bacillus anthracis in the 
first victim of the 2001 anthrax attacks. Since then, the LRN has played a key role in preparedness and response 
activities, including those related to a mysterious new form of pneumonia now known as SARS, monkeypox, E. 
coli food contamination, ricin toxin, and H5N1 (avian influenza). The LRN provided laboratory testing for anthrax 
cases identified in drummers in the Northeast in 2010 and a naturally occurring case of inhalation anthrax in the 
Midwest in 2011. Routinely, the LRN is called upon to provide laboratory services for threat letters containing 
white powders and during major sporting events, national political conventions, and other high-profile events that 
attract large crowds and international media attention.
▲ The Laboratory Response Network is a unique asset in the nation's growing preparedness for biological 
and chemical terrorism. The linking of state and local public health laboratories, veterinary, agriculture, 
military, and water- and food-testing laboratories is unprecedented.
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CDC and the FBI— 
A partnership to combat bioterrorism
Public health and law enforcement agencies have different mandates and, consequently, different ways of looking 
at and investigating biological incidents. In the past, they often conducted separate investigations, but now they 
have recognized the potential to improve effectiveness by working more closely together. To promote collaboration 
between public health and law enforcement personnel, CDC and the Federal Bureau of Investigation (FBI) 
developed the Joint Criminal and Epidemiological Investigations Workshop.
The 2-day workshop, facilitated by CDC and FBI instructors, emphasizes the need for a joint response to biological 
incidents, using lectures to provide an overview of investigative methods and information sharing practices along 
with case studies and exercises to reinforce joint investigation principles and techniques. Implementing joint 
investigation methods can help improve response to naturally occurring or intentionally produced biological 
incidents by mutually supporting the investigative goals of both public health and law enforcement.
Since 2004, CDC and the FBI have conducted 32 workshops, training over 2,900 
staff at the federal, state, and local levels. As a result, several state and local 
jurisdictions have used joint investigation methods to successfully respond to 
biological incidents. For example, local public health officials in North Carolina 
contacted the FBI about a case of potential ricin poisoning possibly due to the 
illicit manufacturing of ricin. The FBI special agents assigned to the case had 
attended the workshop and recognized the need to quickly coordinate with 
public health officials to begin an investigation, including a joint interview of 
a patient using techniques learned in the workshop. The joint investigation 
determined that the individual was not manufacturing ricin, as first reported, 
but rather ingested several castor beans in a possible suicide attempt. FBI 
officials believe that the efficient and coordinated response by public health 
officials and law enforcement staff was due to the training received in the Joint 
Investigations Workshop.
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W h a t ' s  in  t h e  w a t e r ?  
" W a t e r  L a b 's "  u l t r a f i l t r a t i o n  t e c h n i q u e  
h e l p s  e n s u r e  s a f e t y
In the wake of 9/11 and the anthrax letter attacks, CDC researchers and 
laboratorians worked to develop a protocol to rapidly sample drinking water for 
unidentified biothreat agents. They used a technique called ultrafiltration that 
can simultaneously concentrate viruses, bacteria, parasites, and even some large 
toxins in water all from a single water sample instead of having to use a different 
sample and method for each desired microbe. In 2007, the ultrafiltration-based 
water processing protocol was posted as an official Laboratory Response Network 
(LRN) method. Approximately 160 LRN laboratories located in all 50 US states 
provide diagnostic capacity to identify agents that may be connected to biological 
or chemical terrorism events and infectious diseases.
Environmental Microbiology Laboratory— the “Water Lab,” as it is known, is 
leading efforts to establish this water processing protocol. In 2011, Water Lab staff 
began working with the US Environmental Protection Agency to train new LRN 
member labs to perform the protocol. In 2012, Water Lab staff led a hands-on 
laboratory workshop at CDC to train laboratorians from 14 state public health labs 
on the water processing protocol. Recent preparedness exercises confirmed that 
participants would know how to implement the protocol in case of an emergency.
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A  m e d i c a l  v i c t o r y  r e m a i n s  a  m e d i c a l  m y s t e r y
Something rather remarkable happened to a 61-year-old retiree from Florida who took a 3-week vacation with his 
wife to visit the national parks of Wyoming, Montana, and the Dakotas. He acquired— but survived— a rare and 
extremely deadly type of anthrax infection that he may have acquired from exposure to natural sources on 
his road trip.
When he arrived at a friend’s home in Minnesota on August 2, 2011, he was feeling a little “punky.” Two days 
later, on August 4, he was admitted to the hospital and treated for what was thought to be community-acquired 
pneumonia. But he did not improve.
The next day (August 5), the hospital lab identified the bacteria from a culture they had taken as a type of Bacillus 
and alerted the Minnesota Department of Health laboratory, part of the Laboratory Response Network (LRN). 
Following LRN protocol, the state lab identified and then confirmed that it was the highly lethal Bacillus anthracis 
(that causes anthrax) and notified CDC. Because this was inhalation anthrax, the deadliest type that produces toxins 
that can quickly cause multisystem organ failure, CDC rushed in a specialized antitoxin (anthrax immunoglobulin) 
and sent two medical officers to study the case and monitor the treatment. CDC also coordinated with FBI staff who, 
with public health epidemiologists, determined that it was not an act of bioterrorism.
Fortunately, the Florida retiree made a full recovery and was discharged in good 
condition on August 29. That he survived this deadliest form of anthrax is due, 
in part, to alert medical staff and an LRN protocol that guided rapid, and it turns 
out life-saving, diagnosis and initiation of treatment. Afterwards, CDC and state 
and federal partners combed through data and examined potential exposures 
encountered on his trip— from rocks he collected for making jewelry to bison 
herds he and his wife drove through— but were never able to identify the source 
of his exposure to anthrax. Just why he— and not his wife— got the deadly 
infection remains a mystery.
CDC investigated many potential sources in trying to determine how 
the Florida retiree contracted inhalation anthrax. Had he inhaled 
dust (containing anthrax spores) stirred up by hooved animals, such 
as the bison pictured here, during travel? No anthrax cases, however, 
were reported in domestic or wild animals in 2011 prior to August.
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S u p p o r t i n g  C D C s  i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
E x t e n d i n g  o u r  r e a c h  
a r o u n d  t h e  g l o b e
Because pathogens can quickly spread across our 
borders from anywhere on the globe, NCEZID works 
to protect the United States and other countries from 
infectious diseases. We provide technical expertise to 
enhance public health capacity, increase health security, 
and reduce the spread and importation of disease. Our 
partners include ministries of health and multinational 
organizations, such as the World Health Organization, 
the US Agency for International Development, and the 
Bill & Melinda Gates Foundation.
CDC has staff members in outposts around the world. . n , , ,, , ... . „ ,,, u, r. ., r ., . .
Researchers from the Uganda Ministry of Health, African Field Epidemiology Network, 
Uganda, considered a hot zone for emerging infectious Makerere University, and CDC interview the husband of the suspected first case-
diseases that have the potential for far-ranging impact, is one patient in the 2012 Ebola outbreak h°p ing to learn how the spread of disease began.
Looking on is Dr. Richard Besser, ABC News, who was embedded with the CDC team 
such outpost. NCEZID has helped build, staff, and train the during the Ebola investigation. Courtesy Justin Williams
first functioning laboratories at the Uganda Virus Research
Institute for the diagnosis of vector-borne viruses, plague, and hemorrhagic viruses. CDC helps 
local public health authorities in Uganda and other countries in Africa recognize and respond to 
deadly infectious diseases, such as Ebola hemorrhagic fever, monkeypox, plague, and Marburg 
hemorrhagic fever. CDC Director Thomas Frieden was clear when he explained the mission of 
CDC’s work in Uganda and around the world: “We are building systems [abroad] so we don’t have 
to be there forever. It’s very similar to what CDC has done over the past 50 years in the United 
States.... It’s a lot cheaper to identify something at its source before it comes to our shores” 1
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Selected NCEZID Epi-Aid investigations, worldwide, October 2010- September 2012
Each year NCEZID responds to numerous requests for assistance in response to international outbreaks of infectious 
diseases, often through formal requests for epidemic-assistance investigations, called Epi-Aids. Many international Epi-Aid 
investigations are done in collaboration with and support from other CDC centers, in particular the Center for Global Health.
Country
Chad Investigation of an outbreak of a parasitic disease (Guinea worm disease)
Democratic Republic of Congo Training of health workers for enhanced surveillance due to widespread outbreaks of a rare viral disease (monkeypox) related to smallpox
Democratic Republic of Congo Investigation of an outbreak of an often-deadly viral illness (Ebola hemorrhagic fever)
Egypt Evaluation of the first surveillance system for healthcare-associated infections
Federated States of Micronesia Investigation of a mosquito-borne disease (dengue)
Georgia Investigation of an outbreak of anthrax in humans and animals
Haiti Investigation of an outbreak of cholera
Haiti Assessment of deaths from cholera at hospitals and cholera treatment centers
Jamaica Investigation of a fungal infection (from Trichosporon) among patients at a hospital
Kenya Surveillance for illness and death in Somali refugees
Kenya Surveillance and response for bacterial infections (cholera and shigellosis) in Somali refugees
Kenya Surveillance and response for cholera in Somali refugees
Kenya and US multistate Assessment of the need for rabies treatment after exposure to a rabid zebra at a travel lodge
Kenya Rapid field assessment of polio surveillance
Kenya Investigation of an outbreak of canine-associated human rabies
Panama Investigation of drug-resistant bacterial infections (from carbapenem-resistant Klebsiella pneumoniae) at a hospital
Peru Investigation of an outbreak of vampire bat-associated human rabies
Sierra Leone Development of an integrated disease monitoring system, focusing on diseases such as meningitis, viral hemorrhagic fevers, and cholera
Sierra Leone Investigation of an outbreak of cholera
South Sudan Investigation of nodding syndrome outbreak, which causes uncontrolled head nodding, seizure-like activity, and in many cases, death
Tanzania Survey of nodding syndrome
Uganda Investigation of an outbreak of disease of unknown cause associated with high death rates
Uganda Investigation of an outbreak of bacterial infections (typhoid fever) characterized by intestinal perforations (holes)
Uganda Investigation of an outbreak of an often-deadly viral illness (Ebola hemorrhagic fever)
Zambia Investigation of an outbreak of anthrax in humans and animals
Zambia Investigation of an outbreak of bacterial infections (typhoid fever)
Zimbabwe Investigation of an outbreak of bacterial infections (typhoid fever)
International Multistate investigation of a group of wedding attendees who were possibly exposed to foodborne illness-causing bacteria (Listeria monocytogenes)
International Multistate investigation of a suspected cluster of venous thromboembolism (VTE) and pulmonary embolism (PE), which may be life-threatening, among government workers
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S h a r i n g  e x p e r t i s e  t o  e l i m i n a t e  
r a b i e s  a b r o a d
One of the oldest described infectious diseases, “mad crazy 
dog disease” (as it is known in China) or rabies, as it is 
called in this country, has been known for more than 4,000 
years. Because of the remarkable success of public health 
interventions, such as vaccination of people and dogs, human 
rabies cases in the United States are now rare, though still 
deadly and tragic when they do occur, typically due to bites 
of infected bats. Globally, each year, rabies kills more than
55,000 people, mostly children, usually from dog bites. In fact, 
worldwide, 99% of human rabies deaths are from dogs.
Fortunately, rabies is a vaccine-preventable disease. The most cost-effective strategy for preventing rabies in people 
is eliminating rabies in dogs through vaccination. Recent CDC collaborations with international partners in Asia 
and South America have been successful. For example, a collaboration with the Pan American Health Organization 
on canine vaccination has drastically reduced human rabies cases throughout the Americas. More recently, a 
grassroots rabies management project in the Philippines focused at the community level led to elimination of 
cases on the island of Bohol and may help the country obtain a “rabies-free” designation. Projects such as these 
use a multifaceted approach to reduce rabies, including high-level advocacy to make rabies control a priority for 
leadership, aggressively pursuing canine rabies elimination, expanding laboratory diagnostics and training, and 
promoting innovative approaches to responsible dog ownership (like the use of a canine rabies vaccine that also 
induces a contraceptive immune response).
In addition to helping implement interventions to better control rabies, 
in 2012 CDC researchers published an important discovery about the 
disease. Their survey of people living in a remote section of the Peruvian 
Amazon offered strong evidence that an immune response to rabies may 
develop in some people in certain communities where outbreaks caused 
by vampire bat bites have occurred regularly over the past 2 decades.
Several of these people who were previously exposed to rabies virus 
survived without vaccination.
So, it is theorized that under very unique circumstances, certain 
people regularly exposed to the virus might have an enhanced immune 
response that could prevent onset of clinical illness. Nevertheless, the 
lead researcher of the study advised, “a series of injections following 
exposure remains the best way to protect people against rabies” until 
new paradigms, such as improved housing to prevent bat access into 
dwellings and inclusion of rabies vaccine in local childhood immunization 
programs, are implemented.
▲ A common vampire bat (Desmodus rotundus) captured in the Peruvian 
Amazon in Madre de Dios. As part of a collaborative longitudinal capture- 
recapture study between CDC and the University of Georgia, bats have 
been uniquely banded and serosurveyed for exposure to rabies since 2007. 
Courtesy D. Streicker
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T r a i n i n g  t r a i n e r s  i n  H a i t i  t o  
r e s p o n d  t o  c h o l e r a
When epidemic cholera appeared in Haiti in October 2010, the medical 
community there had virtually no experience with the disease and needed rapid 
training as the epidemic spread throughout the country. CDC, including staff 
within NCEZID, developed a set of training materials specific to Haiti and 
launched a cascading training effort. Through a training-of-trainers course 
November 14-15, 2010, and department-level training conducted in French 
and Creole over the following 3 weeks, 521 persons were trained and equipped 
to further train staff at the institutions where they worked. After the training, 
the hospitalized cholera patients’ case-fatality rate dropped from 4% to less 
than 2% by mid-December and was less than 1% by January 2011. Continuing 
in-service training, monitoring, evaluation, and integration of cholera 
management into regular clinical training will help sustain this success.
I m p r o v i n g  h e a l t h  f o r  K e n y a ' s  r e f u g e e s  
b y  b u i l d i n g  l a b o r a t o r y  c a p a c i t y
Not far from the Somalia border in Kenya lies the town of Dadaab, the 
largest refugee camp in the world. Refugees in the camp are faced with 
a host of medical problems, which are compounded by overcrowded 
conditions and limited access to care. It’s easy for infectious 
diseases to spread quickly in such conditions.
CDC works with many partners to offer a wide range of health 
services to refugees living in Dadaab, and from the beginning, 
one of the more pressing concerns was the extremely limited 
laboratory capacity. Determining the pathogen associated 
with an outbreak of watery diarrhea or the cause of someone’s 
pneumonia could take several weeks because specimens had to 
be transported to a laboratory in Nairobi. And there are only two 
flights out of Dadaab each week.
In September 2010, NCEZID, in collaboration with other offices 
at CDC, the United Nations, and the Kenya Medical Research 
Institute set up a functioning laboratory at a site where access 
to water, electricity, space, and staff are significant challenges.
The laboratory serves approximately 1,000 people a month from 
the camp and surrounding community. It has been a long road, but with strong partnerships and continued 
dedication, this project will improve the lives of those seeking refuge in Kenya and beyond.
A  Before and after views of Dadaab's laboratory. 
Today, the lab contains state-of-the-art equipment 
to better diagnose common pathogens.
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D e f e a t i n g  d i a r r h e a l  d i s e a s e —  
A  l e a d i n g  k i l l e r  o f  a d u l t s  a n d  
c h i l d r e n  i n  I n d i a
Public health scientists have measured the 
disproportionate amount of illness and death caused 
by diarrheal disease in India, compared with the rest of 
the world. But what is still unknown and has not been 
measured is how much of this illness— which includes 
cholera, salmonellosis, and shigellosis, also called 
dysentery— is caused by food. Isolating the foodborne 
causes is a critical step toward defeating a disease that is 
common, costly, but largely preventable.
In 2011, CDC’s Global Foodborne Infections Network (GFN), a World Health Organization-sponsored program, 
began working with partners in India to separate the primary culprits of diarrheal disease— water and food. 
Their aim was to focus on the disease caused by contaminated food and to encourage partnerships among 
microbiologists and epidemiologists so they could take the important next step. They needed to move beyond 
simply identifying clusters of diarrheal disease (syndrome-based surveillance) to finding the infections that were 
causing the diarrheal disease (case-based surveillance).
In March 2011, microbiologists from 16 states in India 
traveled to Kolkata to attend GFN’s inaugural workshops 
focused on the foodborne germs that cause a lot of the illness 
and death— Salmonella and Vibrio cholerae. Another GFN 
workshop was held in New Delhi in early 2012, and sparked 
enthusiastic discussion among Indian colleagues about next 
steps needed to reduce foodborne disease outbreaks. GFN’s 
overarching goal is to work with partners to strengthen the 
food safety network throughout India and extend it to the 
larger South Asia region.
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To reduce typhoid fever 
in the developing world, 
safe water teams from CDC 
use bleach models such 
as these to help people 
purify their drinking water.
Courtesy CDC Foundation
A n s w e r i n g  a  c a l l  f o r  h e l p  f r o m  Z a m b i a
Beginning in early 2012, an outbreak of febrile (fever) illness sickened more than 2,500 people across three 
regions in Zambia. The illness was consistent with typhoid fever, a life-threatening illness caused by the 
bacterium Salmonella Typhi that is still common in the developing world, where it affects about 21.5 million 
persons each year. The illness is difficult to diagnose on clinical grounds alone and can be confused with 
common diseases like malaria. The best way to confirm typhoid fever is with a blood culture, which is often 
beyond the capacity of local laboratories.
In February 2012, the Zambia Ministry of Health requested CDC’s assistance, and in early March two Epidemic 
Intelligence Service officers departed to assist local health officials in an Epi-Aid investigation. The team assisted 
the Ministry in conducting an outbreak investigation and strengthened laboratory capacity to diagnose typhoid 
with a new rapid test. It is likely that contaminated water supplies were responsible for the outbreak, consistent 
with other typhoid outbreaks in sub-Saharan Africa.
The investigation further underscored that outbreak control depends on successful water, sanitation, and hygiene 
interventions. Future plans for reducing typhoid fever also include evaluating the cost-effectiveness of typhoid 
immunization, as well as continuing to work with partners to strengthen Zambia’s epidemiologic and laboratory 
surveillance and diagnostic capacity.
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A  n e w  s t r a t e g y  t o  r e d u c e  d e a t h s  d u e  t o  C r y p t o c o c c u s
Each year, the fungus Cryptococcus neoformans causes life-threatening meningitis in almost 1 million people 
with weakened immune systems (like people who have advanced HIV/AIDS). The fungus is found in the soil 
and produces spores that can be inhaled. People can inhale spores early in life but never know it. In healthy 
people, the fungus usually does not cause serious illness because the immune system can fight off the infection. 
However, in people with weakened immune systems, the fungus can stay hidden in the body and later 
reactivate, spreading to other parts of the body and causing serious disease.
In sub-Saharan Africa, cryptococcal meningitis (when the infection has spread from the lungs to the brain) 
is one of the leading causes of death among HIV/AIDS patients; it may kill more people each year than 
tuberculosis. Although it is not possible to prevent the initial infection, a blood test can catch the infection 
before meningitis develops.
CDC has worked with other public health partners to perform “targeted screening” in HIV clinics, using a 
point-of-care dipstick screening test that is simple, quick, and effective. The test can be performed in the clinic, 
so it can be used by people who live in remote rural areas where there are no laboratories nearby. If screening 
detects the presence of Cryptococcus, beginning treatment before meningitis develops is affordable— the 
medication is sometimes free or only $1 to $2 dollars per month. CDC’s call to action is to equip half of all 
HIV clinics in Africa and Asia to perform Cryptococcus screening and treatment by 2015, which could save 
50,000-100,000 lives every year.
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U s i n g  d i s e a s e  p r e v e n t i o n  k n o w - h o w  
t o  r e d u c e  d e a d l y  E b o l a
In July 2011, when a patient in Uganda fell ill with deadly Ebola 
hemorrhagic fever (or Ebola), the diagnosis was made in about 8 days, far 
shorter than previous diagnoses, which took several weeks. And, largely 
because of that quick diagnosis, CDC Director Thomas Frieden explained, 
“You didn’t read about it in the papers because for the first time ever we 
identified a single case, not an outbreak.”2
Ebola hemorrhagic fever is a severe, often fatal disease in humans and 
nonhuman primates (monkeys, gorillas, and chimpanzees) that has 
appeared sporadically since its initial recognition in 1976, when there were 
more than 600 cases and 400 deaths reported. The disease is caused by 
infection with Ebola virus, named after a river in the Democratic Republic 
of the Congo (formerly Zaire) in Africa, where it was first recognized.
As the single case from 2011 suggests, there has been progress in stemming 
the tide of this horrific disease. In recent years, CDC has helped Uganda, 
an emerging disease “hot spot” for some of the world’s most dangerous 
pathogens, build capacity in all parts of its public health system to recognize 
and control outbreaks of infectious disease. Of particular note was a recently implemented viral hemorrhagic fever 
surveillance program. And the system, in this particular case, worked well— the local laboratory quickly identified 
the infection, the hospital used proper infection control measures to prevent spread of the virus, and the mortuary 
followed guidelines in handling the body. Local customs of preparing a body for burial can dangerously expose the 
handlers to infectious body fluids.
Clusters of outbreaks in 2012 in Uganda and the Democratic Republic of the Congo (DRC) are sobering reminders, 
however, that Ebola has not been extinguished. Comparing current outbreaks with earlier outbreaks does offer 
some room for hope. Instead of the more than 400 deaths reported in 1976, there were fewer than 40 deaths 
reported in the 2012 outbreaks in Uganda and DRC. So although Ebola has not been eliminated, putting infection 
control measures in place once it has been detected seems to be effective in reducing its spread.
▲ The burial team from the Uganda Ministry of Health putting on
personal protective equipment. During an Ebola outbreak, unexplained 
community deaths are treated with caution. Courtesy Justin WIlliams
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S u p p o r t i n g C D C s  i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
S e c u r i n g  s t a t e ,  l o c a l ,  a n d  t r i b a l  c a p a c i t y
CDC invests in a flexible and adaptable public health system at national, 
state, local, territorial and tribal levels. This includes building a sufficient 
and competent public health workforce; supporting surveillance systems; 
supporting modern and efficient laboratory facilities with well-trained 
laboratory staff; and improving information systems to support 
rapid exchange of health information for surveillance and outbreak 
investigation and response. This support, particularly for state, local, 
and territorial health departments, is extremely critical in combatting 
the ongoing and increasing threat posed by emerging (e.g., caused by 
antimicrobial-resistant bacteria) and re-emerging infectious disease 
(e.g., recent dengue fever outbreaks), in improving public health 
(e.g., food safety), and in responding to other public health emergencies.
NCEZID supports state, local, and territorial health departments in 
these efforts to prevent and control a wide range of infectious diseases, 
including zoonotic and vector-borne diseases, high-consequence 
pathogens, drug-resistant pathogens, those associated with healthcare 
infections, and infections of refugees and immigrants through the 
Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) 
and the Emerging Infections Program (EIP) cooperative agreements.
The ELC supports all 50 states, 6 local health departments (Los 
Angeles County, Philadelphia, New York City, Chicago, Houston, and 
Washington, DC), and the health departments in all 8 territories with 
sustaining core epidemiology and laboratory capacity to address 
public health concerns. EIP supports a network of 10 state health 
departments and their academic and other partners to conduct gold 
standard surveillance and state-of-the-art specialized applied epidemiologic 
research and to evaluate the impact of prevention programs and policies. In 
2011, EIP data were used in more than 65 articles published in peer-reviewed 
journals. Together, ELC and EIP funding supports well over 900 full- and part-time positions in the 
state, territorial, local, and tribal health departments, including epidemiologists, laboratorians, and 
health information systems experts to ensure basic capacity at the local level where many infectious 
diseases are first identified. In addition, NCEZID staff work in close collaboration with state and local 
health departments, providing technical expertise, guidance, outbreak support, access to surveillance 
systems, and unique laboratory capacities.
▲ Home treatment kits are ready for distribution as part of the 
"RMSF Rodeo," a pilot project targeted at reducing Rocky 
Mountain spotted fever in a large Indian reservation in 
eastern Arizona. Courtesy Brooke DiPetrillo, CDC Foundation
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B u l l ' s  e y e —
A n  E l P - f u n d e d  
s t u d y  t a r g e t s  
L y m e  d i s e a s e  
in  t h r e e  s t a t e s
In July 2011, John took his son 
on a Boy Scout camping trip in 
the woods of Virginia. A few 
years earlier in Maryland, Linda 
played with her young daughter 
in their yard that bordered a 
park where deer are plentiful.
John and Linda each got Lyme 
disease. They’re not unique, 
as John’s physician observed:
“Every one of us seems to know 
somebody who has dealt with 
Lyme disease.”
Lyme disease is caused by the bite of an infected blacklegged tick and is the Northeast’s second most common 
reportable disease— a list that includes hepatitis, sexually transmitted diseases, and many foodborne diseases, 
to name just a few. In the mid-Atlantic and the upper Midwestern states, Lyme and other tick-borne diseases are 
also a serious public health problem. To understand which measures would be most effective in preventing Lyme 
and other tick-borne diseases, CDC’s Emerging Infections Program is funding a 2-year prevention study through a 
collaborative group called TickNET in Connecticut, New York, and Maryland.
The TickNET partners found that more households wanted to participate than the study could accommodate, 
indicating an unmet need for tick-borne disease prevention. The study called for a one-time spraying of a widely 
available pesticide around the perimeters of yards (typically shrubby areas where most of the ticks live). Preliminary 
results from Year 1 showed that the pesticide reduced ticks by 76%. However, the number of ticks found on 
household members and the number of self-reported tick-borne disease cases were not significantly reduced.
Year 2 is currently underway, and scientists hope that results will help clarify and support public health 
recommendations for the use of pesticides to prevent disease. If the results from Year 1 and Year 2 are similar and 
tick-borne disease does not decrease, it may suggest that people are picking up ticks in places other than their yards. 
This finding would support recommending a reduction in residential pesticide use and would spur on additional 
prevention research for this serious public health problem.
And what happened to John and Linda? They each developed a bull’s-eye rash (one of the common symptoms of 
Lyme disease), quickly got medical attention and started taking antibiotics, and fully recovered.
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N o t  j u s t  c h o p p e d  l i v e r —  
N e w  Y o r k  C i t y ' s  " T e a m  S a l m o n e l l a " t r a c k s  d o w n  
t h e  s o u r c e  o f  a n  o u t b r e a k
Successful investigations often depend on asking the right question. Student interviewers, who were assisting 
the New York City Department of Health and Mental Hygiene in the investigation of an outbreak of Salmonella 
infections in the fall of 2011, did just that. They asked the question that led to identifying the source of the outbreak.
The students were part of the Foodborne Diseases Centers for Outbreak Response Enhancement (FoodCORE)- 
funded “Team Salmonella” trained interviewers who assist the public health staff in epidemiologic investigations 
of Salmonella-caused outbreaks in New York City. Six other FoodCORE centers, in addition to the one in New York 
City, work to improve state and local responses to foodborne disease outbreaks.
FoodCORE resources enable investigators to quickly conduct interviews with ill people while they still can 
remember what they ate, which is critical in stopping widespread outbreaks. FoodCORE support also helps 
laboratorians more swiftly conduct DNA fingerprinting of the bacteria and share information so public health 
officials can collaborate to determine sources of contaminated foods.
In this particular case, the breakthrough in the investigation came when two students on the team were discussing 
the results of their interviews. They theorized that chicken livers— a food not originally included on their 
questionnaires— might be the source of the Salmonella. The students, assisted by other FoodCORE and New York 
City public health staff, visited specialty stores where some of the people who became ill shopped to learn more 
about how the chicken livers were being prepared.
Suspect food items were collected for testing, and the outbreak strain was found in “kosher broiled chicken liver” 
products. As a result, the contaminated products were recalled from grocery stores on November 8, 2011, and 
additional illnesses were prevented.
These students were part of the Foodborne Diseases Centers for Outbreak Response Enhancement (FoodCORE)-funded "Team Salmonella',' 
which assisted in epidemiologic investigations of Salmonella-caused outbreaks in New York City. ▼
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R u n n i n g  o n  e m p t y —  
T h e  h e a l t h  i m p a c t  o f  h o u s e h o l d  
r u n n i n g  w a t e r  o n  A l a s k a  N a t i v e s
Which is the largest US state? Most people would quickly— and 
correctly— answer “Alaska.” But if asked, “Which state ranks last for 
having running water in the home?” probably far fewer would know 
that the correct answer is also “Alaska.” In fact, nearly one-quarter of 
rural Alaskan homes lack running water, also called in-home water 
service and defined as complete plumbing, with a working sink, toilet, 
and a shower or bathtub. Not surprisingly, there is increasing evidence 
that in-home water service is linked to better health.
Providing data to determine the effect of in-home water service on 
the health of Alaska Native people is one of many studies conducted 
by CDC’s Arctic Investigations Program (AIP). Located in Anchorage, 
AIP is CDC’s infectious disease field station in the Arctic whose 
mission is to prevent disease in people of the Arctic and sub-Arctic. 
AIP’s focus on running water and infectious disease also aligns with 
one of NCEZID’s fundamental commitments— to prevent and reduce 
infectious disease disparities among vulnerable populations, such as 
Alaska Natives.
The AIP team has conducted several studies that matched hospitalization rates to water service. They found 
higher rates of “water-washed disease” diseases caused by inadequate hand or body hygiene that tie directly to 
an inadequate supply of clean water. These diseases spread from person to person or can be prevented through 
hygienic habits that involve water. The studies found that the most common included pneumonia, influenza, 
a type of respiratory virus common among children, skin infections due to MRSA (methicillin-resistant 
Staphylococcus aureus), and dental caries (cavities) among children. A particularly disturbing finding was that 
the rate of pneumonia among Alaska Native infants is 11 times higher than the overall US rate. Interestingly, 
diarrhea-associated hospitalizations (which would suggest contaminated water that was ingested) did not 
differ according to the type of water service in the home. This is probably due to the availability of safe 
drinking water at a central watering point in all rural Alaska villages. However, hauling sufficient water 
quantities to the home for cooking, washing dishes, and hygienic habits is a barrier that likely explains the 
higher rates of water-washed diseases.
The AIP study recognizes that an inadequate supply of safe water was not the only infectious disease risk. 
Other social determinants, such as household crowding, indoor air quality, and nutrition also contributed to 
the problem. But the study brings researchers significantly closer to answering perhaps the most challenging 
question: “How much water is needed to maximize healthy behaviors?”
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G e t t i n g  t h e  n u m b e r s  r i g h t —  
T e n n e s s e e  c o n f i r m s  s u c c e s s  in  i n f e c t i o n  r e d u c t i o n
Could the numbers be trusted? That is what Tennessee public health officials wanted to know when they saw 
a dramatic decrease throughout the state in one of the deadliest healthcare-associated infections (HAIs). 
Tennessee, compared with all states during 2009-2010, had the second-largest reported decrease in central 
line-associated bloodstream infections (CLABSIs). CLABSIs are caused by unclean or incorrectly inserted 
central lines, which are tubes placed in large veins to give patients important medical treatment. Up to 1 in 
4 patients who get a CLABSI can die. But CLABSIs are largely preventable when healthcare providers use 
CDC-recommended infection control steps.
To validate this dramatic decrease, the Tennessee Department of Health charged its Healthcare-Associated 
Infections Team to reexamine the data. Since 2008, Tennessee has required hospitals to report CLABSIs and 
certain other HAIs to CDC’s National Healthcare Safety Network (NHSN). CDC manages NHSN, the largest 
healthcare-associated infections reporting system in the United States, with more than 11,000 healthcare 
facilities participating. To ensure the CLABSI reductions reported to the NHSN were accurate, Tennessee’s HAI 
Team undertook extensive validation efforts using resources provided by CDC.
The validation project targeted facilities with either very high or very low CLABSI rates during 2009 and 2010. 
They also included a random selection of facilities with average infection rates. The validation project gives the 
Tennessee Department of Health, its partners, and Tennessee hospitals confidence in the reported data. The 
dramatic reduction of CLABSIs reported in the state was verified to be accurate.
How patients with central lines can 
get infected with germs
Where medicines 
are injected can 
get dirty
À
Hand or glove 
touching the line 
can be dirty
Central line
Skin where line 
is placed can 
be dirty
▲ Central line-associated bloodstream infections (called CLABSIs) are caused by unclean or incorrectly inserted central lines, 
which are tubes placed in large veins to give patients important medical treatment.
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T h e  s u m m e r  o f  o u r  d i s c o n t e n t —  
A r b o N E T  g i v e s  s t a t e s  v i t a l  i n f o r m a t i o n  
d u r i n g  o u t b r e a k  o f  W e s t  N i l e  v i r u s
In the United States, the summer of 2012 will be remembered for records 
that were set— the worst drought since the Dust Bowl and the most 
destructive wildfire season in history. Unfortunately, it also may be 
remembered for the second-largest outbreak of West Nile virus disease 
since it first appeared in the United States in 1999. By late November, 
more than 5,000 cases including 236 deaths had been reported to 
CDC. Of these cases, 51% were classified as “neuroinvasive,” meaning 
that those people developed serious illnesses, such as encephalitis or 
meningitis. More than 80% of the cases were reported from 13 states; 
nearly one-third of the cases were from Texas.
West Nile virus is a pathogen that is transmitted to people by infected 
mosquitoes that got the virus from diseased birds. Many people who are 
bitten by an infected mosquito won’t get sick— but many others aren’t as 
lucky. The virus generally peaks in late summer, which is why the 2012 
outbreak’s early start was cause for concern. “It is not clear why we are 
seeing more activity than in recent years,” said Marc Fischer, medical 
epidemiologist with CDC. Although they haven’t yet been able to answer 
“why” there is more activity, scientists are current on “how much” 
activity there is in the record-setting outbreak, thanks to a surveillance 
system that tracks West Nile virus in all 50 states.
The tracking system, called ArboNET (National Arboviral Surveillance 
System), collects and shares human, animal, and ecologic data with 
states— real-time information about West Nile activity to help local 
authorities make decisions about mosquito control or outbreak 
preparation and response. ArboNET (so named because it focuses on 
arbovirus diseases that are transmitted by an arthropod vector like a 
mosquito or tick) was developed in response to the introduction of West 
Nile virus into the United States in 1999. Strong collaboration between CDC, state and local health departments, 
blood services agencies, and the US Geological Survey enables ArboNET to provide a broad picture of virus 
transmission activity and migration. These data also provide the basis for developing predictive models to help 
identify risk factors and anticipate disease trends. In addition to West Nile virus, ArboNET reports on several 
other viruses including dengue, chikungunya, and eastern equine encephalitis.
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West Nile virus activity by state, 2011 and 2012*
September 2012
*Data for 2011 are final; data for 2012 are provisional.
A  The number of cases of West Nile virus in 2012 was the second-highest number of cases recorded since West Nile virus first 
appeared in the United States in 1999. The striking difference in incidence between 2011 and 2012 is due, in part, to the 
notably reduced (compared with prior years) number of West Nile virus cases reported in 2011.
Our many roles: Securing state, local, and tribal capacity 49
NCEZID: Our Work, Our Stories 2011-2012
▲ 2011 ELC funding helped strengthen public 
health capacity in several states including 
Montana, where it supported rural infection 
preventionists—  part of an effort to reduce 
healthcare-associated infections.
C r i t i c a l  s u p p o r t  d i r e c t e d  a t  c r i t i c a l  n e e d s
In March 2011, test results of four patients with salmonellosis (illness caused by Salmonella 
infection) were reported by a hospital lab to a local health department in Maryland. 
Interviews were conducted, and it was quickly confirmed that all four had attended a 
drop-in charity fundraiser breakfast. Laboratories further identified the exact type of 
Salmonella infection, the food vehicle (sausage) was identified, and the product quickly 
recalled. The rapid and coordinated response from epidemiologists, information technology 
specialists, and laboratorians illustrates the Epidemiology and Laboratory Capacity for 
Infectious Diseases Cooperative Agreement (ELC) at work.
The ELC was formed in 1995 as a key component of CDC’s national strategy to prevent, 
detect, and respond to new and emerging infectious diseases. The ELC serves as a platform 
to support all 50 state health departments, 6 local health departments (Los Angeles County, 
Philadelphia, New York City, Chicago, Houston, and Washington, D.C.), Puerto Rico, and 
the Republic of Palau in their infectious disease work in epidemiology and in the laboratory. 
In early fiscal year 2012, the ELC was expanded to include all of the other Pacific Island 
territories and the US Virgin Islands.
With ELC support, health departments build and strengthen their public health capacity by 
hiring and training staff, buying laboratory equipment and supplies for detecting emerging 
pathogens, and investing in information technology to improve disease reporting and 
monitoring. In fiscal year 2011, funding provided through the ELC cooperative agreement 
supported programs that focused on zoonotic, vector-borne, prion, and foodborne diseases; 
influenza; healthcare-associated infections and antimicrobial resistance; and public health 
informatics. A small sampling of recent work includes:
• Colorado— Early identification of outbreaks of a type of E. coli infection that was 
associated with ground bison and raw milk gouda cheese.
• Montana— Support for rural infection preventionists, part of an effort to prevent 
healthcare-associated infections.
• Florida— Laboratory testing that documented the emergence and disappearance of 
dengue in Key West, Florida.
• Arkansas— Epidemiology and lab staff working in concert to solve a waterborne infection 
associated with people swimming in a section of a river near agricultural operations.
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S u p p o r t i n g C D C s  i n f e c t i o u s  d i s e a s e  m i s s i o n  b y . . .
I n v e s t i g a t i n g  h o w  
d i s e a s e s  f r o m  a n i m a l s  
a r e  s p r e a d  t o  p e o p l e
Zoonotic diseases account for over 60% of all 
communicable diseases causing illness in humans 
and 75% of recently emerging infectious diseases.
To reduce the public health impact of zoonotic 
and other emerging infectious diseases, NCEZID 
promotes a comprehensive, interdisciplinary 
One Health approach that engages the principles 
of human health, veterinary medicine, and 
ecosystem health.
NCEZID is actively working at the human-animal 
interface to increase understanding of the ecology 
and risk factors for transmission of disease 
between animals and humans and to advance 
evidence-based One Health strategies that will protect and improve human health. Rabies and 
brucellosis are examples of diseases where the best solution for preventing humans from getting a 
severe illness is not in treating the person, but by monitoring and treating the disease in animals. 
That way, humans are protected and the health of the animal is improved.
Unprecedented collaborations between NCEZID and animal health entities at the international, 
regional, and country level are being established to implement integrated and comprehensive 
response to zoonotic diseases that could pose public health threats. We are working collaboratively 
with human and animal health partners to improve global preparedness and response to pandemic 
threats of zoonotic origin through multidisciplinary and multi-sectoral collaborations.
NCEZID is also assuming a leadership role by building One Health partnerships and promoting 
trust-based relationships among multiple sectors and disciplines, internal and external to CDC. 
NCEZID facilitates the exchange of information and enhances communication across disciplines by 
sponsoring visiting scientists and fellows, lectures, and meetings. We also manage resources from 
across the agency and help allocate resources from outside of the agency to maximize impact.
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A sample of zoonotic disease outbreaks caused by contact with animals
What caused the outbreak Details about the outbreaks
S i r Frogs (amphibians)
A 2009-2011 outbreak resulted in >250 reported cases of infection with Salmonella, 
primarily involving young children.
Turtles (reptiles)
Since 2006, 9 large multistate outbreaks have resulted in hundreds of reported illnesses. 
Young children are primarily affected. An estimated 6% of all Salmonella infections are 
associated with contact with reptiles; an estimated 11% of all Salmonella Infections in 
persons under age 21 are associated with contact with reptiles.
Reptile-associated human Salmonella illnesses have been reported since 1963. In 
1975, the US Food and Drug Administration established a ban prohibiting the sale 
or distribution of small turtles in the United States, except for bona fide scientific, 
exhibition, or educational purposes.
* Live poultry
Live poultry-associated Salmonella illnesses have been reported since 1955.
Since the 1990s, more than 35 outbreaks have been reported to CDC, primarily 
involving young children.
Outbreaks occur year-round. Most live poultry come from mail-order hatcheries or 
agricultural feed stores.
Frozen feeder rodents
A 2010 outbreak led to at least 34 cases of Salmonella infection, primarily among 
children; a similar outbreak was also reported from the United Kingdom.
In 2011-2012, 26 cases of Salmonella infection were linked to feeder rodents.
Previous outbreaks of human Salmonella infections have been linked to frozen rodents 
used as reptile feed.
*
Pet food products: 
Dry dog and cat food 
and pet treats
Since 2006, two outbreaks of Salmonella infection linked to dry pet food have been 
reported in the US:
79 Salmonella Schwarzengrund infections were reported in 2006- 2008, primarily in 
children under the age of 2.
22 Salmonella Infantis infections were reported from the US and Canada in 2012 
(as of June 14, 2012).
In both outbreaks, Illnesses were linked to contact with multiple brands of 
contaminated dry dog and cat food from single pet food production facilities. Pet treats 
such as pig ear chews have also been associated with human Salmonella infections.
T
Animal exhibits in 
public settings, such 
as petting zoos, fairs, 
schools, etc.
Since 1996, more than 150 infectious disease outbreaks of Salmonella, E. coli, and 
other zoonotic pathogens associated with contact with animals in public settings have 
been reported to CDC.
Animals can make people sick, but many people are not aware o f the risks. CDC uses the Web, social media, and educational flyers to  
alert consumers and the pet industry about infections, like Salmonella and E. coli (two enteric, or intestinal, zoonoses), tha t people can 
get from  direct contact w ith  high-risk animals—  including birds, amphibians, and reptiles.
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L e s s  i s  m o r e —  
N e w  h o p e  f o r  a  n e g l e c t e d  d i s e a s e
Although rare in the United States, each year rabies causes more than 55,000 deaths worldwide. CDC has developed 
a less costly, less complicated test that offers the prospect that this age-old scourge could be significantly reduced, or 
even possibly eliminated.
The rabies test is the only routine diagnostic test applied to an animal that directly determines the need for 
life-saving medical intervention in humans. For example, if a person is bitten by a suspect animal, and the test is 
negative, no vaccination is needed for that individual. However, if the animal tests positive, the bitten person can 
undergo a series of shots to prevent this fatal disease.
Today, in much of the developing world, rabies surveillance and diagnosis in domestic animals and wildlife face 
many challenges. High temperatures make it difficult to collect and preserve fresh specimens. The gold standard test 
currently used to diagnose rabies is limited by the high cost of acquiring and maintaining a fluorescent microscope. 
Difficulties in obtaining diagnostic results from the field have led to widespread underreporting of disease. 
Consequently, the true public health impact of rabies has been greatly underestimated.
A new test developed by CDC’s Rabies Lab requires no specialized equipment or refrigeration, making it ideal 
for use in developing countries. The laboratory developed a highly concentrated cocktail of rabies antibodies that 
allows a diagnosis to be made in less than 1 hour.
This new test has been found to be as reliable a diagnostic method as the current and more expensive gold standard 
test. It has the advantage of requiring only a light microscope, which is widely available and 10 times less expensive 
than a fluorescent microscope. Reduced cost suggests high potential for making rabies diagnosis available in other 
cities and even rural areas of Africa, which could improve the ability to manage rabies, better respond to outbreaks, 
and support the need for critical vaccination for disease prevention after exposure to rabid animals, or reduce 
unnecessary use of post-exposure rabies shots.
Rabies: Global distribution of reservoirs
•4 Although rare in the United 
States, each year rabies 
causes more than 55,000 
deaths worldwide. A new 
rabies diagnostic test 
developed by CDC's Rabies 
Lab requires no specialized 
equipment or refrigeration, 
making it ideal for use 
in developing countries. 
Courtesy Kevin Liske
Our many roles: Investigating how diseases from animals are spread to people 53
NCEZID: Our Work, Our Stories 2011-2012
H u n g r y ,  h u n g r y  h i p p o s
But in this case it was hungry people who were eating 
hippos. A chain of events was started in late summer 2011 
during the dry season in Zambia. Hippos, hunting for 
food by rooting in the soil, became infected with anthrax.
People living near the sites of hippo deaths started to see 
the carcasses as a convenient and free source of food.
The resulting outbreak of anthrax among people who 
had either eaten the meat of— or butchered— infected 
hippopotamuses became a serious and deadly twist on the 
title of a popular children’s game.
When the Zambia Ministry of Health contacted CDC in mid-September, the anthrax outbreak had already 
sickened 500 people and caused 5 deaths. Mark Lehman, an Epidemic Intelligence Service officer, was sent to 
Chama in eastern Zambia to investigate the problem and make recommendations. Dr. Lehman first needed to 
determine how people were contracting the anthrax, most of which was the less lethal cutaneous (skin) form 
of the infection. Dr. Lehman and the team trained local community health workers to conduct surveys, which 
showed that the primary way people were getting infected was by carrying the hippo meat home from the 
butcher site. The survey also confirmed the reason they were eating hippo meat— food insecurity, or in other 
words, having nothing else to eat.
Armed with survey results, Dr. Lehman next assisted in resolving the outbreak, touring areas that had been 
affected as well as those still believed to be unaffected. He scoured game parks and lagoons in 100-plus degree 
temperatures and was gratified to discover many untouched hippo carcasses— an indication that people were 
probably understanding the risks of handling or eating the infected meat.
Mark Lehman’s recommendations to the Ministry of Health 
included an offer of laboratory support and outbreak management 
strategies. He also encouraged Zambian officials to address 
the connection between the outbreak and environmental and 
food insecurity issues. Above all else, Dr. Lehman encouraged 
health officials to follow the World Health Organization (WHO) 
guidelines about anthrax outbreaks. Although they had copies of 
the WHO guidelines, they still looked to Mark Lehman for advice; 
as he later reflected, “I really just continued to tell them to follow 
WHO guidelines, but sometimes just being there in person makes 
a difference.”
Epidemic Intelligence Service Officer Dr. Mark Lehman 
with children in eastern Zambia.
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B i g g e r  t h a n  a  b r e a d b o x —  
A  w i n - w i n  s o l u t i o n  f o r  c u r b i n g  
p l a g u e  in  U g a n d a
In the past 30 years, human plague outbreaks have become common in the previously 
plague-free West Nile region of Uganda. A new food storage device that CDC has 
developed and tested might not only reduce plague, but may also address the problem 
of food insecurity (not having enough food to eat) in this poverty-stricken area. And 
there’s an added bonus— they are built from native materials and could be locally 
produced to provide a source of employment.
The recent increase in plague is associated with many factors— native forests and 
savannas being converted to fields used for subsistence farming, rapid increases 
in human population, and an invasion of black rats into new habitats created by 
vegetation clearing and village construction. This highly prolific black rat is the 
preferred host for fleas that spread plague to people.
Food items stored in open baskets and on the floor makes 
them easily accessible to rodents in search of food. In 
addition to bringing plague-infested fleas into the huts, the 
rats also eat a significant amount of the villagers' food.
A key to reducing plague is cutting off rats’ access to food supplies. After collecting information about local food 
storage practices and types of crops raised, rats were radio-collared, which resulted in cooking huts— rather than 
sleeping huts— being targeted for rat reduction measures. The roughly 100 food storage cabinets that were designed 
specifically to limit rat access to food supplies had another advantage. Because they can be secured, the food boxes 
could help curb the widespread problem of stealing food that contributed to food insecurity in the region. The food 
storage boxes are currently being evaluated to determine whether a larger scale trial will follow to document if there 
has also been a reduction in human plague.
Ugandan carpenters constructed lockable 
food storage pantries like this from locally 
available materials to protect stored foods 
from rodents and theft.
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A pproxim ately 75% o f  recently em erging infectious diseases 
affecting people are zoonotic— they originate in anim als.
C u t e  b u t  c o n t a m i n a t e d —  
A  c a u t i o n a r y  t a l e  a b o u t  s m a l l  t u r t l e s
For many of us, infection with Salmonella is associated with 
eating— as in eating food contaminated with Salmonella such 
as undercooked eggs, ground turkey, or chicken. But Salmonella 
infection can also be caused by touching— as more than 160 people 
discovered after they had handled small turtles. As of early September 
2012, 6 overlapping outbreaks reported in 30 states of Salmonella- 
caused illness were linked to small turtles, those with a shell length of 
less than 4 inches. Of the 160 illnesses, 64% were in children aged 10 
years or younger; 56% of those who became ill were Hispanic.
Infections caused by small turtles are a recurrent problem, despite the 
fact that the US Food and Drug Administration (FDA) has banned the 
sale and distribution of small turtles since 1975. In the outbreaks in 
2012, almost half of ill people reported purchasing turtles from street 
vendors, making it difficult to determine the original source of the turtles.
Salmonella are naturally occurring bacteria in turtles, and those with Salmonella still appear healthy and clean. 
Contact with other reptiles (such as snakes and lizards) and amphibians (such as frogs and toads) can also be a 
source of Salmonella infections. Salmonella germs are shed in their droppings and can easily contaminate their 
bodies and anything else in areas where these animals live.
Of particular concern is that small turtles cause infection 
especially among young children. Salmonella infection can be 
caused by actually handling the turtles or contact with their 
environment (like the water in the turtle habitat). Despite the 
health risk, turtles remain popular pets. CDC collaborated 
with public health officials in multiple states and the FDA to 
investigate the six overlapping, multistate outbreaks. CDC posts 
updates about the outbreaks on their website, in addition to 
providing educational information designed to alert consumers 
to the dangers of handling small turtles.
▲ Small turtles cause Salmonella infection, 
especially among young children. Of the 160 
illnesses in a 2012 outbreak, 64% were in 
children aged 10 years or younger.
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T a k i n g  a c t i o n
S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
H e a l t h c a r e - a s s o c i a t e d  i n f e c t i o n s
C u r r e n t  c h a l l e n g e s
Healthcare-associated infections (HAIs) are a leading cause of preventable illness and death in the United States 
and a critical public health problem that affects 1 in 20 hospitalized patients. HAIs are caused by a variety of 
bacteria, fungi, and viruses, yet are preventable with proper adherence to evidence-based infection control 
practices. HAIs occur in all settings where patients receive medical care, including hospital and non-hospital 
settings (e.g., ambulatory surgical centers, long-term care and dialysis facilities), are associated with increased 
mortality, and account for at least $28 billion in excess healthcare expenditures annually.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  h e a l t h c a r e - a s s o c i a t e d  
i n f e c t i o n s ?
CDC’s healthcare-associated infections (HAIs) program began over 4 decades ago and leads the nation towards 
the goal of eliminating HAIs. It has formed the basis for healthcare facility, local, state, and national prevention 
programs that include surveillance, prevention research, developing guidelines to promote US healthcare quality, 
outbreak response and control, and laboratory support. CDC’s role in preventing HAIs involves the following 
activities:
• Conducting surveillance for HAIs through the National Healthcare Safety Network (NHSN) and the 
Emerging Infections Program (EIP). NHSN is the largest Web-based medical surveillance system in the 
US, used by more than 11,000 healthcare facilities in all 50 states. EIP, a population-based network of state 
and local health departments in 10 states, is a national resource for surveillance, prevention, and control of 
emerging infectious diseases. CDC’s surveillance systems serve as the national standard for defining HAI 
problems, identifying and prioritizing populations at risk, and measuring the impact of prevention efforts. 
CDC data are used by healthcare facilities for HAI prevention and by state and federal agencies for public 
reporting and quality improvement programs. (continued on the next page)
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H a v i n g  c a n c e r  i s  b a d  e n o u g h —  
d o n ' t  l e t  a n  i n f e c t i o n  h a p p e n
One of the most dangerous side effects of chemotherapy cannot 
be seen. A low white blood cell count, or neutropenia, puts cancer 
patients at a higher risk for getting an infection. White blood cells 
are the body’s main defense against infection. For patients with this 
condition, any infection can become serious quickly.
Cancer patients who are treated with chemotherapy are more likely 
to get infections through everyday activities with their family and 
friends or from healthcare settings. It has been estimated that each year,
60,000 cancer patients are hospitalized for chemotherapy-induced neutropenia, and every 2 hours a patient 
dies from this complication. Because of the nature of their illness, great attention to infection prevention is 
warranted in the care of cancer patients.
Preventing Infections in Cancer Patients is a comprehensive program, resulting from the collaboration of 
CDC through a partnership between the CDC Foundation and Amgen. The two main components include 
the Basic Infection Control and Prevention Plan for Outpatient Oncology Settings and a patient and caregiver 
website: www.preventcancerinfections.org. The program also produced a variety of additional materials 
for patients, caregivers, and healthcare providers that provide information, action steps, and tools to help 
reduce the risk of developing potentially life-threatening infections during chemotherapy treatment.
▲ Courtesy CDC Foundation
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  h e a l t h c a r e - a s s o c i a t e d
i n f e c t i o n s ?  (continued from previous page)
• Developing evidence-based guidelines that provide the scientific basis for HAI prevention tools and 
oversight requirements by working with the Healthcare Infection Control Practices Advisory Committee 
through a transparent, public process. These guidelines establish the standard of care and provide evidence 
for provider and surveyor checklists and federal prevention initiatives, such as the Agency for Healthcare 
Research and Quality’s Comprehensive Unit-Based Safety Program and the Centers for Medicare & Medicaid 
Services’ (CMS) healthcare facility Survey and Certification process.
• Maximizing HAI prevention efforts through working with healthcare facilities, health departments, federal 
agencies, and professional organizations to implement HAI prevention programs. CDC supports state health 
departments’ efforts to expand HAI prevention beyond hospitals. For example, in June 2012, CDC released
a report and updated recommendations that detail how states and healthcare facilities should deal with 
carbapenem-resistant Enterobacteriaceae, deadly germs that can cause healthcare-associated infections.
• Investigating and controlling outbreaks and maintaining critical core laboratory capacities, including 
the national reference laboratory for antimicrobial susceptibility testing, environmental microbiology, and 
diagnostic methods for emerging healthcare-associated pathogens.
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A c c o m p l i s h m e n t s
NHSN data show dramatic reductions in
healthcare-associated infections. In 2011, the
following reductions in infections occurred
(compared with the baseline):
• 41% reduction in central line-associated 
bloodstream infections (CLABSIs)
• 7% reduction in catheter-associated urinary 
tract infections (CAUTIs)
• 17% reduction in surgical site infections (SSIs)
• Additionally, a 25% reduction in the number 
of people developing healthcare-associated 
invasive MRSA infections, as measured by the 
Emerging Infections Program
• NCEZID will publish the Standardized 
Infection Ratio (SIR) Report using NHSN 
data, providing a state-by-state breakdown of 
healthcare-associated infections and detailing 
reductions in infection rates across the 
country in early 2013. CDC’s support to states 
has contributed to a national CLABSI SIR 
reduction from 0.68 in 2010 to 0.59 in 2011.
• Projects in three states have documented 
approximately a 20% reduction in 
Clostridium difficile when clinicians 
followed CDC infection prevention 
recommendations. C. difficile is a pathogen 
that causes serious diarrhea and has been 
linked to 14,000 U.S. deaths and an estimated 
$1 billion each year in excess costs to the 
healthcare system. Although many HAIs have 
declined, the incidence of C. difficile infections 
remains at historic highs. The recent CDC 
Vital Signs report indicates that about 75% of 
C. difficile infections begin in medical settings 
such as nursing homes and outpatient clinics. 
In March 2012, CDC issued a call to action to 
prevent C. difficile infections.
(continued on the next page)
State-level public reporting HAI policy, 2004
State-level public reporting HAI policy, 2012
□  :Disclosures of healthcare-associatedinfections required
Requires use of NHSN for reporting 
HAI data to the state (29 states and DC)
▲ In 2012, more states are requiring public reporting of healthcare-associated infections (HAIs). More 
than 11,000 hospitals in all 50 states use cDc 's National Healthcare Safety Network (NHSN) to track 
HAIs. To date, 29 states and the District of Columbia require reporting of HAIs using CDC's NHSN.
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S t o p p i n g  t h e  s p r e a d  o f  a  d i f f i c u l t  i n f e c t i o n
People getting medical care can have serious healthcare- 
associated infections (HAIs). Although most types of 
HAIs are declining, one— caused by the germ Clostridium 
difficile*— remains at historically high levels. C. difficile 
causes diarrhea and is linked to 14,000 US deaths each 
year. Those most at risk are people— especially older 
adults— who take antibiotics and also get medical care. 
When a person takes antibiotics, good bacteria are 
destroyed for several months. During this time, patients 
can get sick from C. difficile picked up from contaminated 
surfaces or spread from a healthcare provider’s hands. 
About 25% of C. difficile infections first produce 
symptoms in hospital patients, but 75% start in nursing 
home patients or in people recently cared for in doctors’ 
offices and clinics. C. difficile infections cost at least 
$1 billion in extra healthcare costs annually. A March 
2012 CDC Vital Signs reports that C. difficile infections 
can be prevented by following CDC recommendations. 
Hospitals that have implemented these recommendations 
saw C. difficile infection rates decline by 20%. The US 
Department of Health and Human Services has targeted 
a 30% reduction in C. difficile infections by 2015.
*Clostridium difficile (klah-STRID-ee-um DIFF-i-seel)
A c c o m p l i s h m e n t s  (continued from previous page)
• NCEZID has expanded prevention of HAIs across all healthcare settings by increasing the types of 
HAIs reported to NHSN. As of December 2012, more than 11,000 facilities, including approximately
5.000 hospitals, are using NHSN to track HAIs and target prevention. In October 2012, approximately
5.000 dialysis facilities, 430 long-term acute care facilities, and 1,200 inpatient rehabilitation centers began 
reporting HAIs through NHSN.
• NCEZID developed and published evidence-based guidelines including the Guide to Infection 
Prevention for Outpatient Settings: Minimum Expectations for Safe Care (2011), the 2011 Guidelines 
for the Prevention of Intravascular Catheter-Related Infections, and the Guideline for the Prevention and 
Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings (2011). CDC continues to work with 
professional and federal partners to ensure that CDC guidelines become the standard of care. For example, 
CMS has incorporated CDC HAI prevention recommendations into surveyor tools used by CMS for facility 
survey and certification.
62 Taking action: Healthcare-associated infections
NCEZID: Our Work, Our Stories 2011-2012
8 8
Tl'
C o n t r o l l i n g  d e a d l y  i n f e c t i o n s  
i n  d i a l y s i s  t r e a t m e n t
Hemodialysis (often called “dialysis”) is a life-saving 
treatment for people with advanced kidney disease. About 
350,000 people receive hemodialysis treatment at any given 
time, and roughly 8 in 10 of these patients start treatment 
through a central line. A central line is a tube that a doctor 
places in a large vein of a patient s neck or chest to give 
important medical treatment. When not put in correctly 
and kept clean, central lines can become a freeway for 
germs to enter the body and cause serious bloodstream 
infections (called BSIs). Of patients who get a bloodstream 
infection from having a central line, up to 1 in 4 die.
About 37,000 bloodstream infections occurred in 2008 in hemodialysis patients 
with central lines. The CDC Dialysis BSI Prevention Collaborative is a partnership 
aimed at preventing bloodstream infections in hemodialysis patients. Open to 
free-standing and hospital-based outpatient dialysis facilities across the country, 
the collaborative measures how many bloodstream infections are occurring and 
offers evidence-based practices to prevent these devastating infections.
It’s working! After a New Jersey outpatient hemodialysis center began using the 
CDC Dialysis BSI Prevention Collaborative’s infection-control practices, along 
with a program that enlisted staff member support in using safer procedures, 
they had only one vascular access-related BSI in 12 months.
W h a t ' s  n e x t ?
CDC’s goal is to eliminate HAIs across all 
healthcare settings and support state public 
health activities related to HAI monitoring, 
response, and prevention. In the coming 
years we will focus on
• Extending prevention activities to non-hospital settings (e.g., long-term care facilities, ambulatory surgical 
centers) where increasingly, more complex medical care is being provided and rates of HAIs have not decreased.
• Providing NHSN data to measure the impact of state and national HAI prevention initiatives including state 
HAI prevention collaboratives, the HHS Action Plan to Prevent HAIs: Roadmap to Elimination, the CMS Value- 
Based Purchasing program, and other HHS HAI prevention initiatives.
• Developing and disseminating evidence-based guidelines and prevention tools to ensure that the safest care 
is delivered in all healthcare settings.
• Guiding prevention strategies and best practices to target HAIs whose rates have not decreased to address 
important scientific gaps in HAI prevention.
• Supporting state-based efforts to prevent HAIs, including providing technical expertise and training, 
outbreak response, support for HAI prevention programs, policy evaluation, and laboratory support.
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S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
A n t i m i c r o b i a l  r e s i s t a n c e
C u r r e n t  c h a l l e n g e s
Antimicrobial resistance (AR) is one of the world’s most pressing public health threats. A wide range of 
pathogens— including the bacteria that cause tuberculosis and healthcare-associated infections, the viruses that 
cause influenza, the parasites that cause malaria, and the fungi that cause yeast infections— are becoming resistant 
to the antimicrobial agents used for treatment. Antibiotics have been used so widely and for so long that the 
infectious organisms the antibiotics are designed to kill have adapted and continue to adapt to them, making the 
drugs less effective. Patients infected with drug-resistant microbes are more likely to require hospitalization, remain 
in the hospital longer, and have a poor prognosis. Effectively combating antimicrobial resistance requires developing 
new drugs, appropriately using existing drugs, and vigilantly tracking and stopping the spread of resistance.
W h a t  i s  C D C 's  r o l e  
in  p r e v e n t i n g  
a n t i m i c r o b i a l  
r e s i s t a n c e ?
NCEZID plays a critical and unique 
role in combating AR and uses a 
multifaceted approach to prevent and 
control antimicrobial resistance through 
surveillance, laboratory work, outbreak 
response, educational campaigns, and partnerships with state agencies and national organizations. We work closely 
with federal partners, the Interagency Task Force on Antimicrobial Resistance, and international organizations.
Our role includes the following:
• Monitoring disease, deaths, antibiotic use, and resistance trends caused by microbial infections of public 
health importance. We also monitor antibiotic use and resistance rates, inform and guide prevention efforts, 
and evaluate the effectiveness of prevention programs.
• Providing technical assistance and laboratory support for outbreak investigations of AR organisms. We use 
molecular fingerprinting (DNA analysis) to understand the epidemiology of multidrug-resistant organisms, 
compare strain types, and identify emerging mechanisms of resistance for healthcare-associated pathogens.
(continued on the next page)
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W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  a n t i m i c r o b i a l  r e s i s t a n c e ?
(continued from previous page)
• Developing and refining methods to detect new resistant pathogens and susceptibility to antimicrobials. 
NCEZID reference laboratories provide gold-standard laboratory testing services for state health departments, 
clinical diagnostic laboratories, academic researchers, and hospital laboratories.
• Developing evidence-based infection control and antimicrobial stewardship guidelines to prevent 
transmission of infections and promote appropriate use of antimicrobials. CDC also has education campaigns 
that promote appropriate use of antibiotics in physicians’ offices (called Get Smart: Know When Antibiotics 
Work) and in inpatient, outpatient, and long-term care settings (called Get Smart for Healthcare).
A  d a n g e r o u s —  a n d  s p r e a d i n g —  i n f e c t i o n
In August 2000, an infectious disease expert in a New York City hospital 
received a disturbing call from the microbiology laboratory about 
a patient in the intensive care unit from whom they had isolated a 
bacterium called Klebsiella*pneumoniae. This bacterium, as the doctor 
recalled in a 2008 New Yorker article titled “Superbugs,” was “literally 
resistant to every meaningful antibiotic that we had.” By 2012, 
Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella 
infections, which in 2001 had been seen in only 2 states, had spread to 
more than 40 states and Puerto Rico. KPC and other carbapenemases 
are enzymes produced by certain bacteria, making them resistant to 
last-resort antibiotics. The group of highly resistant bacteria together 
are carbapenem-resistant Enterobacteriaceae (CRE).
In healthcare settings, CRE infections commonly occur among sick 
patients who are receiving treatment for other conditions. Patients 
whose care requires devices like ventilators (breathing machines) 
or intravenous (vein) catheters, and patients who are taking certain 
antibiotics are most at risk for CRE infections. Healthy people 
usually do not get CRE infections.
Some CRE bacteria have become resistant to most if not all 
available antibiotics and can be deadly— one report cites they can 
cause death in 40% of patients who become infected. Antibiotic 
stewardship programs and interventions, like CDC’s Get Smart for 
Healthcare, work to combat unnecessary and inappropriate use of 
antibiotics that has contributed to the rise of antibiotic-resistant 
infections. The program aims is to ensure that patients get the 
right antibiotics at the right time for the right duration.
*Klebsiella (kleb-see-ell-uh)
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A c c o m p l i s h m e n t s
NCEZID continued efforts to assess and combat increasing antimicrobial resistance in fiscal years 2011 and 2012.
Significant accomplishments include the following:
• Identifying and characterizing 3 new strains of carbapenemase-resistant Enterobacteriaceae (CRE) 
bacteria that are resistant to nearly all antimicrobial agents. NCEZID assisted states with 12 CRE outbreak 
investigations over the past 2 years and is expanding programs to eradicate newly emerging AR pathogens 
in specific localities or regions, using surveillance and aggressive infection control measures in all healthcare 
facilities that share patients within those geographical areas.
• Launching CDC’s National Healthcare Safety Network’s new Antimicrobial Use module in March 2011 to 
allow facilities to electronically report inpatient antimicrobial usage data and compare facility-specific usage 
rates to a national risk-adjusted benchmark. Information from this national surveillance program will help 
facilities detect whether antimicrobial agents are being used excessively or inappropriately and, if so, target 
education and prevention. (continued on the next page)
T a i n t e d  t u r k e y —  
T r a c k i n g  a n t i m i c r o b i a l  
r e s i s t a n c e  in  f o o d
Antimicrobial use in food-producing animals may result in 
antimicrobial resistance that can be transmitted to people through the 
food supply. In summer 2011, scientists at CDC collaborated with public 
health officials in many states and the US Department of Agricultures 
(USDA) Food Safety and Inspection Service to investigate a multistate 
outbreak of Salmonella infections. Ultimately, more than 36 million 
pounds of ground turkey that may have been contaminated with a 
multidrug-resistant strain of Salmonella Heidelberg were recalled, 
making it the largest USDA recall to date— of any food— in history.
The National Antimicrobial Resistance Monitoring System (NARMS) played a pivotal role in helping 
identify ground turkey as a likely source of infection. NARMS is a collaboration of CDC, the US Food and 
Drug Administration Center for Veterinary Medicine (FDA-CVM), and the US Department of Agriculture 
(Agricultural Research Service) that monitors trends in antimicrobial resistance among foodborne bacteria 
from humans, retail meats, and animals. In this case, a strain of Salmonella Heidelberg, highly similar to the 
outbreak strain, was detected by NARMS in ground turkey from two states. This information led NCEZID 
and its partners to emphasize ground turkey as a possible source in their investigation, ultimately leading to 
the factory where the meat was processed.
A total of 136 people in 34 states were infected. The outbreak strain of Salmonella Heidelberg was resistant to 
several antibiotics. There are still questions about whether the severity of this outbreak was due to pathogen 
dose (a high degree of contamination in the turkey that was consumed), the multidrug resistance of this 
particular strain of Salmonella, or treatment failure (medical management or procedures were unsuccessful).
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A c c o m p l i s h m e n t s  (continued from previous page)
• Conducting a randomized trial, REDUCE-MRSA, in partnership with the Agency for Healthcare Research 
and Quality, in 45 hospital intensive care units to assess the comparative effectiveness of 3 strategies for 
preventing MRSA, a type of staph bacteria that is resistant to certain antibiotics.
• Testing bacteria isolated from people involved in foodborne disease outbreaks to help determine what foods 
or other exposures might be causing those outbreaks and testing over 5,000 samples of microbes including 
Salmonella, Shigella, Campylobacter, E. coli, and Vibrio to document the emerging resistance to antimicrobial 
drugs using the National Antimicrobial Resistance Monitoring System.
a n t im ic r o b ia l




It t a k e s  a  t a s k  f o r c e . . .
The problem is severe, growing, and unfortunately, here to stay.
The extensive use of antimicrobial drugs has resulted in drug 
resistance that threatens to reverse the medical advances of the 
last half century. The world may soon be faced with previously 
treatable diseases that have again become untreatable.
The challenge is to transform an increasingly urgent threat of 
antimicrobial resistance into a manageable problem. Enter the 
Interagency Task Force on Antimicrobial Resistance (ITFAR), 
multiple federal agencies working together to address the 
complex issue of antimicrobial drug resistance. In 2011, the 
task force released an updated revision of A Public Health 
Action Plan to Combat Antimicrobial Resistance. The revised plan focuses on federal activities in four 
topic areas dealing with antimicrobial resistance: surveillance, prevention and control, research, 
and product development. The original Action Plan (2001) focused primarily on domestic issues; 
the revised Action Plan also includes global issues, since resistance is a problem worldwide. The 
past decade has seen extraordinary change in the microbiology and epidemiology of antimicrobial 
resistant microbes and subsequent changes in treatment and patient outcomes.
Although development of new antimicrobial agents and effective stewardship of existing agents are 
key in protecting health in the face of ever-expanding antimicrobial resistance, success in preventing 
or eliminating resistance occurs with successful prevention or elimination of resistant microbes.
The Task Force and all participating federal agencies are continuing to stress the importance of 
good communication with the many stakeholders who share the goals of preventing and controlling 
antimicrobial-resistant infections. The Task Force remains committed to continuing communication 
with the public and health professionals, since antimicrobial resistance so profoundly affects public 
health and clinical medicine. Given the public health consequences of antimicrobial resistance and its 
ever-changing nature, the Task Force will continue to address the issue of antimicrobial resistance in 
this and future versions of the Action Plan.
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“A pproxim ately 50% o f  antib iotic use in hospitals is 
unnecessary or inappropriate."
W h a t ' s  n e x t ?
NCEZID will continue to support state and local health departments to enhance AR surveillance, prevention, and
control interventions and applied research for AR by
• Enhancing national, regional, and local surveillance capacity through electronic reporting to detect and 
track emerging AR organisms, and identifying “hotspots” where multidrug-resistant organisms and other 
healthcare-associated pathogens are being amplified. We are also piloting regional prevention collaborative 
projects to use early detection systems for new AR threats. The aim is to trigger aggressive infection control 
measures in communities and states to prevent these emerging threats from spreading.
• Strengthening capacity in both clinical and public health laboratories to accurately detect priority, high- 
consequence antimicrobial-resistant pathogens, such as carbapenem-resistant Enterobacteriaceae (CRE), in 
collaboration with state public health departments.
• Updating the A Public Health Action Plan to Combat Antimicrobial Resistance published by the 
Interagency Task Force on Antimicrobial Resistance. This plan is the federal blueprint for combating AR.
• Working with FDA to implement provisions of the GAIN (Generating Antibiotic Incentives Now) Act, 
including developing, implementing, and measuring antimicrobial stewardship programs, and identifying 
a list of serious antimicrobial-resistant pathogens of public health significance. In 2013, CDC and FDA will 
finalize the GAIN list of AR pathogens of public health importance and share this with the members of the 
Interagency Task Force on Antimicrobial Resistance.
CDC's Emerging Infections Program tracks infections caused by 
gram-positive Clostridium difficile (pictured) that patients can 
get in a hospital or other healthcare facility. Y
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“There are certain things only a governm ent can do. A nd one o f  those th in  
is ensuring th a t the foods we ea t are safe and do n o t cause us harm
President Barack Oban
S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
F o o d b o r n e  d i s e a s e  a n d  f o o d  s a f e t y
C u r r e n t  c h a l l e n g e s
A  From late September through late November 2012, 
a total of 42 persons in 20 states were infected with 
Salmonella bacteria after eating contaminated peanut 
butter. A collaborative investigation among federal, 
state, and local public health authorities resulted in 
a voluntary recall of the contaminated peanut butter 
and other products containing nuts and seeds.
CDC estimates that roughly 1 in 6 Americans (or 48 million 
people) gets sick, 128,000 are hospitalized, and 3,000 die of 
foodborne diseases each year. The 1,000 or more outbreaks 
that are reported annually reveal familiar culprits, like 
Salmonella. Approximately 6.5 million illnesses are caused 
by food contaminated with norovirus and Salmonella each 
year. Infections caused by Listeria outbreaks led to 33 deaths 
in the United States in 2011 alone.
Foodborne illness also results in billions of dollars in 
healthcare-related and industry costs annually. Reducing 
foodborne illness by just 10% would keep 5 million 
Americans from getting sick each year.
In recent years, large multistate foodborne outbreaks 
have become more common, in part because an extensive 
network of foodborne illness surveillance systems identifies 
outbreaks and tracks trends that previously would have 
been missed. Also, an increasingly centralized food supply 
means that foods contaminated in production can be rapidly 
shipped to many states, causing widespread outbreaks.
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W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  f o o d b o r n e  i l l n e s s ?
Foodborne illness is a preventable and largely underreported public health problem. CDC has strong partnerships 
with state and local health departments and federal regulatory agencies, such as the US Food and Drug 
Administration (FDA) and US Department of Agriculture (USDA), to ensure a robust national food safety system. 
Our overarching goal in food safety is to gather information from ill persons about the germs that made them sick 
and use that knowledge to prevent further illness and death. We gather high-quality scientific data on food-related 
human illness that regulators, industry, and consumers can use to develop food safety priorities and improve food 
safety policies and practices in the United States. With additional effort and support for evidence-based, cost- 
effective strategies that we can put in place now, we can have a significant effect on our nation’s health.
We provide the vital link between foodborne illness 
in people and the food safety systems of government 
regulatory agencies and food producers by
• Monitoring human illnesses through a network 
of complementary surveillance systems needed 
to detect and investigate outbreaks from tainted 
food in near real-time.
• Estimating how many people get sick from 
contaminated food and attributing those illnesses 
to specific foods and settings.
• Conducting state-of-the-art laboratory testing
to detect emerging food-related diseases and 
track antimicrobial resistance trends.
• Providing expert epidemiological and 
reference laboratory consultation to local 
and state partners on outbreaks that they are 
investigating. (continued on the next page)
Foods that caused 1,000 foodborne  
disease outbreaks, 2 0 0 6 -2 0 1 1 *
*There were 1,011 outbreaks and 25,200 illnesses reported. 
Foodborne Disease Outbreak Surveillance System, 2012
U s i n g  d a t a  t o  r e d u c e  E  c o l i  c o n t a m i n a t i o n
What do ground beef, leafy greens, unpasteurized apple juice, and raw cookie dough have in common? 
They all have been associated with one of the most lethal, and now one of the best known, foodborne 
pathogens—E. coli. Shiga toxin-producing Escherichia coli (often shortened to STEC 0157 or E. coli 
0157) captured media attention in the United States in the 1990s after outbreaks of infections caused 
widespread sickness and even death.
After CDC and its partners launched the Foodborne Diseases Active Surveillance Network (FoodNet) 
in 1996, studies began linking sporadic cases of foodborne illness caused by E. coli to ground 
beef. When regulators and industry leaders started using CDC data to improve food handling and 
production standards, the incidence of£. coli-associated illness in foods such as ground beef, raw 
juice, and leafy greens rapidly declined. In fact, during the past 15 years, a dangerous type of E. coli 
infection, responsible for the recall of millions of pounds of ground beef, has been cut almost in half.
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T h e  c a n t a l o u p e  c r i s i s
In 2011, CDC confronted one of the deadliest foodborne outbreaks in the United States in nearly 
a century. The outbreak killed 33 people and caused one miscarriage. However, a coordinated 
public health response— built on rapid detection and investigation— likely prevented many 
more illnesses and deaths from the bacteria Listeria, found in cantaloupes from Colorado.
The outbreak was detected, its source was identified, and a national warning was issued, all in just 10 days, as 
compared with weeks that it took to respond to previous Listeria outbreaks. The rapid response was due to the work of 
many government agencies and healthcare professionals, in addition to PulseNet laboratories that identified the illnesses 
through DNA “fingerprints.” PulseNet labs identified outbreak strains in Colorado patients, then connected them with 
illnesses in 27 other states. A nationwide network of 87 labs, PulseNet is designed to connect cases of illness across the 
country to quickly spot outbreaks, including many that otherwise would go undetected.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  f o o d b o r n e  i l l n e s s ? ^ ^  from previous page)
• Extending detection and response globally through several programs, including the Global Foodborne 
Infections Network. In 2000-2011, over 2,600 professionals have been trained in more than 25 countries.
• Supporting implementation of the Food Safety Modernization Act by prioritizing prevention, strengthening 
surveillance, and improving outbreak response and recovery.
A c c o m p l i s h m e n t s
NCEZID’s food safety program accomplished a number of important steps towards improving the safety of our food
supply during 2011 and 2012. For example, we
• Published the first estimates of foodborne illness in more than a decade, and found that 48 million Americans, 
or 1 in 6, become sick each year from contaminated food. Some 3,000 die every year because of a food-related 
illness.
• Rapidly detected and investigated more than 20 multistate outbreaks and tracked some 150 clusters 
of suspected food-related illness— resulting in fewer illnesses and deaths. For example, we led early, rapid 
detection and investigation of the deadliest US outbreak in nearly a century. As tragic as this outbreak of 
Listeria was, swift and coordinated public health actions, starting in Colorado, saved lives. A new source of 
Listeria infection— cantaloupe— was identified, and the outbreak was stopped quickly. Although serious, 
listeriosis can be prevented. However, it takes teamwork. Everyone has a role— from farmers to families.
• Developed new and better methods to detect, investigate, respond to, and control multistate outbreaks
of foodborne diseases. As a result, one state reported an 86% drop in the time it took to first interview patients 
after they reported an illness that seemed to be food-related— falling from 21 days down to just 3 days. This 
quicker communication opens the door to faster action that can save lives.
• Used scientific evidence to guide development and implementation of important prevention policies like FDA’s 
Egg Safety Rule and the Food Safety Modernization Act. These new policies, along with related regulations and 
industry guidance, will help prevent people from becoming sick and dying from food gone bad.
• Estimated the attribution of illness to specific foods and communicated the dangers of raw milk and raw milk 
products. These efforts will help food safety partners figure out how to prevent foodborne illnesses and deaths.
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foodborne illnesses; detect, investigate, and stop outbreaks when they occur; and provide information to prevent
disease. In the coming years, we will focus on
• Building state and local capacity to detect outbreaks through strong laboratories to identify pathogens and 
detect outbreaks early and training partners in outbreak detection, investigation, and response.
• Developing and assessing next-generation laboratory tests to improve surveillance, outbreak detection, and 
response capacity nationally.
• Adapting our surveillance systems to respond to and integrate with technology changes like culture- 
independent laboratory tests.
• Improving investigation and control of foodborne health threats through the development of new tools, 
methods, and analytics to allow faster and more complete identification of foodborne outbreaks and their causes.
• More accurately attributing illness to specific foods, which will allow for the identification of prevention 
policies targeted to the highest risk foods.
• Tracking trends and sharing data widely and rapidly with public health partners, regulatory agencies, industry, 
and the public to guide safety and prevention policies to address food safety problems.
1996-2010 T a r g e t i n g  S a l m o n e l l a —  
A  s t u b b o r n  f o o d b o r n e  i n f e c t i o n
The 1,000 or more reported outbreaks of foodborne disease that
happen each year reveal a familiar culprit— Salmonella. But 
the good news is that we know that reducing contamination 
works. During the past 15 years, a dangerous type of E. coli 
infection, responsible for the recall of millions of pounds of
ground beef, has been cut almost in half. Yet during that same 
time, Salmonella infection, which causes more hospitalizations 
and deaths than any other type of germ found in food and $365 
million in direct medical costs annually, has not declined.
In 2011, a new CDC Vital Signs report focused on Salmonella contamination, which sickens 1 million 
people each year. Strong and specific action to identify and prevent contamination from the farm to 
the table, and other lessons learned from reducing E. coli 0157 infections could help reduce illness 
caused by Salmonella.
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S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
V e c t o r - b o r n e  d i s e a s e s
C u r r e n t  c h a l l e n g e s
Americans and millions of others are at risk for severe and fatal 
illness from vector-borne diseases. Vector-borne diseases include 
bacterial and viral diseases transmitted by mosquitoes, ticks, 
and fleas. Some of these diseases have long been present in the 
United States while others have recently emerged. These include 
some of the world’s most destructive diseases, many of which 
are increasing due, in part, to globalization of trade and travel 
and global climate change. Of diagnosed diseases that must 
be reported to US federal, state, or local health officials, Lyme 
disease is the sixth most commonly reported, with 30,000 cases 
reported annually. Since 1999, more than 3 million people in the 
country have been infected with West Nile virus, including more 
than 12,700 people whose infections have been severe. Dengue 
infects as many as 100 million people worldwide. Many other 
vector-borne pathogens are also found in the United States.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  v e c t o r - b o r n e  d i s e a s e s ?
NCEZID is the acknowledged national and international leader in the prevention and control of infection with 
vector-borne viruses and bacteria. We have a unique capability, expertise, and mandate to fill this role at a time 
when vector-borne diseases are emerging and spreading at an alarming rate. Our core vector-borne disease 
activities include:
• Developing and sharing cutting-edge laboratory technology for the rapid identification of pathogens and 
diagnosis of emerging diseases.
• Developing innovative vaccines and vaccine implementation strategies.
• Training and assisting front-line disease surveillance and response staff. (continued on the next page)
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F i g h t i n g  t i c k s  a n d  m o s q u i t o e s ,  n a t u r a l l y
Virtually all prevention campaigns against tick- and mosquito-borne diseases recommend 
repellent use. Unfortunately, much of the public opts to take their chances with West Nile virus or 
Lyme disease rather than use repellent. In a recent national study, only 26% of people in the Lyme disease 
endemic northeastern states regularly applied repellent during warm months.
Is it possible to make a repellent that is both effective and marketable?
“Yes,” says Marc Dolan, CDC entomologist. Nootkatone, a compound found in both Alaska yellow cedar trees 
and citrus fruits, has a unique action against insects and ticks. Dolan explains that it is “non-greasy, dries 
very quickly, and it has a very pleasant, citrus-y grapefruit odor to it.”
But does it work?
“This stuff has incredible knock-down,” said Dolan. “It kills ticks very, very 
quickly, usually within about 15 seconds.” In recent trials, nootkatone sprayed 
in a Lyme disease endemic area suppressed more than 90% of ticks. “Since 
nootkatone is a natural compound, we believe it may have a broad appeal and 
will ultimately increase the number of people using repellent and insecticide to 
protect themselves from ticks and mosquitoes,” said Dolan.
CDC and its academic partners are collaborating to develop nootkatone 
products. And the tests that CDC has run so far have gone very well. CDC 
I has licensing agreements with commercial partners to develop nootkatone- 
containing products, including insecticides, repellents, soaps, and shampoos. 
These items could be available for purchase in the next few years.
•4 Ticks don't venture beyond the red line on the 
finger, indicating where nookatone was applied.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g
v e c t o r - b o r n e  d i s e a s e s ?  ('continued from previous page)
• Developing clinician education programs, including a much-praised program for training clinicians how to 
manage severe dengue cases.
• Detecting, preventing, and controlling mosquito-borne diseases through the ArboNET surveillance 
system and tick-borne diseases through the TickNET system. Both systems further NCEZID’s surveillance, 
research, and prevention efforts in collaboration with state and local health departments.
• Closely collaborating with state, local, and tribal health departments, industry, and international 
partners, such as the World Health Organization, to rapidly detect and implement timely, effective responses 
to known and newly identified pathogens.
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Each dot represents one case. Cases are reported from the infected person's county of residence, not necessarily the place where they were infected.
1 In 2009, a new Ehrlichia species w ith  close genetic s im ilarity to  £  muris (called £  Muris-like, or EML) was discovered in some patients residing in 
Minnesota and Wisconsin.The new EML agent has since been confirmed in a tota l o f 36 patients from  these tw o  states through the end o f  2011.
Note: In 2009, a new phlebovirus, called the  Heartland virus, was isolated from  the  tw o  patients w ith  severe febrile  illness in northwestern Missouri. 
Only tw o  cases o f the Heartland virus have been confirmed since 2009.
A c c o m p l i s h m e n t s
In fiscal years 2011 and 2012, NCEZID continued efforts to better understand and prevent vector-borne 
diseases around the world through surveillance, response to outbreaks, and scientific innovation. Examples of 
accomplishments include
Innovation: Innovative, applied research led to new methods for the diagnosis, prevention, and control of vector- 
borne diseases.
• Discoveries include the identification of two new tick-borne pathogens in the United States, found in partnership 
with state health departments— an Ehrlichia mum-like agent from Minnesota and Heartland virus from 
Missouri— and the identification of two new significant causes of human heart disease in Southeast Asia. 
Fieldwork and clinical epidemiology continue to identify the public health impact of these discoveries and ways 
to prevent infection.
• Vaccine efforts include clinical trials of a CDC-developed candidate dengue vaccine produced by commercial 
partners, which is effective against all four dengue serotypes. There has also been an assessment of a new vaccine 
against Japanese encephalitis virus in Cambodia. This is the first large-scale, prospective evaluation of this 
vaccine’s effectiveness and is critical to future widespread adoption.
• Development of a clinician education program that has saved lives and reduced hospitalization costs by training 
more than 10,000 clinicians on optimal clinical management of severe dengue in Puerto Rico.
(continued on the next page)
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D e v e l o p i n g  a  v a c c i n e
Despite decades of effort by many scientists to develop a vaccine for 
dengue, no licensed vaccine is available (although several are currently in 
the later stages of development). Dengue is caused by infection with any of 
four closely related dengue viruses, and a successful dengue vaccine must 
offer immunity against all four.
CDC scientists in Fort Collins, Colorado, have developed a dengue vaccine 
candidate that is now being clinically evaluated in the United States 
and Colombia for safety and immunogenicity (ability to stimulate an 
adequate immune response). The first human Phase-I trial showed that 
the vaccine was safe, was well tolerated, and produced antibody levels that should protect 
against all four dengue viruses. Because of these encouraging results, a Phase-II clinical trial 
to assess immunogenicity began in late 2011. A successful Phase-II trial would be followed 
by Phase-IIb or Phase-III trials to determine the efficacy of the vaccine to prevent dengue. 
Clearly, development and testing of a human vaccine requires many steps.
This technology has been awarded multiple US and international patents. CDC’s dengue 
vaccine team has partnered with Inviragen, Inc., a Colorado-based vaccine developer. 
Inviragen has produced the vaccine, named DENVax, and is conducting clinical development 
and testing of the vaccine for human use. The goal is to provide a safe, effective, and affordable 
dengue vaccine to protect people living in or traveling to dengue-endemic countries.
A c c o m p l i s h m e n t s  (continued from previous page)
Surveillance: Surveillance is critical to good public health decision making, allowing public health officials to 
make the best use of limited resources to prevent and respond to disease. NCEZID’s TickNET works with state 
health departments to optimize surveillance and prevention activities for bacterial tick-borne diseases, such as 
Lyme disease and Rocky Mountain spotted fever. A study of the effectiveness of home pesticide use is under way 
through TickNET, addressing critical questions about the prevention of Lyme disease. ArboNET is a network for 
viral (largely mosquito-borne) disease detection, prevention, and control. ArboNET funding assists states, Puerto 
Rico, and six large municipalities to conduct case investigations, field collections, and analyses and submission of 
information to rapidly monitor and respond to potential epidemic conditions.
Outbreak response: NCEZID conducted outbreak investigations, helping state and foreign governments quickly 
respond to and contain vector-borne disease threats. Recent investigations include fatal cases of Rocky Mountain 
spotted fever on tribal lands in Arizona; the first yellow fever epidemic in Uganda in 40 years; human Q fever illness 
in western states; and dengue investigations among Ugandan peacekeeping troops in Somalia, dengue epidemics in 
the Western Pacific, the largest epidemic in Puerto Rico’s history, and the first local transmission of dengue in Florida 
in 75 years.
▲ Dr. Claire Huang (center) and her team 
(L-R), Janae Stovall, Karen Boroughs, 
and Betty Luy, developed a dengue 
vaccine candidate in their CDC 
laboratory in Fort Collins, Colorado. 
Courtesy Judith Lavelle
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W h a t ' s  n e x t
Rapidly evolving trends such as urbanization and land use changes, migration, global climate change, invasive 
species, and globalization of trade all contribute to the dynamics of risk from emerging vector-borne pathogens. 
To move forward in the control and prevention of emerging vector-borne diseases, we must analyze and 
understand these trends and their impact on every aspect of the disease transmission cycle. By combining 
specialized epidemiology, ecology, laboratory, and prevention expertise, we will deliver
• continued surveillance, detection, prevention and control of vector-borne diseases;
• new rapid, field-use diagnostic tests for plague and yellow fever;
• expansion of regional surveillance centers and FDA-approved diagnostics/guidelines 
in preparation for dengue vaccine introduction; and
• broadened capability to identify and characterize unknown pathogens using next-generation 
genome sequencing.
A  d a n g e r o u s  n e w  v i r u s  k n o c k i n g  a t  o u r  d o o r
Hundreds of people who have traveled from the Americas to Asia and Africa in the past 5 years 
have become infected with chikungunya*, a virus transmitted by mosquitoes that causes fever and 
severe joint pain. To date, it has been introduced in the Western Hemisphere by returning travelers 
who have caught the virus abroad. Experts say, however, that outbreaks could easily occur if local 
mosquito populations become infected.
In early 2012, the Pan American Health Organization and World 
Health Organization, in collaboration with CDC, published new 
guidelines on chikungunya to help countries throughout the Americas 
improve their ability to detect the virus and to prepare to monitor, 
prevent, and control the disease, if— or more likely, when— it appears.
The name chikungunya means “that which bends up.” The disease is 
rarely fatal, but the severe joint pain experienced with the disease can 
last for months. There is no specific treatment or commercially available 
vaccine for chikungunya virus infection. Chikungunya virus is spread 
through the bite of infected mosquitoes, particularly Aedes aegypti and 
Aedes albopictus (the “Asian Tiger” mosquito). Aedes aegypti is common 
in tropical and subtropical areas of the Americas, including the southern 
United States.
“Chikungunya-infected travelers continue to bring the virus to the 
Americas, including the United States,” said Roger S. Nasci, a CDC 
scientist. “These guidelines provide the information needed to develop a 
comprehensive regional plan for rapidly detecting and, hopefully, reducing 
the potential impact of chikungunya virus in the Western Hemisphere.”
*Chikungunya (chick-un-gun-ya)
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S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
CDC scientists in 2011 
study bats in Uganda to 
learn more about their 
relationship to Marburg 
virus which, like Ebola, 
can cause a rare but 
deadly hemorrhagic 
fever in humans and 
other primates.A
H i g h l y  p a t h o g e n i c  o r g a n i s m s
C u r r e n t  c h a l l e n g e s
Select pathogens and diseases, such as rabies, anthrax, and viral hemorrhagic fevers, 
are of high consequence for those affected— often resulting in severe illness or death. 
Although rabies kills an estimated 55,000 people worldwide each year, many other 
high-consequence pathogens cause significantly less illness and death. Nonetheless, 
sporadic cases and small outbreaks do occur in the United States and all over the 
world and, importantly, these pathogens are potential bioterrorism agents. Our public 
health response efforts combine epidemiological, laboratory, ecological, and veterinary 
expertise to diagnose and stop the spread of these deadly diseases.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  i l l n e s s  a n d  d e a t h  c a u s e d  b y  
h i g h l y  p a t h o g e n i c  o r g a n i s m s ?
NCEZID maximizes public health and safety nationally and internationally through the detection, prevention, and 
control of disease, disability, and death caused by suspected and known highly pathogenic organisms. In many 
cases, we are the world experts and have the laboratory and epidemiologic capacity to respond to disease caused 
by these organisms. Our technical assistance is often sought by ministries of health and other international health 
organizations. Domestically, we investigate suspected cases of known highly pathogenic organisms and of infectious 
diseases of unknown causes reported by state and local health departments.
NCEZID’s role is multifaceted but primarily focused on laboratory expertise and diagnostic development. We
• Conduct research to increase our understanding of pathogens, many of which must be handled in special 
biosafety level four (BSL-4) containment facilities, and apply that knowledge to achieve better disease outcomes.
• Respond to outbreaks all over the world to help control the spread of deadly diseases and prevent future 
outbreaks.
• Provide knowledge, training, and the transfer of technologies to partners and collaborators.
• Lead surveillance and pathogen discovery to increase our ability to rapidly identify newly emerging pathogens 
associated with high-fatality disease outbreaks.
• Ensure the expertise, capacity, and preparedness to safely handle, identify, and control known and previously 
unidentified highly pathogenic organisms.
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B e w a r e  o f  d i s e a s e —  
T h a t  c a n  a t t a c k  y o u r  d o g !
In October 2011, the Michigan Department of Agriculture and 
Rural Development reported an outbreak of what was suspected 
to be a particularly virulent type of leptospirosis among dogs 
in the southeastern part of the state. Leptospirosis is among 
the most widespread of zoonotic diseases, which are infections 
transmitted naturally from domestic or wild animals to people.
A team from CDC was called in to help define the size of the 
outbreak, to identify likely places where the dogs were getting 
infected, and to assess health risks among animal care workers, 
veterinarians, and owners of ill dogs.
Pet owners have probably seen brochures about leptospirosis in their veterinarian’s office. It’s a bacterial 
disease that can lead— without treatment with antibiotics— to potentially fatal infections of the kidney, 
liver, brain, lung, or heart. Leptospirosis used to be rare in household pets, but in the past few years it 
has been diagnosed more frequently. It’s also found in farm animals and wildlife (rodents, raccoons, 
opossums). The bacteria that cause the disease can be spread through the urine of infected animals 
(especially rodents) and can get into water and soil and survive there for weeks. The two most common 
ways that people develop leptospirosis is drinking or swimming in contaminated water. Leptospirosis 
can also be caused by direct exposure to the urine or body fluids of infected animals.
CDC’s team worked with local public health departments in Michigan to help control the outbreak 
and prevent its spread. They contacted veterinarians and pet owners and developed a plan to collect 
samples from rodents, which were identified as the likely primary source of the infection. The team 
also developed safety guidelines for those working with pets and pests, including demonstrating how 
protective equipment— such as respiratory masks, protective eyewear, and gloves— can help reduce 
the risk of infection.
Reducing that risk is also important for pet owners. CDC encouraged pet owners to talk with their 
veterinarian about yearly shots for their dogs, which can provide better protection for owners as well as 
dogs. CDC and local partners concluded that controlling populations of rats and stray dogs will reduce 
the threat of leptospirosis.
A c c o m p l i s h m e n t s
NCEZID has successfully completed several high-impact public health research projects and response activities to 
further our prevention and control efforts. These include
• Conducting animal trials of a genetically engineered, live-attenuated Rift Valley fever vaccine for use in 
livestock. Rift Valley fever is an acute viral disease that affects domestic animals and humans. Vaccination of 
livestock will help eliminate one of the most significant sources of human infection in Africa and the Arabian 
Peninsula. (continued on the next page)
Taking action: Highly pathogenic organisms 79
NCEZID: Our Work, Our Stories 2011-2012
Z e b r a s  c a n  h a v e  m o r e  t h a n  s t r i p e s
They sometimes have rabies, as several travelers from the United 
States discovered after returning from a safari adventure in Kenya 
in late summer 2011. Many people who travel to Kenya are looking 
for close encounters with exotic animals like lions, giraffes, and 
zebras. But for several US visitors and international travelers from 
16 countries it may have been a lesson in “be careful what you wish 
for," because the lodge they chose also happened to be home to Zoe, 
an orphaned baby zebra that the lodge had adopted. Some guests 
visited Zoe in the stables where they could feed and pet her.
What the lodge and its guests did not know at the time was that Zoe 
had rabies. She was not showing signs of rabies yet but could have 
been “shedding" the rabies virus in her saliva for up to 2 weeks before she became ill. After she did show signs of illness, the staff 
thought she had a common gastrointestinal ailment. But once Zoe died, the results came back that she had died of rabies.
Because the rabies virus is transmitted through saliva, there was immediate concern. If the infected saliva entered an open wound 
or contaminated the eyes or mouth, a guest might have been exposed to rabies. CDC staff stationed in Kenya corroborated the rabies 
diagnosis. The Kenya Ministry of Health, CDC, and the World Health Organization worked quickly to track down the guests who 
might have been exposed to the deadly virus. CDC-Kenya worked with local officials and the lodge, and the team in Atlanta notified 
state health officials to contact travelers to assess for possible exposure and answer questions about the disease.
All US travelers were located for risk assessment, and 28 travelers received postexposure rabies shots. There have been no reports of 
rabies in travelers who had contact with Zoe, thanks to the quick response of the CDC and its public health partners.
A c c o m p l i s h m e n t s  (continued from previous page)
• Enabling the rapid diagnosis of Ebola hemorrhagic fever in Uganda by expanding surveillance in-country 
for viral hemorrhagic fever (VHF)— a group of diseases that include Ebola and Marburg hemorrhagic fevers. 
The expanded program included assigning a staff member to the Uganda Virus Research Institute (UVRI), 
providing training for case recognition and management for health professionals, providing reagents and 
training for diagnostic testing, and completing renovation of the VHF diagnostic laboratory at UVRI.
• Providing training for enhanced laboratory-based surveillance for monkeypox in the Democratic Republic 
of Congo (DRC). As a result, DRC has been sending monthly disease reports with laboratory samples for 
confirmation so that disease transmission dynamics can be better understood and to provide evidence for new 
disease control efforts.
• Continuing to evaluate, update, and develop recommendations for the use of medical countermeasures 
for anthrax and smallpox. For example, we completed a study to verify that alternative drugs for anthrax 
exposure can be of equal effectiveness as current first-line drugs.
• Providing training to multiple international partners in diagnosing rabies infection by a direct rapid 
immunohistochemistry test. This simple test, which requires only a standard light microscope, can provide 
local authorities with the information they need to make life-saving decisions about when to treat persons 
who have been bitten by dogs.
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W h a t ' s  n e x t ?
NCEZID continues to seek better ways to 
ensure public health and safety nationally 
and internationally through the diagnosis, 
prevention, and control of disease, disability, 
and death caused by suspected and known viral, 
bacterial, prion, and related infections. NCEZID 
will not only conduct surveillance, investigations, 
and studies of these diseases, including 
bioterrorism agents and emerging infections, but 
also will expand its focus to include— but not be 
limited to— outcomes, such as:
• Advancements in pathogen discovery
by testing for viruses in over 700 bat and 
rodent samples collected from multiple 
international study sites.
• Better medical countermeasures by
advancing applied research on smallpox/ 
orthopoxvirus medical countermeasures and 
safer vaccines.
• Enhancements to efforts to control global 
canine rabies through continued in-country 
consultations, diagnostic support, training, 
and health education to ministries of 
agriculture and health representatives.
• Expansion of MicrobeNet, a Web-based 
system that allows public health partners to 
rapidly identify unusual bacteria associated 
with individual cases or clusters of illness.
During the past century, rabies in the 
United States has changed dramatically. 
More than 90% of all animal cases reported 
annually to CDC now occur in wildlife; 
before I960 the majority of cases were 
in domestic animals. The principal rabies 
hosts today are wild carnivores and bats. ►
B i z a r r e  b i t s
CDC received a rather unusual request 
from the Virginia Department of 
Health in March 2011. We were asked 
to come to a historical museum to 
help retrieve a letter from a display 
case in an exhibit called “Bizarre 
Bits.” This letter, which had been 
sent through the mail, purportedly 
contained a highly lethal pathogen. 
Thinking the 2001 anthrax attacks? 
Different pathogen, different century.
▲ Depicts a number of what were "suspected” 
smallpox scab fragments from the archives 
of the Virginia Historical Society.
It was actually a 135-year-old smallpox vaccine scab enclosed in a letter, dated 1876, 
that a son had sent to his physician father who had requested it to make life-saving 
vaccine. The scab was not from the son but had been given to him from a Dr. Harris, 
“perfectly fresh.. .taken from an infant’s arm yesterday.” Because a smallpox scab 
even that old could potentially contain living virus, a team from CDC traveled to 
the museum to decontaminate the exhibit display case and safely transport the scab 
to CDC’s laboratory for testing. After careful examination, they concluded that the 
scab posed no infectious threat, was not smallpox virus (variola virus), and likely 
represented material from the smallpox vaccine used in the late 1800s.
Terrestrial rabies reservoirs in the United States*, 2010
*Also includes Puerto Rico, where mongoose rabies are present
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S u p p o r t i n g  t h e  p r e v e n t i o n  o f  i n f e c t i o u s  
d i s e a s e  b y  f o c u s i n g  o n . . .
▲ The Yellow Book 
is a reference for 






G l o b a l  m i g r a t i o n  a n d  q u a r a n t i n e
C u r r e n t  c h a l l e n g e s
In today’s globalized world, more than 1 billion people annually cross international borders, with more 
than 2 million traveling to or through the United States each day. In addition, about 500,000 immigrants 
and on average, 50,000 refugees come to the United States each year. Globally mobile populations, such as 
immigrants, refugees, travelers, and expatriates, face increased risk of transmission of infectious diseases, 
such as tuberculosis, intestinal parasites, and other neglected tropical diseases.
USrefugee a rriva ls ,O cto b er2010-S ep tem b er2011
These countries were the top 10 countries for US refugee arrivals for October 2010-September 2011. 
CDC provides guidelines for disease screening and treatment for refugees coming to the United States.
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W h a t  i s  C D C 's  r o l e  in  g l o b a l  m i g r a t i o n  a n d  q u a r a n t i n e ?
NCEZID improves and protects the health of international populations, such as refugees, immigrants, tourists, 
and students. Our global migration health and quarantine activities reduce infectious diseases among immigrants, 
refugees, and international travelers and prevent disease importation and spread within the United States. We also 
have a unique regulatory function in preventing disease spread in mobile populations.
To address infectious disease health risks associated with international travel and migrating populations, NCEZID
• Provides technical and regulatory oversight of health screening and post-arrival health monitoring of 
immigrant and refugee populations undergoing US resettlement.
• Modernizes regulations to ensure swift and appropriate response to events of public health significance. 
Through delegated authority, CDC has statutory responsibility for preventing the introduction, transmission, 
and spread of communicable diseases into the United States.
• Operates up to 20 quarantine 
stations across the United 
States that serve to limit the 
introduction and spread of 
infectious diseases by working 
with federal, state, and local 
partners to respond to public 
health events and develop 
comprehensive operational plans 
to manage ill and/or exposed 
travelers.
• Manages CDC’s Travelers’
Health website, one of the CDC’s 
most popular websites, with 
20-30 million hits annually.
NCEZID has specialized knowledge 
of the complex issues surrounding 
border and migration health 
and strong relationships with 
international and domestic partners. 
NCEZID has a greater impact 
by training and leveraging these 
partnerships (e.g., with 50,000 US 
Customs and Border Protection 
agents, 600 physicians who conduct 
health assessments overseas, and 
5,000 civil surgeons who assess 
vaccination status in the United 
States) to execute frontline public 
health activities.
▲ Perry Camagong, Quarantine Public Health 
officer at the Los Angeles Quarantine 
Station, grabs supplies for a response. 
Courtesy ©David Snyder/CDC Foundation
C D C  q u a r a n t i n e  
o f f i c e r s  d e f e n d  
a g a i n s t  a r r i v i n g  
h e a l t h  t h r e a t s
In August 2011, the Los Angeles 
Quarantine Station was notified 
by California public health 
officials that during air travel, an 
unvaccinated adolescent refugee 
from Malaysia was diagnosed with 
measles and contagious. Thirty refugees 
who traveled from Malaysia on the same 
flight and 35 passengers who sat near the index case-patient (the adolescent refugee) 
were now scattered over 12 states. The Los Angeles station quickly coordinated with 
other partners to find other refugees and travelers who may have been exposed. Six 
additional measles case-patients were identified following the flight. The Los Angeles 
Quarantine Station’s swift response in orchestrating the work with many partners 
helped contain what could have been a larger outbreak of measles.
As the story illustrates, CDC’s quarantine staff play a critical role in safeguarding the 
nation’s health. They work closely with first responders, public health departments, 
hospitals, airlines, and ships to take fast action when potential health threats are 
identified. CDC has 20 quarantine stations at entry points to the United States where 
most international travelers arrive.
CDC staff also train US Customs and Border Protection officers and others at airports, 
seaports, and land borders to recognize and report any symptoms in travelers that 
might represent a contagious communicable disease that could threaten the public’s 
health— for instance, severe diarrhea, fever, cough, or jaundice. These important 
partners serve as eyes and ears for the quarantine staff.
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U s i n g  n e w  m e d i a  t o  w a r n  
t r a v e l e r s  a b o u t  a n  o l d  d i s e a s e
In 2011, measles cases quadrupled in the United States, 
with 222 cases reported. Most of these people got infected 
with measles virus when they were traveling abroad; nearly 
one-half of those had traveled to Europe where there were 
more than 38,000 confirmed and suspect cases of measles. 
Most of the US travelers who got infected had not been 
vaccinated. Because travelers often do not consider infectious disease risks when traveling to Europe, CDC 
worked to develop communication messages on the need to be vaccinated before international travel.
Recognizing the need to reach travelers through social media and nontraditional communication 
channels, CDC posted a series of weekly messages on its Facebook page. Similar messages were sent out 
through Twitter and text messaging. CDC also developed an animated short of two characters discussing 
the need for measles vaccination, which was posted to its YouTube channel and promoted on Facebook. 
CDC used multiple nontraditional communication channels to creatively engage their audience and 
spread positive, science-based messages.
A c c o m p l i s h m e n t s
In fiscal years 2011 and 2012, NCEZID took steps to mitigate health risks associated with globally mobile
populations that resulted in measurable public health benefits. Examples of NCEZID’s accomplishments during
this time include
• Implementing improved tuberculosis (TB) screening and treatment of immigrants and refugees using 
Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed 
Therapy. This has resulted in a 200% increase in TB case diagnosis and treatment at an annual cost savings to 
states of greater than $30 million. Individuals identified are referred to state and local health departments for 
follow-up after arrival into the United States to prevent new cases of TB infection.
• Developing and releasing new tools for addressing travelers’ health needs: published print and electronic 
copies (including a mobile app) of CDC Health Information for International Travel 2012, also known as The 
Yellow Book, and posted a new online course, “Yellow Fever: Information for Healthcare Professionals Advising 
Travelers,” at www.cdc.gov/travel. This updated guidance better educates the public on destination-specific 
travel risks and provides useful recommendations to prevent travel-related illness.
• Assessing and revising procedures for contact tracing of commercial aviation passengers with infectious 
TB during extended flights. The revised procedures are expected to cut the number of contact investigations 
by about 50% while still detecting infected passengers. These new procedures will reduce the burden on state 
and local public health departments and free up resources for other public health priorities.
• Collaborating with other centers at CDC in investigating and responding to binational US-Mexico 
outbreaks of Legionnaires’ disease and Guillain-Barré syndrome and responding to and providing technical 
assistance for more than a dozen outbreaks of infectious diseases, including cholera, dengue fever, diphtheria, 
malaria, measles, meningitis, mumps, rubella, and varicella in refugee camps and migrant populations 
throughout Africa and Asia.
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P r o t e c t i n g  t r a v e l e r s  d u r i n g  t h e  
J a p a n e s e  n u c l e a r  d i s a s t e r
On March 11, 2011, a 9.0 magnitude earthquake occurred off the 
east coast of Japan and triggered a tsunami. These events killed 
thousands of people and caused serious, widespread damage 
to buildings, roads, and power lines. Damage to the Fukushima 
Daiichi nuclear power plant after the earthquake and tsunami 
resulted in a leak of radioactive material from this facility.
As part of CDC’s response to the Fukushima Daiichi nuclear 
disaster, NCEZID provided health information on the Travelers’
Health website for travelers leaving for or returning from Japan, 
including humanitarian aid workers, as well as for US citizens living 
in the country. US Health and Human Services Secretary Kathleen 
Sebelius personally thanked CDC’s communication team and other 
HHS staff who worked together to quickly deal with the significant 
health and communication challenges, commending them all for the 
“long hours and good work in a very difficult situation.”
During the event, CDC collaborated with the US Customs and Border Protection and the Conference of Radiation Control 
Program Directors to rapidly develop and implement a protocol for airport and maritime radiation exposure entry screening in 
the United States. During March-April 2011, approximately 353,000 travelers arriving directly from Japan were screened at 25 
US airports using this protocol. No travelers were detected with contamination sufficient to require a public health response. The 





W h a t ' s  n e x t ?
Over the next 5 years, we will to continue to safeguard the health of globally mobile populations by enhancing 
domestic and international detection and surveillance of infectious diseases using electronic information sharing. 
We will continue to strengthen partnerships and engage with partner agencies and organizations to develop, 
implement, and support measures that improve the health status of vulnerable populations, reduce health risks 
for frequent travelers and US citizens living abroad, prevent importation of communicable diseases to the United 
States, and ensure timely and effective response to public health emergencies. Primary areas of focus include
• Strengthening the Refugee Resettlement Health Program to improve efficiency and health outcomes in 
domestic and overseas refugee populations.
• Improving surveillance and response to communicable diseases in travelers, immigrants, and imported 
animals entering the United States.
• Reducing the importation of infectious diseases across the US-Mexico border by enhancing US-Mexico 
collaboration with comprehensive and systematic bi-national information sharing, coordinating to improve 
disease surveillance and control, and identifying appropriate interventions for mobile populations in the 
border region.
• Maintaining, strengthening, and expanding our international and domestic partnerships.
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S u p p o r t i n g  t h e  p r e v e n t i o n  o f  
i n f e c t i o u s  d i s e a s e  b y  f o c u s i n g  o n . . .
W a t e r b o r n e  d i s e a s e s  a n d  
w a t e r  s a f e t y
C u r r e n t  c h a l l e n g e s
Worldwide, 780 million people do not have access to safe water, and an estimated 
2.5 billion people— 50% of the developing world— lack access to adequate 
sanitation. Diarrheal diseases such as cholera kill more children than AIDS, 
malaria, and measles combined, making it the second leading cause of death 
among children under 5. Approximately 88% of deaths due to diarrheal illness are 
attributable to unsafe water, poor sanitation, and inadequate hygiene.
Despite drinking water treatment advances, an estimated 4-33 million annual 
diarrheal illness episodes still occur in the United States from exposure to 
contaminated municipal drinking water. At least 40,000 hospitalizations at a cost 
of $970 million per year result from just five waterborne diseases. In addition, we face emerging public health 
concerns such as chlorine-tolerant pathogens and the increasing complexity of waterborne diseases.
1%










*Includes neonatal deaths 
Source: Liu et al. Lancet 2012
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CDC scientist Amy Kahler 
works with a colleague, 
Bradd Haley from the 
University of Maryland, 
to sample water for 
Vibrio cholerae in a canal 
near Port-au-Prince,
Haiti, that is used as a 
drinking water source 
by the local community. 
Courtesy Bonnie Mull ►
C D C 's  " W a t e r  L a b "  l e a d s  q u e s t  
t o  f i n d  V. c h o l e r a e  i n  H a i t i
During the 2010 cholera outbreak in Haiti, CDC’s Environmental 
Microbiology Laboratory (called the “Water Lab”) led the effort 
to collect and analyze water and seafood samples for Vibrio 
cholerae. Since the initial outbreak investigation, the Water 
Lab has conducted an environmental surveillance project for 
V. cholerae and other enteric (intestinal) pathogens in Haiti.
In conjunction with the environmental surveillance field 
investigations, CDC staff have trained several laboratorians 
in the Haiti National Public Health Laboratory (LNSP) and 
have plans to further assist LNSP in developing environmental 
microbiology laboratory testing capacity.
Even 1 year after the outbreak, the CDC environmental 
surveillance project continued to detect V. cholerae in 
freshwater in Haiti. They trained LNSP on new water 
sampling testing methods for cholera, including ultrafiltration (capable of concentrating 
pathogenic bacteria, viruses, and parasites all from a single water sample) and plankton 
net sampling. Using these new sampling methods will enable LNSP and CDC staff to 
evaluate whether V. cholerae is becoming established in the Haitian environment.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  w a t e r b o r n e  d i s e a s e s ?
NCEZID’s water program has a global and a domestic component. Our global program seeks to reduce the burden 
of disease in developing countries due to unsafe water, poor sanitation, and inadequate hygiene. Our domestic 
water program focuses on surveillance and prevention to ensure healthy drinking and recreational water in the 
United States.
Globally, NCEZID provides a vital resource for testing, evaluating, and monitoring interventions to improve water 
quality and hygiene by
• Making water safe through CDC’s Safe Water System, a point-of-use/household water treatment, safe 
storage, and behavior change system being promoted in over 30 countries. Enough chlorine solution has been 
sold in 1998-2010 to treat 90 billion liters of water, which will help prevent the spread of waterborne diseases.
• Improving hygiene by measuring the impact of hand washing and improving the efficacy, sustainability, 
and integration of hygiene interventions into communities and institutions, such as schools and clinics.
• Assisting foreign governments and the UN during outbreaks of waterborne disease. In particular, CDC 
provides key surveillance, epidemiologic, laboratory, training, and WASH (water, sanitation, and hygiene) 
expertise to reduce illness and death from cholera in Haiti. (continued on the next page)
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▲ Courtesy CDC Foundation
P a c k a g i n g  p r e v e n t i o n s  p a y s  o f f
An estimated 780 million people don’t have access to an improved drinking water 
source, and 2.5 billion people— half of the developing world— lack access to adequate 
sanitation. That amounts to more than 35% of the world’s population. In countries 
like Malawi, where there is limited access to safe water and inadequate sanitation, 
there are also other health issues not related to safe water, such as a high rate of HIV.
A group of public health interventions were successfully packaged in Malawi for 
pregnant women getting services at antenatal clinics.
Guidance about proper hand washing, safe water treatment and storage practices, and 
HIV testing and counseling were integrated at the clinics into the services provided 
for their patients. An evaluation of this program revealed that, from their first visit to 
the follow-up visit after the birth of their baby, there was a significant increase in the 
percentage of women who had residual chlorine in water stored in their homes and 
who were able to demonstrate proper hand washing technique.
Success begets success: 56% of evaluation participants had four or more antenatal clinic visits, 90% delivered 
at a health facility, 99% of women and their partners were tested for HIV, and 98% had disclosed their 
status to their partner. In addition, there was an increase in the percentage of pregnant women receiving 
antiretroviral drugs (drugs that help people who are HIV-positive) and an increase in the use of antiretroviral 
medication for prevention in HIV-exposed infants.
W h a t  i s  C D C 's  r o l e  in  p r e v e n t i n g  w a t e r b o r n e  d i s e a s e s ?
(continued from previous page)
Domestically, NCEZID provides critical systems, programs, and data to better prevent waterborne disease in the
United States by
• Tracking waterborne disease and outbreaks through the national Waterborne Disease and Outbreak 
Reporting System, which identifies causes, risk factors, and trends that can be used for establishing national 
public health prevention priorities.
• Assisting state and local governments with investigations of waterborne outbreaks.
• Evaluating new methods for removing or inactivating waterborne pathogens.
• Developing and operating public health programs like CDC’s Healthy Swimming Program, the primary 
federal program to reduce the spread of infectious disease at swimming pools.
• Developing, with partners, the national Model Aquatic Health Code (MAHC), an effort to create a 
national resource to help state and local health agencies develop pool regulations and codes.
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N o v e l  v i d e o  c o n t e s t  
h e l p s  s w i m m e r s  
s t a y  h e a l t h y
In 2011, CDC’s Healthy Swimming 
Program was looking to catch a wave, 
so to speak. They needed a novel way 
to alert the public to a problem that 
had substantially increased during 
the past 20 years— recreational 
water illness (RWI) associated with 
swimming. They especially needed 
to get the word out about crypto (short for Cryptosporidium)— a germ that had 
become the leading cause of swimming pool-related outbreaks of diarrheal illness. 
Cases of crypto had increased more than 200% from 2004 to 2008. Crypto can 
stay alive for days even in well-maintained pools, and, contrary to popular belief, 
chlorine does not kill all germs (like crypto) instantly.
The Healthy Swimming Program came up with an innovative solution— a video 
contest (CDC’s first ever) which challenged the public to create 60-second videos 
that included four healthy swimming messages. A panel of CDC judges selected the 
top 5 out of 49 entries, and the public was asked to vote online for the winner.
During a 2-month period, the video contest generated a lot of interest— 56,110 
website page views, more than 475,000 Facebook impressions, 2,000-plus individual 
votes for the finalists, and approximately 10,000 views of the top five videos. The 
winning video, titled “RWI Police” was selected in late July.
There were, in fact, many winners. The Healthy Swimming Program and its state 
and local partners got high-quality, humorous, evergreen videos (including the 
four runner-up videos) that could help them continue to spread the word about 
RWIs. The Healthy Swimming Program also won some important visibility at a 
substantially reduced rate. If the program had tried to produce similar videos, the 
production costs alone would have been more than $10,000. And, most importantly, 
swimmers received useful information to help them avoid getting sick.
▲ And the winner of the 
video contest is...
RWI Police (which stands for
recreational water illness).
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A c c o m p l i s h m e n t s
NCEZID has made substantial progress in demonstrating the importance of 
water, sanitation, and hygiene-related-disease and laying the groundwork for 
prevention activities. Examples from fiscal years 2011 and 2012 include
• Response: Helped investigate the cholera outbreak in Haiti and 
reduce the mortality rate below 1% by identifying the key risk factors, 
developing tracking systems, providing clinical and community 
health worker training, providing water treatment and sanitation 
guidance, and giving laboratory assistance. These efforts have 
continued to keep disease in check, track possible resurgence, and 
prevent future transmission. We also assisted other governments with 
international outbreaks of cholera and typhoid fever. In the United 
States, CDC investigated risk factors associated with elevated levels of 
Acanthamoeba keratitis, an eye infection that can result in permanent 
visual impairment or blindness, demonstrating that inadequate hygiene 
and contact lens use are associated with this eye infection.
• Data for action: Demonstrated the efficacy and benefits of integrating safe water and hygiene supplies into 
other public health initiatives, such as HIV care packages and programs targeted at pregnant women and 
school-aged children. We also published national tracking numbers for waterborne outbreaks reported for 
2007-2008 and lessons learned from drinking water outbreaks over the past 36 years. This information can be 
used by policy makers, partners in industry and state and local health departments, and individuals to reduce 
potential risks from drinking and recreational water. NCEZID also documented that five waterborne diseases 
alone cause 40,000 annual hospitalizations that cost almost $1 billion a year. Understanding the costs of these 
diseases can help us and others focus on interventions to reduce their prevalence.
• Guidelines and information: Worked closely with partners to develop and post for public comment 14 
Model Aquatic Health Code modules. The finalized first edition will be available by the end of 2013. These 
modules, developed with partners, provide an evidence-based set of model health codes to local and state 
regulating organizations. They can be adopted as needed to help keep the public safe— from injuries as well as 
from waterborne pathogens— when they’re engaged in recreational water activities.
• Developed new detection methods: Developed a laboratory platform that uses one blood test to determine 
exposure to 17 pathogens. We also developed a new rapid sampling and concentration method for water that 
detects parasitic, viral, and bacterial contaminants.
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W h a t ' s  n e x t ?
Our focus internationally will be on expanding programs 
that have been proven to work well, continuing to 
assisting other countries on outbreak investigations, 
and exploring new technologies and interventions to 
increase access to safe water and improved hygiene. In 
the United States, our programs will focus on increasing 
surveillance for new waterborne diseases and finalizing 
the Model Aquatic Health Code project to provide an 
evidence-based health code for states and localities to 
use as appropriate.
Specific activities we are focusing on include
• Conducting a pilot intervention of ceramic 
filters to reduce the burden of cryptosporidiosis in 
household drinking water in rural Kenya.
• Testing the impact of a targeted vaccine campaign 
on control of an outbreak of typhoid fever in Uganda.
• Pilot testing CryptoNet, the first state-based 
molecular tracking system for a parasitic infection, 
cryptosporidiosis. CryptoNet will help us better 
understand the spread of cryptosporidiosis in the 
United States.
Diarrhea and Swimming
D O N 'T  M IX
If you have, or recently had, diarrhea, stay out of the water.
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N C E Z I D  in t h e  p u b l i c  e y e
N C E Z I D  i n  t h e  m e d i a
Pick up a newspaper, flip through the major news channels, or 
log onto news websites on any given day and you’re likely to find 
a handful of stories about the work that CDC staff, and more 
specifically NCEZID scientists, do.
Foodborne disease outbreaks and healthcare-associated infections 
are perennial media favorites because they are universal and may 
affect millions of people each year. After all, everyone eats and 
everyone either needs healthcare or has a loved one who does.
Media stories on our foodborne outbreak responses become 
THE story of the day for as long as the outbreaks continue. And 
reporters closely follow the twists and turns of our investigations 
into healthcare-associated outbreaks like the recent meningitis 
outbreak caused by fungus in steroid injections. Each year, they 
also cover our annual foodborne disease reports to not only provide 
the numbers but useful tips to help their audience protect themselves
Experts in NCEZID provided technical advice to the makers of the movie Contagion, 
which premiered in September 2011. Kate Winslet, who starred in the movie, is 
pictured here with technical advisor Ian Lipkin and Stuart Nichol (from the Division 
of High-Consequence Pathogens and Pathology) during a laboratory tour.
t C lL U - '
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▲ In 2011, the TV network Animal Planet's series "Killer Outbreaks” featured 
potentially deadly viruses, bacteria, and infections (including anthrax,
E. coli, hantavirus, rabies, West Nile virus, monkeypox, and Salmonella) and 
incorporated commentary from CDC experts and victims of outbreaks.
NCEZID also houses a wide variety of other 
topics that tickle the media’s interest by being 
unique, unexpected, occasionally bizarre, 
and sometimes fatal.
During 2011- 2012, these have included 
cases of Naegleria, which the media dubbed 
“brain eating ameba,” rare fungal infections 
in people injured during a tornado, a man 
who contracted anthrax while traveling 
in the upper Midwest, hepatitis outbreaks 
following unsafe surgery practices during 
transplants, evidence of people in Peru 
possibly surviving rabies exposure without 
treatment, discovery of a new phlebovirus, 
and the second-largest West Nile outbreak 
since the virus arrived in 1999.
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And it’s not just the bizarre that catches the media’s attention. Each year, we provide useful information for 
thousands of media stories that help the public stay safe and healthy. The advice makes its way into stories 
on healthy swimming, avoiding mosquito and tick bites, safely cooking and storing food, and preparing for 
international travel.
The diversity and distinctiveness of the diseases NCEZID covers helps ensure that our work will never be out of 
the media for long. We are constantly watching for and ready to respond to the next infectious disease threat, 
and the media are watching us. We never know what the next outbreak or discovery will be, but we can bet the 
media will be there ready to write, talk, and blog about it. As they do, they will continue to keep NCEZID, our 
staff, and the tremendous work we do in the public eye.
S c i e n c e  i s  n o t  j u s t  f o r  
s c i e n t i s t s  a n y m o r e
During the past 2 years, CDC has been using different forms of media to bring 
visibility to important public health issues. Recognizing that people are “hungry” 
for accurate guidance concerning their health, CDC launched Vital Signs in 
summer 2010 to shine a light on topics of special concern. Each month, Vital Signs 
takes the latest CDC science on topics, including NCEZID topics such as foodborne 
disease or healthcare-associated infections, and turns it into health information 
that is accessible, clear, and actionable for everyone. The scientific content from 
the Morbidity and Mortality Weekly Report is transformed into consumer-friendly 
fact sheets, web features, podcasts, and social media messages. In its first year, 
Vital Signs got off to a great start, with an estimated reach of approximately 4.4 
billion potential viewings through a variety of different media, hugely exceeding 
their original expectations of reaching about 1 million.
NCEZID, along with the rest of CDC, is fully embracing social media to push 
public health messages out to the broadest audience possible. Each month,
Vital Signs regularly updates its Facebook pages and Twitter feeds with messages 
such as, “Salmonella is a common culprit that can contaminate a variety of 
foods,” that cautions about foodborne disease. The Center has also participated in recent Twitter chats about 
medication safety and travel health. One of the more novel attempts to engage the public on important issues 
in public health was NCEZID’s Healthy Swimming Program contest. People were encouraged to submit creative 
videos to promote healthy swimming, and the top videos were posted on CDC’s YouTube channel.
Each month, the webcast “Public Health Grand Rounds” fosters discussion on major public health issues.
Each session focuses on key challenges related to a specific health topic, many with an infectious disease 
focus such as Lyme disease, rabies elimination, healthcare-acquired infections, and foodborne disease.
Grand Rounds explores cutting-edge scientific evidence and the potential impact of different interventions.
A new collaboration between CDC and Medscape is the CDC Expert Commentary, designed to deliver 
CDC’s authoritative guidance directly to Medscape’s physicians, nurses, pharmacists, and other healthcare 
professionals on current topics, such as the dangers of consuming raw milk and raw sprouts, Salmonella and 
Listeria contamination, Lyme disease, dangerous healthcare-acquired infections such as C. difficile, and the 
health risks in recreational water. The commentaries are also posted on CDC’s website.
94 NCEZID in the public eye: NCEZID in the media
NCEZID: Our Work, Our Stories 2011-2012
“The m ost im portan t m edical advance in the tw entieth  century m ay be that 
ordinary people were able to use science, even i f  they were n o t scientists them selves"
William Foege, MD, MPH, Senior Fellow, Global Health Program, Bill & Melinda Gates Foundation
and former Director of the Centers for Disease Control and Prevention
NCEZID also has a blog presence. The Safe Healthcare blog initiates 
conversations on a variety of topics— antibiotic use, injection and 
medication safety, and infections in dialysis clinics to name just a few. 
The Center’s work also is highlighted in the Public Health Matters 
blog. First-hand accounts of fighting cholera in Haiti, responding to a 
dengue outbreak in the remote Marshall Islands, and experiencing the 
consequences of petting rabid zebras in Kenya are a few of the blog 
posts that have been published.
Current food safetychallenges
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A  w i n n i n g  s t r a t e g y  t o  m a k e  a  
m e a s u r a b l e  i m p a c t
To keep pace with emerging public health challenges and address the leading 
causes of death and disability, CDC began work on “Winnable Battles” in fall 2010.
Winnable Battles are public health priorities, which have large-scale impact on health 
and known, effective strategies that can produce positive outcomes. The charge 
under Winnable Battles is to identify optimal strategies and rally resources and 
partnerships to achieve measurable impact quickly in a few targeted areas.
NCEZID is home to two Winnable Battles. With one in six Americans getting 
sick from contaminated food each year, reducing foodborne diseases is an 
important— and attainable— public health goal, or Winnable Battle. For example, 
during the past 15 years, a dangerous type of E. coli infection has been cut almost 
in half. But Salmonella infections, which account for $365 million in direct medical 
costs each year, have not declined. Applying lessons learned from reducing E. coli 
to reducing Salmonella could help reduce 1 million illnesses each year.
At any given time, about 1 in every 20 patients has an infection related to their 
hospital care. Healthcare-associated infections (HAIs) not only affect patient lives but also add to our 
growing healthcare costs. CDC has identified eliminating HAIs as another Winnable Battle. For example, 
if healthcare providers use CDC’s infection control steps, bloodstream infections in patients with central 
lines— one of the most deadly but also most preventable HAIs— could be significantly reduced.
Fo°d  Safety: A CDC Winnable Batti
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E m e r g i n g  I n f e c t i o u s  D i s e a s e s
Emerging Infectious Diseases'" has consistently 
ranked as one of the nation’s premier public 
health infectious disease journals since 
its founding in 1995. Widely read within 
the infectious disease community and 
expanding its reach to a broader audience, 
the journal explains factors that lead 
to emergence of new diseases; reports 
laboratory and epidemiologic findings; 
provides updates of trends and research; 
highlights developments in antimicrobial 
drugs and vaccines; and through insightful 
analysis and commentary, promotes disease 
prevention and elimination.
Always at the forefront, the journal 
tracks emergence and reemergence, 
from Schmallenberg virus and MRSA 
(methicillin-resistant Staphylococcus 
aureus) to prions and pandemic flu, and 
brings the latest information online to 
more than 60,000 subscribers. Emerging 
Infectious Diseases® reaches out to diverse 
audiences with continuing medical 
education, podcasts, and social media.
▲ Images for the cover of Emerging Infectious Diseases are selected 
for artistic quality and are drawn from many periods, ancient to 
contemporary. The covers are used to "humanize” and enhance 
the scientific content by illustrating ideas, raising consciousness, 
revealing truth, stimulating the intellect, and firing the emotions.
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K e y  p u b l i c a t i o n s
NCEZID nominated the following articles for CDC’s 2012 Shepard 
Awards, which recognize the best manuscripts reporting original research 
published by a CDC or ATSDR scientist in a reputable, peer-reviewed 
journal. Established in 1986, the Charles C. Shepard Award was named 
in honor of Charles C. Shepard, MD, the internationally recognized 
microbiologist who was chief of the Leprosy and Rickettsia Branch at 
CDC for more than 30 years, until his death in 1985.
W inner o f th e  2012  S h ep a rd  A w ard in th e  
L ab o ra to ry  Science ca teg o ry :
Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, 
Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova 
ML, Albarino CG, Nichol ST. Rift Valley fever virus vaccine lacking the 
NSs and NSm genes is safe, nonteratogenic, and confers protection from 
viremia, pyrexia, and abortion following challenge in adult and pregnant 
sheep. J Virol 2011;85:12901-9.
O th e r  n o m in ees:
▲ Barbara Knust (one of the winners of the 2012 Shepard Award in the 
Laboratory Science category) checks the temperature of a sheep during 
a Rift Valley fever vaccine trial in South Africa.
Abrams JY, Schonberger LB, Belay ED, Maddox RA, Leschek EW, Mills JL, Wysowski DK, Fradkin JE. Lower risk of 
Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol 
Metab 2011;96:E1666-9.
Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older 
Americans. N Engl J Med 2001 Nov 24;365(21):2002-12.
Cavallaro E, Date K, Medus C, Meyer S, Miller B, Kim C, Nowicki S, Cosgrove S, Sweat D, Phan Q, Flint J, Daly ER, 
Adams J, Hyytia-Trees E, Gerner-Smidt P, Hoekstra RM, Schwensohn C, Langer A, Sodha SV, Rogers MC, Angulo 
FJ, Tauxe RV, Williams IT, Behravesh CB; Salmonella Typhimurium Outbreak Investigation Team. Salmonella 
Typhimurium infections associated with peanut products. N Engl J Med 2011 Aug 18;365(7):601-10.
Dolan MC, Schulze TL, Jordan RA, Dietrich G, Schulze CJ, Hojgaard A, Ullmann AJ, Sackal C, Zeidner NS, Piesman 
J. Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in rodent reservoirs and Ixodes scapularis 
ticks using a doxycycline hyclate-laden bait. Am J Trop Med Hyg 2011 Dec;85(6):1114-20.
Ellingson K, Muder RR, Jain R, Kleinbaum D, Feng PJ, Cunningham C, Squier C, Lloyd J, Edwards J, Gebski V, 
Jernigan J. Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization 
or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol 2011 
Jan;32(1):1-8.
Gibney KB, Fischer M, Prince HE, Kramer LD, St George K, Kosoy OL, Laven JJ, Staples JE. Chikungunya fever in 
the United States: a fifteen year review of cases. Clin Infect Dis 2011 Mar 1;52(5):e121—6.
Hornstra HM, Priestley RA, Georgia SM, Kachur S, Birdsell DN, Hilsabeck R, Gates LT, Samuel JE, Heinzen RA, 
Kersh GJ, Keim P, Massung RF, Pearson T. Rapid typing of Coxiella burnetii. PLoS One 2011;6(11):e26201.
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Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila 
B, Zajdowicz MJ, Scarborough R, Lobue PA, Lardizabal AA, 
Daley CL, Reves RR, Bernardo J, Campbell BH, Whitworth WC, 
Mazurek GH. Multiple cytokines are released when blood from 
patients with tuberculosis is stimulated with Mycobacterium 
tuberculosis antigens. PLoS One. 2011;6(11):e26545.
McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball 
M, Homan C, Parkinson AJ. Elimination of hepatocellular 
carcinoma and acute hepatitis B in children 25 years after a 
hepatitis B newborn and catch-up immunization program. 
Hepatology 2011 Sep 2;54(3):801-7.
Phares CR, Kapella BK, Doney AC, Arguin PM, Green M, 
Mekonnen L, Galev A, Weinberg M, Stauffer WM. Presumptive 
treatment to reduce imported malaria among refugees from 
East Africa resettling in the United States. Am J Trop Med Hyg 
2011;85(4):612-5.
Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz 
SM, McElroy KM, McFadden JD, Binnicker MJ, Neitzel DF,
Liu G, Nicholson WL, Nelson CM, Franson JJ, Martin SA, 
Cunningham SA, Steward CR, Bogumill K, Bjorgaard ME, 
Davis JP, McQuiston JH, Warshauer DM, Wilhelm MP, Patel 
R, Trivedi VA, Eremeeva ME. Emergence of a new pathogenic 
Ehrlichia species, Wisconsin and Minnesota, 2009. N Engl J 
Med 2011 Aug 4;365(5):422-9.
Reimer AR, Van Domselaar G, Stroika S, Walker M, Kent H, Tarr C, Talkington D, Rowe L, Olsen-Rasmussen M, 
Frace M, Sammons S, Dahourou GA, Boncy J, Smith AM, Mabon P, Petkau A, Graham M, Gilmour MW, Gerner- 
Smidt P; V. cholerae Outbreak Genomics Task Force. Comparative genomics of Vibrio cholerae from Haiti, Asia, 
and Africa. Emerg Infect Dis 2011 Nov;17(11):2113-21.
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness 
acquired in the United States— major pathogens. Emerg Infect Dis 2011;17(1):7-15.
Smith SK, Self J, Weiss S, Carroll D, Braden Z, Regnery RL, Davidson W, Jordan R, Hruby DE, Damon IK. Effective 
antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox 
virus. J Virol 2011;85:9176-87.
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L a t e - b r e a k i n g  n e w s . . .
C D C  r e s p o n d s  t o  
m u l t i s t a t e  o u t b r e a k  o f  
f u n g a l  m e n i n g i t i s  a n d  
o t h e r  i n f e c t i o n s
In fall 2012, just as NCEZID: Our Work, Our Stories 2011-2012 
was in the final stage of production, NCEZID was called on 
to assist state and local health departments and the US Food 
and Drug Administration in the investigation of a large,
▲ Drs. Ben Park (left) and Tom Chiller helped lead CDC's multistate outbreak of fungal meningitis and other infections. 
investigation into the outbreak of fungal meningitis. The infections were first reported in September 2012 among 
patients who received contaminated steroid injections from the New England Compounding Center. Several 
patients suffered strokes that were believed to have resulted from their infections. The investigation also included 
infections from injections in a peripheral joint, such as a knee, shoulder, or ankle. Patients who received injections 
in peripheral joints only were not believed to be at risk for meningitis, but they could be at risk for other fungal 
infections. As of early December 2012, more than 500 cases of fungal infections and 36 deaths had been linked to 
the contaminated steroid injections.
Healthcare facilities that received three recalled lots of methylprednisolone acetate 
from New England Compounding Center on September 26,2012
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O u r  o r g a n i z a t i o n
F a c t  c h e c k
Name: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Mission: To reduce illness and death associated with emerging and zoonotic infectious diseases and to 
protect against the unintentional and intentional spread of infectious diseases
Established: 2010, as part of the Organizational Improvement initiative of 2009-2010. Two centers, the 
National Center for Preparedness, Detection, and Control of Infectious Diseases and the National Center for 
Zoonotic, Vector-borne, and Enteric Diseases, were combined to form NCEZID.
Organization: NCEZID is made up of seven divisions:
• Division of Foodborne, Waterborne, and Environmental Diseases (DFWED)
• Division of Global Migration and Quarantine (DGMQ)
• Division of High-Consequence Pathogens and Pathology (DHCPP)
• Division of Healthcare Quality Promotion (DHQP)
• Division of Preparedness and Emerging Infections (DPEI)
• Division of Scientific Resources (DSR)
• Division of Vector-Borne Diseases (DVBD)
Leadership: Beth P. Bell, MD, MPH, Director 
Staff: 1100 (approximate) full-time equivalents (FTEs)
900 (approximate) FTE staff in Atlanta
200 (approximate) FTE staff outside Atlanta (Ft. Collins, CO; Anchorage, AK;
San Juan, Puerto Rico; quarantine stations; international)
+ 900 (approximate) contract employees, students, fellows, etc.
2000  (approximate) tota l NCEZID FTE and non-FTE staff
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N C E Z I D  b u d g e t
CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) was appropriated $304.2 million 
in fiscal year (FY) 2012. In both FY 2012 and FY 2011*, $51.7 million of NCEZID’s total funding was directed 
from the Prevention and Public Health Fund. NCEZID’s FY 2012 appropriation is approximately level with its FY 
2011 appropriation; however, the FY 2013 President’s Budget proposes increases of $16.7 million for Food Safety 
and $12.6 million for the National Healthcare Safety Network (NHSN) activities. In addition, the FY13 President’s 
Budget outlined a decrease of $2.4 million for Core Infectious Diseases.
The FY13 President’s Budget consolidated several of NCEZID’s FY 2012 appropriated budget lines into one 
line entitled Core Infectious Diseases. This line reflects approximately 60% of NCEZID’s FY12 appropriation 
($184 million), and includes the following FY 2012 appropriated budget lines:
• Vector-borne diseases
• Lyme disease
• Chronic Fatigue Syndrome
• Prion
• Hanta/Special pathogens 
(renamed high-consequence pathogens)
• Emerging Infections
In addition, the Core Infectious Disease 




• Scientific resources and laboratory support
• Preparedness and emerging infections
*Fiscal year 2011 (FY 2011) began Octoberl, 2010, and ended September 30,2011. Fiscal year 2012 (FY 2012) began Octoberl, 2011, 
and ended September 30,2012.
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N C E Z I D  b u d g e t  h i s t o r y






FY 2013 PB 
+/- 
FY 2012
Emerging and Zoonotic Infectious Diseases $304.193 $304.226 $331.227 $27.001
Core Infectious Diseases $186.216 $184.657 $182.232 $(2.425)
Food Safety $25.323 $27.113 $43.848 $16.735
National Healthcare Safety Network $14.872 $14.840 $27.468 $12.628
Quarantine $26.032 $25.866 $25.929 $0.063
Epi and Lab Capacity Program (PPHF)* $40.000 $40.000 $40.000 $0
Healthcare-associated Infections (PPHF)* $11.750 $11.750 $11.750 $0
*A ffordable Care Act Appropriation; not part o f Budget Authority. (in millions)
PPHF is the abbreviation for Prevention and Public Health Fund
N C E Z I D  b u d g e t  h i s t o r y
Core Infectious Diseases 
National Healthcare Safety Network 
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I n d e x
Entries for US states reference pages that feature US maps or
provide information about specific states.
A
Acanthamoeba keratitis................................  15, 16, 90
adverse drug event................................................... 97
Aedes aegypti; Aedes albopictus
[see also: mosquitoes]...................................  29, 77; 77
Africa.............. 5, 9, 25, 27, 35, 40-42, 53, 77, 79, 84, 97-98
African Field Epidemiology Network............................ 35
Agency for Healthcare Research and Quality............ 60, 67
airline flights; airports................................  15; 4, 83, 85
Alabama (AL)..................  14, 31, 44, 49, 61, 65, 75, 81, 99
Alaska (AK); Anchorage..............................6, 11, 14, 24,
31, 44, 46, 61, 65, 74, 75, 81, 99, 101; 101
Alaska Native............................................ 6, 11, 24, 46
Alaska Native Tribal Health Consortium........................24
Amgen...................................................................60




anthrax, Bacillus anthracis.............................3, 5, 6, 10,
27, 30, 31, 33, 34, 36, 54, 78, 80, 81, 93
antibiotics................ ii, 10, 25, 27, 44, 62, 64-68, 79, 94, 95
antimicrobial agents.................................  27, 64, 66, 67
antimicrobial resistance (AR),
antimicrobial-resistant bacteria........................2, 3, 5, 10,
27, 43, 50, 64-68, 70, 100, 102
• A Public Health Action Plan to Combat 
Antimicrobial Resistance.............................  67, 68
• Action Plan (2001)............................................. 67
• Antimicrobial Use module....................................66
antitoxins...........................................................7, 34
Apangu, Titus......................................................... 25
Arabian Peninsula................................................ 9, 79
ArboNET, National Arboviral
Surveillance System......................................  48, 74, 76
arbovirus diseases................................................... 48
Arctic Investigations Program....................... 24, 46, 100
Arizona (AZ); Arizona Department of
Health Services.................................... 14, 17, 21, 23, 31,
43, 44, 49, 61, 65, 75, 76, 81, 99; 23
Arkansas (AR)  14, 15, 31, 44, 49, 50, 61, 65, 75, 81, 99
Arzate, Francisco.....................................................23
Asia........................................ 37, 39, 41, 75, 77, 84, 98
assisted living facility............................................. 5, 15
Association of Public Health Laboratories..................28, 31
Australia............................................................... 19
B
Bacillus, Bacillus anthracis...............................6, 31, 34
bacteria, bacterial disease, bacterial infection ii, 5-7,
10, 14-17, 23, 26-30, 33, 34, 36, 40, 43, 45, 56, 59, 62, 64-67,
69, 71, 73, 76, 79, 81, 87, 90, 93, 98, 100
Basic Infection Control and Prevention Plan for 
Outpatient Oncology Settings....................................60
bats.............................................. 15, 36, 37, 57, 78, 81
Bayer Chemical Company.......................................... 21
beans............................................................... 32, 70
beef.................................................................70, 72
Bell, Beth P............................................ 2, 25, 100, 101
Besser, John............................................................ 26
Besser, Richard........................................................35
Bhutan; Bhutanese refugees.............................82; 14-16
Bill & Melinda Gates Foundation............................ 35, 95
bioinformatics................................................... 28, 29
bioterrorism, biothreat agents........... 3, 6, 30, 32-34, 78, 81
biosafety level four (BSL-4) containment facilities.......... 78
birds.................................................................18, 52
bison............................................................... 34, 50
blood.................... 5, 14, 25, 29, 40, 41, 48, 60, 90, 98, 100
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I n d e x . . .  c o n t i n u e d
blood, organ, and tissue safety.............................  5, 100
bloodstream infections.................... 17, 27, 47, 61, 63, 95
borders.....................  4, 13, 14, 23, 35, 38, 82, 83, 85, 100
Boroughs, Karen...................................................... 76
Borrelia burgdorferi................................................ 97
botulism, Clostridium botulinum.....................  6, 16, 98
brain.....................................................  5, 41, 79, 93
brucellosis..............................................................51




California (CA); Los Angeles County; Los Angeles
Quarantine Station...................... 14, 15, 31, 44, 49, 61, 65,
75, 81, 83, 99; 43, 50; 83
Camagong, Perry.....................................................83
Cambodia..............................................................75
campylobacteriosis, Campylobacter............  23, 26, 67, 98
cancer....................................................15-17, 22, 60
candidiasis..............................................................4
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